Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jacob BauerDIRECTOR ELECTIONSISSUER519952.00000079098.000000FOR519952.000000FORS000005321Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas HughesDIRECTOR ELECTIONSISSUER519952.00000079098.000000FOR519952.000000FORS000005321Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Robert SusmanDIRECTOR ELECTIONSISSUER519952.00000079098.000000FOR519952.000000FORS000005321Immunovant, Inc.45258J102US45258J102508/27/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER519952.00000079098.000000FOR519952.000000FORS000005321Immunovant, Inc.45258J102US45258J102508/27/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER519952.00000079098.000000FOR519952.000000FORS000005321argenx SE04016X101US04016X101911/18/2025Approve Remuneration PolicyCOMPENSATIONISSUER103700.0000000FOR103700.000000FORS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Nevan Charles ElamDIRECTOR ELECTIONSISSUER1615679.000000660121.000000FOR1615679.000000FORS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Gil LabrucherieDIRECTOR ELECTIONSISSUER1615679.000000660121.000000FOR1615679.000000FORS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Philippe FauchetDIRECTOR ELECTIONSISSUER1615679.000000660121.000000FOR1615679.000000FORS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Nerissa KreherDIRECTOR ELECTIONSISSUER1615679.000000660121.000000WITHHOLD1615679.000000AGAINSTS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Wladimir HogenhuisDIRECTOR ELECTIONSISSUER1615679.000000660121.000000WITHHOLD1615679.000000AGAINSTS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Young-Jin KimDIRECTOR ELECTIONSISSUER1615679.000000660121.000000FOR1615679.000000FORS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Erik HarrisDIRECTOR ELECTIONSISSUER1615679.000000660121.000000WITHHOLD1615679.000000AGAINSTS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accountants for the fiscal year ending on June 30, 2026.AUDIT-RELATEDISSUER1615679.000000660121.000000FOR1615679.000000FORS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1615679.000000660121.000000AGAINST1615679.000000AGAINSTS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To approve an amendment to the 2021 Equity Incentive Plan, as amended, to increase the number of shares available for issuance thereunder from 14,450,000 shares of common stock to an aggregate of 21,950,000 shares of common stock (the "2021 Equity Plan Amendment Proposal").COMPENSATIONISSUER1615679.000000660121.000000FOR1615679.000000FORS000005321Rezolute, Inc.76200L309US76200L309611/19/2025To authorize an adjournment of the meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the Plan Amendment Proposal.CORPORATE GOVERNANCEISSUER1615679.000000660121.000000FOR1615679.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Elect Chair of MeetingCORPORATE GOVERNANCEISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Accept Financial Statements and Statutory Reports; Approve Discharge of Management and BoardCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Approve Treatment of Net LossCAPITAL STRUCTUREISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Albert Cha as DirectorDIRECTOR ELECTIONSISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Lars Holtug as DirectorDIRECTOR ELECTIONSISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Jan Moller Mikkelsen as DirectorDIRECTOR ELECTIONSISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Lisa Jane Morrison as DirectorDIRECTOR ELECTIONSISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect William Carl Fairey Jr as DirectorDIRECTOR ELECTIONSISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Siham Imani as DirectorDIRECTOR ELECTIONSISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Elect Jean-Jacques Bienaime as New DirectorDIRECTOR ELECTIONSISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Ratify Deloitte as AuditorAUDIT-RELATEDISSUER357925.00000012700.000000FOR357925.000000FORS000005321Ascendis Pharma A/SK08588103DK006061575503/23/2026Authorize Share Repurchase ProgramCAPITAL STRUCTUREISSUER357925.00000012700.000000FOR357925.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.DIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.DIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.DIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. KramerDIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.DIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish ManwaniDIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'DayDIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. RodriguezDIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony WeltersDIRECTOR ELECTIONSISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan.COMPENSATIONISSUER813900.0000000FOR813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.CORPORATE GOVERNANCESECURITY HOLDER813900.0000000AGAINST813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting.OTHER SOCIAL ISSUESSECURITY HOLDER813900.0000000AGAINST813900.000000FORS000005321Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER813900.0000000AGAINST813900.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Approve Financial Statements, Allocation of Income, and Dividends of EUR 1.45 per ShareCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Approve Remuneration ReportCOMPENSATIONISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Approve Discharge of AuditorsAUDIT-RELATEDCORPORATE GOVERNANCEISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Reelect Jean-Christophe Tellier as DirectorDIRECTOR ELECTIONSISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Reelect Cedric van Rijckevorsel as DirectorDIRECTOR ELECTIONSISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Approve Renewal of Change-of-Control Clause Re: EMTN Program - Art. 7:151 of the BCCASHAREHOLDER RIGHTS AND DEFENSESCAPITAL STRUCTUREISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Renew Authorization to Increase Share Capital within the Framework of Authorized CapitalCAPITAL STRUCTUREISSUER65200.0000000FOR65200.000000FORS000005321UCB SAB93562120BE000373953004/30/2026Authorize Share Repurchase Program and Reissuance of Repurchased SharesCAPITAL STRUCTUREISSUER65200.0000000FOR65200.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Approve Remuneration ReportCOMPENSATIONISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Approve Allocation of Income to the Retained Earnings of the CompanyCAPITAL STRUCTUREISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Approve Discharge of Executive DirectorsCORPORATE GOVERNANCEISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Approve Discharge of Non-Executive DirectorsCORPORATE GOVERNANCEISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Elect Karen Massey as Executive DirectorDIRECTOR ELECTIONSISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Elect Tim Van Hauwermeiren as Non-Executive DirectorDIRECTOR ELECTIONSISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Reelect Ana Cespedes as Non-Executive DirectorDIRECTOR ELECTIONSISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Reelect Camilla Sylvest as Non-Executive DirectorDIRECTOR ELECTIONSISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Reelect Pamela Klein as Non-Executive DirectorDIRECTOR ELECTIONSISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Grant Board Authority to Issue Shares Up to 10 Percent of Issued Capital and Limit/Exclude Preemptive RightsCAPITAL STRUCTUREISSUER53100.00000024100.000000FOR53100.000000FORS000005321argenx SE04016X101US04016X101905/06/2026Ratify Ernst & Young Accountants LLP as AuditorsAUDIT-RELATEDISSUER53100.00000024100.000000FOR53100.000000FORS000005321Moderna, Inc.60770K107US60770K107905/06/2026To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Sandra Horning, M.D.DIRECTOR ELECTIONSISSUER674300.0000000FOR674300.000000FORS000005321Moderna, Inc.60770K107US60770K107905/06/2026To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Abbas HussainDIRECTOR ELECTIONSISSUER674300.0000000FOR674300.000000FORS000005321Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER674300.0000000FOR674300.000000FORS000005321Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER674300.0000000ONE YEAR674300.000000FORS000005321Moderna, Inc.60770K107US60770K107905/06/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER674300.0000000FOR674300.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Jennifer L. DavisDIRECTOR ELECTIONSISSUER1346080.0000000FOR1346080.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Melody B. MeyerDIRECTOR ELECTIONSISSUER1346080.0000000FOR1346080.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Robert A. MichaelDIRECTOR ELECTIONSISSUER1346080.0000000FOR1346080.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Frederick H. WaddellDIRECTOR ELECTIONSISSUER1346080.0000000FOR1346080.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026AUDIT-RELATEDISSUER1346080.0000000FOR1346080.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Say on Pay - An advisory vote on the approval of executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1346080.0000000FOR1346080.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority votingCORPORATE GOVERNANCEISSUER1346080.0000000FOR1346080.000000FORS000005321AbbVie Inc.00287Y109US00287Y109105/08/2026Stockholder Proposal - to Adopt a Policy to Require an Independent ChairCORPORATE GOVERNANCESECURITY HOLDER1346080.0000000AGAINST1346080.000000FORS000005321X4 Pharmaceuticals, Inc.98420X202US98420X202705/11/2026Election of Class III Directors for terms expiring in 2029: Gary J. Bridger, Ph.D.DIRECTOR ELECTIONSISSUER1341800.0000000FOR1341800.000000FORS000005321X4 Pharmaceuticals, Inc.98420X202US98420X202705/11/2026Election of Class III Directors for terms expiring in 2029: Francoise De CraeckerDIRECTOR ELECTIONSISSUER1341800.0000000FOR1341800.000000FORS000005321X4 Pharmaceuticals, Inc.98420X202US98420X202705/11/2026Election of Class III Directors for terms expiring in 2029: Murray W. Stewart, M.D.DIRECTOR ELECTIONSISSUER1341800.0000000FOR1341800.000000FORS000005321X4 Pharmaceuticals, Inc.98420X202US98420X202705/11/2026To ratify the selection of PricewaterhouseCoopers LLC as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1341800.0000000FOR1341800.000000FORS000005321X4 Pharmaceuticals, Inc.98420X202US98420X202705/11/2026To approve the second amendment and restatement of the X4 Pharmaceuticals, Inc. 2017 Equity Incentive Plan, increasing the number of shares available for issuance under the plan.COMPENSATIONISSUER1341800.0000000AGAINST1341800.000000AGAINSTS000005321X4 Pharmaceuticals, Inc.98420X202US98420X202705/11/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1341800.0000000FOR1341800.000000FORS000005321Zenas BioPharma, Inc.05/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James BoylanDIRECTOR ELECTIONSISSUER86234.0000000FOR86234.000000FORS000005321Zenas BioPharma, Inc.05/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick EnrightDIRECTOR ELECTIONSISSUER86234.0000000FOR86234.000000FORS000005321Zenas BioPharma, Inc.05/11/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER86234.0000000FOR86234.000000FORS000005321Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James BoylanDIRECTOR ELECTIONSISSUER16.000000519300.000000FOR16.000000FORS000005321Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick EnrightDIRECTOR ELECTIONSISSUER16.000000519300.000000FOR16.000000FORS000005321Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER16.000000519300.000000FOR16.000000FORS000005321Insmed Incorporated457669307US457669307505/13/2026Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee AndersonDIRECTOR ELECTIONSISSUER489600.0000000FOR489600.000000FORS000005321Insmed Incorporated457669307US457669307505/13/2026Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D.DIRECTOR ELECTIONSISSUER489600.0000000FOR489600.000000FORS000005321Insmed Incorporated457669307US457669307505/13/2026An advisory vote on the 2025 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER489600.0000000FOR489600.000000FORS000005321Insmed Incorporated457669307US457669307505/13/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER489600.0000000FOR489600.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. AustinDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. BradwayDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. DrakeDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. DrukerDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. EckertDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. GarlandDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.DIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar IshrakDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler JacksDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. KlotmanDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. KullmanDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. MilesDIRECTOR ELECTIONSISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER150703.0000000FOR150703.000000FORS000005321Amgen Inc.031162100US031162100905/19/2026Stockholder proposal to require an independent board chairman.CORPORATE GOVERNANCESECURITY HOLDER150703.0000000AGAINST150703.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Roy BaynesDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Suzanne BruhnDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Timothy CoughlinDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Eric DubeDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Gary LyonsDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Jeffrey MecklerDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: John OrwinDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Sandra PooleDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ron SquarerDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ruth Williams-BrinkleyDIRECTOR ELECTIONSISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares.COMPENSATIONISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER301200.0000000FOR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER301200.0000000ONE YEAR301200.000000FORS000005321Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER301200.0000000FOR301200.000000FORS000005321Viking Therapeutics, Inc.92686J106US92686J106005/19/2026ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): J. Matthew SingletonDIRECTOR ELECTIONSISSUER232037.000000218150.000000WITHHOLD232037.000000AGAINSTS000005321Viking Therapeutics, Inc.92686J106US92686J106005/19/2026ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): S. Kathryn Rouan, Ph.D.DIRECTOR ELECTIONSISSUER232037.000000218150.000000WITHHOLD232037.000000AGAINSTS000005321Viking Therapeutics, Inc.92686J106US92686J106005/19/2026TO RATIFY THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER232037.000000218150.000000FOR232037.000000FORS000005321Viking Therapeutics, Inc.92686J106US92686J106005/19/2026TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER232037.000000218150.000000FOR232037.000000FORS000005321Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Stuart A. ArbuckleDIRECTOR ELECTIONSISSUER339486.0000000FOR339486.000000FORS000005321Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Yvonne L. Greenstreet, M.D.DIRECTOR ELECTIONSISSUER339486.0000000FOR339486.000000FORS000005321Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Elliott Sigal, M.D., Ph.D.DIRECTOR ELECTIONSISSUER339486.0000000FOR339486.000000FORS000005321Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER339486.0000000FOR339486.000000FORS000005321Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER339486.0000000FOR339486.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Jacqueline E. Shea, Ph.D.DIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Simon X. BenitoDIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Roger D. Dansey, M.D.DIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Ann C. Miller, M.D.DIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Jay P. ShepardDIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: David B. Weiner, Ph.D.DIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Wendy L. YarnoDIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To elect the following directors to serve for a term ending upon the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Lota S. ZothDIRECTOR ELECTIONSISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To approve, on a non-binding advisory basis, the resolution regarding compensation of our named executive officers described in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER704481.000000178600.000000FOR704481.000000FORS000005321Inovio Pharmaceuticals, Inc.45773H409US45773H409205/20/2026To approve an amendment and restatement of our Amended and Restated 2023 Omnibus Incentive Plan.COMPENSATIONISSUER704481.000000178600.000000FOR704481.000000FORS000005321Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay KangoDIRECTOR ELECTIONSISSUER303062.000000427000.000000FOR303062.000000FORS000005321Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeDIRECTOR ELECTIONSISSUER303062.000000427000.000000FOR303062.000000FORS000005321Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D.DIRECTOR ELECTIONSISSUER303062.000000427000.000000FOR303062.000000FORS000005321Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To approve, on an advisory basis, the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER303062.000000427000.000000FOR303062.000000FORS000005321Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER303062.000000427000.000000FOR303062.000000FORS000005321Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D.DIRECTOR ELECTIONSISSUER331100.0000000WITHHOLD331100.000000AGAINSTS000005321Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H.DIRECTOR ELECTIONSISSUER331100.0000000WITHHOLD331100.000000AGAINSTS000005321Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne KarydasDIRECTOR ELECTIONSISSUER331100.0000000FOR331100.000000FORS000005321Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER331100.0000000FOR331100.000000FORS000005321Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.DIRECTOR ELECTIONSISSUER90671.000000192400.000000FOR90671.000000FORS000005321Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D.DIRECTOR ELECTIONSISSUER90671.000000192400.000000FOR90671.000000FORS000005321Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Nancy J. WysenskiDIRECTOR ELECTIONSISSUER90671.000000192400.000000FOR90671.000000FORS000005321Cytokinetics, Incorporated23282W605US23282W605705/27/2026To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock.COMPENSATIONISSUER90671.000000192400.000000FOR90671.000000FORS000005321Cytokinetics, Incorporated23282W605US23282W605705/27/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER90671.000000192400.000000FOR90671.000000FORS000005321Cytokinetics, Incorporated23282W605US23282W605705/27/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER90671.000000192400.000000FOR90671.000000FORS000005321Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Mark McKennaDIRECTOR ELECTIONSISSUER825789.00000021600.000000FOR825789.000000FORS000005321Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Cameron Turtle, D.Phil.DIRECTOR ELECTIONSISSUER825789.00000021600.000000FOR825789.000000FORS000005321Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Laurie StelzerDIRECTOR ELECTIONSISSUER825789.00000021600.000000FOR825789.000000FORS000005321Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER825789.00000021600.000000FOR825789.000000FORS000005321Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER825789.00000021600.000000FOR825789.000000FORS000005321Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To approve the Company's amended and restated 2016 Employee Stock Purchase Plan.COMPENSATIONISSUER825789.00000021600.000000FOR825789.000000FORS000005321Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. DableDIRECTOR ELECTIONSISSUER332100.00000022100.000000FOR332100.000000FORS000005321Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E.DIRECTOR ELECTIONSISSUER332100.00000022100.000000FOR332100.000000FORS000005321Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert MoreDIRECTOR ELECTIONSISSUER332100.00000022100.000000FOR332100.000000FORS000005321Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER332100.00000022100.000000FOR332100.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. BiggarDIRECTOR ELECTIONSISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley ColeDIRECTOR ELECTIONSISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. QuartDIRECTOR ELECTIONSISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025.CORPORATE GOVERNANCEISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025.COMPENSATIONISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve the Company's UK Statutory Directors' Remuneration Policy.COMPENSATIONISSUER417600.0000000FOR417600.000000FORS000005321Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER417600.0000000FOR417600.000000FORS000005321Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Sean P. NolanDIRECTOR ELECTIONSISSUER244400.000000695400.000000FOR244400.000000FORS000005321Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Laura Sepp-Lorenzino, Ph.D.DIRECTOR ELECTIONSISSUER244400.000000695400.000000FOR244400.000000FORS000005321Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026.AUDIT-RELATEDISSUER244400.000000695400.000000FOR244400.000000FORS000005321Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER244400.000000695400.000000FOR244400.000000FORS000005321Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER244400.000000695400.000000ONE YEAR244400.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To elect the seven directors nominated by our board of directors and named herein to hold office until the 2027 Annual Meeting of Stockholders: Michael HeffernanDIRECTOR ELECTIONSISSUER133200.000000225100.000000FOR133200.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To elect the seven directors nominated by our board of directors and named herein to hold office until the 2027 Annual Meeting of Stockholders: Garry Neil, M.D.DIRECTOR ELECTIONSISSUER133200.000000225100.000000FOR133200.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To elect the seven directors nominated by our board of directors and named herein to hold office until the 2027 Annual Meeting of Stockholders: Rita Jain, M.D.DIRECTOR ELECTIONSISSUER133200.000000225100.000000FOR133200.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To elect the seven directors nominated by our board of directors and named herein to hold office until the 2027 Annual Meeting of Stockholders: Aaron KantoffDIRECTOR ELECTIONSISSUER133200.000000225100.000000FOR133200.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To elect the seven directors nominated by our board of directors and named herein to hold office until the 2027 Annual Meeting of Stockholders: Gilla Kaplan, Ph.D.DIRECTOR ELECTIONSISSUER133200.000000225100.000000FOR133200.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To elect the seven directors nominated by our board of directors and named herein to hold office until the 2027 Annual Meeting of Stockholders: Kevin LindDIRECTOR ELECTIONSISSUER133200.000000225100.000000FOR133200.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To elect the seven directors nominated by our board of directors and named herein to hold office until the 2027 Annual Meeting of Stockholders: Samantha TruexDIRECTOR ELECTIONSISSUER133200.000000225100.000000FOR133200.000000FORS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To approve the Avalo Therapeutics, Inc. Second Amended and Restated 2016 Employee Stock Purchase Plan;COMPENSATIONISSUER133200.000000225100.000000AGAINST133200.000000AGAINSTS000005321Avalo Therapeutics, Inc.05338F306US05338F306406/02/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER133200.000000225100.000000FOR133200.000000FORS000005321Crescent Biopharma, Inc.G2545C104KYG2545C104206/02/2026Election of Class II Director for term expiring at the 2029 Annual General Meeting of Shareholders or until their successor is duly elected and qualified or until their earlier death, resignation, disqualification or removal: Susan Moran, M.D., MSCEDIRECTOR ELECTIONSISSUER349390.0000000FOR349390.000000FORS000005321Crescent Biopharma, Inc.G2545C104KYG2545C104206/02/2026To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Crescent Biopharma, Inc. for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER349390.0000000FOR349390.000000FORS000005321Crescent Biopharma, Inc.G2545C104KYG2545C104206/02/2026To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc. 's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER349390.0000000FOR349390.000000FORS000005321Crescent Biopharma, Inc.G2545C104KYG2545C104206/02/2026To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve compensation for Crescent Biopharma, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER349390.0000000ONE YEAR349390.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors.AUDIT-RELATEDISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: John W. Smither until the 2030 annual general meetingDIRECTOR ELECTIONSISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Janneke van der Kamp until the 2030 annual general meetingDIRECTOR ELECTIONSISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital.CAPITAL STRUCTUREISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Extension of authorization for the Board of Directors to limit or exclude pre-emption rights.CAPITAL STRUCTUREISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER4800.000000581600.000000FOR4800.000000FORS000005321NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Non-binding, advisory vote to approve the 2025 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4800.000000581600.000000FOR4800.000000FORS000005321Oruka Therapeutics, Inc.687604108US687604108706/02/2026Election of Class II Directors for terms expiring in 2029: Lawrence KleinDIRECTOR ELECTIONSISSUER737386.0000000FOR737386.000000FORS000005321Oruka Therapeutics, Inc.687604108US687604108706/02/2026Election of Class II Directors for terms expiring in 2029: Chris MartinDIRECTOR ELECTIONSISSUER737386.0000000FOR737386.000000FORS000005321Oruka Therapeutics, Inc.687604108US687604108706/02/2026To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER737386.0000000FOR737386.000000FORS000005321Oruka Therapeutics, Inc.687604108US687604108706/02/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER737386.0000000FOR737386.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Election of Directors: June Almenoff, MD, PhDDIRECTOR ELECTIONSISSUER322600.0000000FOR322600.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Election of Directors: Michael Davidson, MDDIRECTOR ELECTIONSISSUER322600.0000000FOR322600.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Election of Directors: Declan Doogan, MDDIRECTOR ELECTIONSISSUER322600.0000000FOR322600.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Election of Directors: Christopher T. GiordanoDIRECTOR ELECTIONSISSUER322600.0000000FOR322600.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Election of Directors: Robyn M. HunterDIRECTOR ELECTIONSISSUER322600.0000000FOR322600.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Election of Directors: Gerald T. ProehlDIRECTOR ELECTIONSISSUER322600.0000000FOR322600.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Election of Directors: Stuart Rich, MDDIRECTOR ELECTIONSISSUER322600.0000000FOR322600.000000FORS000005321Tenax Therapeutics, Inc.88032L605US88032L605606/02/2026Ratification of the appointment of Cherry Bekaert LLP as the independent registered public accounting firm of Tenax Therapeutics, Inc. for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER322600.0000000FOR322600.000000FORS000005321Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Tomas KiselakDIRECTOR ELECTIONSISSUER1782464.0000000FOR1782464.000000FORS000005321Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jennifer K. MosesDIRECTOR ELECTIONSISSUER1782464.0000000FOR1782464.000000FORS000005321Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1782464.0000000FOR1782464.000000FORS000005321Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1782464.0000000FOR1782464.000000FORS000005321Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1782464.0000000ONE YEAR1782464.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn SvoronosDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian CannonDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven GannonDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth GarofaloDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin GoverDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick MachadoDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian MortimerDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary PatouDIRECTOR ELECTIONSISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER456458.0000000ONE YEAR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve the Corporation's 2026 Equity Incentive Plan;COMPENSATIONISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To appoint PricewaterhouseCoopers LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation;AUDIT-RELATEDISSUER456458.0000000FOR456458.000000FORS000005321Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation; andAUDIT-RELATEDISSUER456458.0000000FOR456458.000000FORS000005321Neurogene Inc.64135M105US64135M105306/03/2026Election of Class III Directors for terms expiring in 2029: Robert Baffi, Ph.D.DIRECTOR ELECTIONSISSUER143057.000000100643.000000FOR143057.000000FORS000005321Neurogene Inc.64135M105US64135M105306/03/2026Election of Class III Directors for terms expiring in 2029: Rohan PalekarDIRECTOR ELECTIONSISSUER143057.000000100643.000000FOR143057.000000FORS000005321Neurogene Inc.64135M105US64135M105306/03/2026To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER143057.000000100643.000000FOR143057.000000FORS000005321Neurogene Inc.64135M105US64135M105306/03/2026To ratify on an advisory (non-binding) basis the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER143057.000000100643.000000FOR143057.000000FORS000005321Neurogene Inc.64135M105US64135M105306/03/2026To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years.SECTION 14A SAY-ON-PAY VOTESISSUER143057.000000100643.000000ONE YEAR143057.000000FORS000005321Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: G. Clare Kahn, Ph.D.DIRECTOR ELECTIONSISSUER317700.0000000FOR317700.000000FORS000005321Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D.DIRECTOR ELECTIONSISSUER317700.0000000WITHHOLD317700.000000AGAINSTS000005321Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne SmithDIRECTOR ELECTIONSISSUER317700.0000000WITHHOLD317700.000000AGAINSTS000005321Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER317700.0000000FOR317700.000000FORS000005321Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER317700.0000000AGAINST317700.000000AGAINSTS000005321Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D.DIRECTOR ELECTIONSISSUER2433200.0000000FOR2433200.000000FORS000005321Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul FonteyneDIRECTOR ELECTIONSISSUER2433200.0000000FOR2433200.000000FORS000005321Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER2433200.0000000FOR2433200.000000FORS000005321Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2433200.0000000FOR2433200.000000FORS000005321CG Oncology, Inc.156944100US156944100906/04/2026To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina RossiDIRECTOR ELECTIONSISSUER157700.0000000FOR157700.000000FORS000005321CG Oncology, Inc.156944100US156944100906/04/2026To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr.DIRECTOR ELECTIONSISSUER157700.0000000FOR157700.000000FORS000005321CG Oncology, Inc.156944100US156944100906/04/2026To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER157700.0000000FOR157700.000000FORS000005321CG Oncology, Inc.156944100US156944100906/04/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER157700.0000000FOR157700.000000FORS000005321CG Oncology, Inc.156944100US156944100906/04/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER157700.0000000ONE YEAR157700.000000FORS000005321MBX Biosciences, Inc.55287L101US55287L101706/04/2026Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. HeronDIRECTOR ELECTIONSISSUER292700.00000011900.000000FOR292700.000000FORS000005321MBX Biosciences, Inc.55287L101US55287L101706/04/2026Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. MathersDIRECTOR ELECTIONSISSUER292700.00000011900.000000FOR292700.000000FORS000005321MBX Biosciences, Inc.55287L101US55287L101706/04/2026Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2026.AUDIT-RELATEDISSUER292700.00000011900.000000FOR292700.000000FORS000005321Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David HallalDIRECTOR ELECTIONSISSUER68.000000271500.000000FOR68.000000FORS000005321Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Kristina BurowDIRECTOR ELECTIONSISSUER68.000000271500.000000FOR68.000000FORS000005321Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Michael GilmanDIRECTOR ELECTIONSISSUER68.000000271500.000000FOR68.000000FORS000005321Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie PengDIRECTOR ELECTIONSISSUER68.000000271500.000000FOR68.000000FORS000005321Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER68.000000271500.000000FOR68.000000FORS000005321Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER68.000000271500.000000FOR68.000000FORS000005321Tango Therapeutics, Inc.87583X109US87583X109006/04/2026Election of Class II Directors: Malte Peters, M.D.DIRECTOR ELECTIONSISSUER349826.00000053800.000000FOR349826.000000FORS000005321Tango Therapeutics, Inc.87583X109US87583X109006/04/2026Election of Class II Directors: Kanishka PothulaDIRECTOR ELECTIONSISSUER349826.00000053800.000000FOR349826.000000FORS000005321Tango Therapeutics, Inc.87583X109US87583X109006/04/2026Election of Class II Directors: Mace Rothenberg, M.D.DIRECTOR ELECTIONSISSUER349826.00000053800.000000FOR349826.000000FORS000005321Tango Therapeutics, Inc.87583X109US87583X109006/04/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER349826.00000053800.000000FOR349826.000000FORS000005321Tango Therapeutics, Inc.87583X109US87583X109006/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER349826.00000053800.000000FOR349826.000000FORS000005321Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026Election of Directors: Mark SaadDIRECTOR ELECTIONSISSUER35800.0000000FOR35800.000000FORS000005321Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026Election of Directors: Susan Mahony, Ph.D., MBADIRECTOR ELECTIONSISSUER35800.0000000FOR35800.000000FORS000005321Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER35800.0000000FOR35800.000000FORS000005321Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35800.0000000FOR35800.000000FORS000005321Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David LubnerDIRECTOR ELECTIONSISSUER459000.00000023000.000000FOR459000.000000FORS000005321Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Brian PosnerDIRECTOR ELECTIONSISSUER459000.00000023000.000000FOR459000.000000FORS000005321Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason RhodesDIRECTOR ELECTIONSISSUER459000.00000023000.000000FOR459000.000000FORS000005321Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To vote, on an advisory basis, to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER459000.00000023000.000000FOR459000.000000FORS000005321Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares.CAPITAL STRUCTUREISSUER459000.00000023000.000000FOR459000.000000FORS000005321Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation.CORPORATE GOVERNANCEISSUER459000.00000023000.000000FOR459000.000000FORS000005321Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER459000.00000023000.000000FOR459000.000000FORS000005321Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Election of Directors: Timothy A. Springer, Ph.D.DIRECTOR ELECTIONSISSUER72895.00000048100.000000WITHHOLD72895.000000AGAINSTS000005321Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Election of Directors: Stefan Vitorovic, M.S., M.B.A.DIRECTOR ELECTIONSISSUER72895.00000048100.000000FOR72895.000000FORS000005321Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER72895.00000048100.000000FOR72895.000000FORS000005321Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Advisory approval of the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER72895.00000048100.000000FOR72895.000000FORS000005321Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: Mark C. McKennaDIRECTOR ELECTIONSISSUER452639.0000000FOR452639.000000FORS000005321Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: Jennifer FoxDIRECTOR ELECTIONSISSUER452639.0000000FOR452639.000000FORS000005321Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: William (BJ) Jones, Jr.DIRECTOR ELECTIONSISSUER452639.0000000FOR452639.000000FORS000005321Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER452639.0000000FOR452639.000000FORS000005321Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER452639.0000000FOR452639.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. FreireDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. HawkinsDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. LangerDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. MantasDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd MinorDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas PangalosDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish PatolawalaDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. RowinskyDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. SherwinDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. ViehbacherDIRECTOR ELECTIONSISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER294100.0000000FOR294100.000000FORS000005321Biogen Inc.09062X103US09062X103706/09/2026Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER294100.0000000FOR294100.000000FORS000005321Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris CainDIRECTOR ELECTIONSISSUER1834818.0000000FOR1834818.000000FORS000005321Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. MorrisDIRECTOR ELECTIONSISSUER1834818.0000000FOR1834818.000000FORS000005321Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd ShegogDIRECTOR ELECTIONSISSUER1834818.0000000FOR1834818.000000FORS000005321Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1834818.0000000FOR1834818.000000FORS000005321Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1834818.0000000FOR1834818.000000FORS000005321Enliven Therapeutics, Inc.06/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Richard Fair, M.B.A.DIRECTOR ELECTIONSISSUER73200.0000000FOR73200.000000FORS000005321Enliven Therapeutics, Inc.06/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D.DIRECTOR ELECTIONSISSUER73200.0000000FOR73200.000000FORS000005321Enliven Therapeutics, Inc.06/09/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER73200.0000000FOR73200.000000FORS000005321Enliven Therapeutics, Inc.06/09/2026To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares.CAPITAL STRUCTUREISSUER73200.0000000FOR73200.000000FORS000005321Enliven Therapeutics, Inc.06/09/2026To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER73200.0000000FOR73200.000000FORS000005321Enliven Therapeutics, Inc.06/09/2026To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER73200.0000000ONE YEAR73200.000000FORS000005321Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Richard Fair, M.B.A.DIRECTOR ELECTIONSISSUER325562.0000003300.000000FOR325562.000000FORS000005321Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D.DIRECTOR ELECTIONSISSUER325562.0000003300.000000FOR325562.000000FORS000005321Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER325562.0000003300.000000FOR325562.000000FORS000005321Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares.CAPITAL STRUCTUREISSUER325562.0000003300.000000FOR325562.000000FORS000005321Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER325562.0000003300.000000FOR325562.000000FORS000005321Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER325562.0000003300.000000ONE YEAR325562.000000FORS000005321Jade Biosciences, Inc.008064206US008064206106/09/2026To elect two Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Christopher Cain, Ph.D.DIRECTOR ELECTIONSISSUER582543.000000311800.000000FOR582543.000000FORS000005321Jade Biosciences, Inc.008064206US008064206106/09/2026To elect two Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Tom FrohlichDIRECTOR ELECTIONSISSUER582543.000000311800.000000FOR582543.000000FORS000005321Jade Biosciences, Inc.008064206US008064206106/09/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER582543.000000311800.000000FOR582543.000000FORS000005321Jade Biosciences, Inc.008064206US008064206106/09/2026To approve an amendment to our Articles of Incorporation to waive jury trials in certain circumstances; andCORPORATE GOVERNANCEISSUER582543.000000311800.000000FOR582543.000000FORS000005321Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. IngramDIRECTOR ELECTIONSISSUER1028900.0000000FOR1028900.000000FORS000005321Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Claire Mazumdar, Ph.D.DIRECTOR ELECTIONSISSUER1028900.0000000FOR1028900.000000FORS000005321Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER1028900.0000000FOR1028900.000000FORS000005321Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER1028900.0000000FOR1028900.000000FORS000005321Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000; andCAPITAL STRUCTUREISSUER1028900.0000000FOR1028900.000000FORS000005321Upstream Bio, Inc.91678A107US91678A107906/09/2026To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSISSUER691003.0000000FOR691003.000000FORS000005321Upstream Bio, Inc.91678A107US91678A107906/09/2026To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: Liam Ratcliffe, M.B.Ch.B., Ph.D.DIRECTOR ELECTIONSISSUER691003.0000000FOR691003.000000FORS000005321Upstream Bio, Inc.91678A107US91678A107906/09/2026To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER691003.0000000FOR691003.000000FORS000005321Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory NordenDIRECTOR ELECTIONSISSUER67900.0000000FOR67900.000000FORS000005321Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio SouzaDIRECTOR ELECTIONSISSUER67900.0000000FOR67900.000000FORS000005321Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungDIRECTOR ELECTIONSISSUER67900.0000000FOR67900.000000FORS000005321Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER67900.0000000FOR67900.000000FORS000005321Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.SECTION 14A SAY-ON-PAY VOTESISSUER67900.0000000FOR67900.000000FORS000005321Solid Biosciences Inc.83422E204US83422E204606/10/2026Election of Class II Directors: Clare KahnDIRECTOR ELECTIONSISSUER677565.0000000FOR677565.000000FORS000005321Solid Biosciences Inc.83422E204US83422E204606/10/2026Election of Class II Directors: Adam StoneDIRECTOR ELECTIONSISSUER677565.0000000FOR677565.000000FORS000005321Solid Biosciences Inc.83422E204US83422E204606/10/2026Election of Class II Directors: Lynne SullivanDIRECTOR ELECTIONSISSUER677565.0000000FOR677565.000000FORS000005321Solid Biosciences Inc.83422E204US83422E204606/10/2026The ratification of the appointment of Ilan Ganot, on an advisory basis, to the Company's Board of Directors as a Class I Director to hold office until the 2028 annual meeting of stockholders.CORPORATE GOVERNANCEISSUER677565.0000000FOR677565.000000FORS000005321Solid Biosciences Inc.83422E204US83422E204606/10/2026The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER677565.0000000FOR677565.000000FORS000005321Solid Biosciences Inc.83422E204US83422E204606/10/2026The approval of an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 240,000,000 to 480,000,000.CAPITAL STRUCTUREISSUER677565.0000000FOR677565.000000FORS000005321Solid Biosciences Inc.83422E204US83422E204606/10/2026The approval of an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER677565.0000000FOR677565.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Adoption of the 2025 Dutch statutory annual accounts for the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Reappointment of Madhavan Balachandran as non-executive director.DIRECTOR ELECTIONSISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Reappointment of Jack Kaye as non-executive director.DIRECTOR ELECTIONSISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Reappointment of Leonard Post, Ph.D. as non-executive director.DIRECTOR ELECTIONSISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Designation of the Board as the competent body to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares.CAPITAL STRUCTUREISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Designation of the Board as the competent body to exclude or limit preemptive rights upon the issuance of Ordinary Shares.CAPITAL STRUCTUREISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Reauthorization of the Board to repurchase Ordinary Shares.CAPITAL STRUCTUREISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Appointment of KPMG Accountants N.V. as external auditor of the Company for the fiscal year 2026.AUDIT-RELATEDISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER223500.0000000ONE YEAR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan.COMPENSATIONISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the amendment to the Articles of Association to reflect Dutch large company regime.CORPORATE GOVERNANCEISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the amendment to the Articles of Association to increase the authorized share capital and number of Ordinary Shares.CAPITAL STRUCTUREISSUER223500.0000000FOR223500.000000FORS000005321uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the amendment to the Articles of Association to include a federal forum selection provision.SHAREHOLDER RIGHTS AND DEFENSESCORPORATE GOVERNANCEISSUER223500.0000000FOR223500.000000FORS000005321Annexon, Inc.03589W102US03589W102706/11/2026To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Bettina M. Cockroft, M.D.DIRECTOR ELECTIONSISSUER1661500.0000000FOR1661500.000000FORS000005321Annexon, Inc.03589W102US03589W102706/11/2026To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Douglas Love, Esq.DIRECTOR ELECTIONSISSUER1661500.0000000FOR1661500.000000FORS000005321Annexon, Inc.03589W102US03589W102706/11/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1661500.0000000FOR1661500.000000FORS000005321Annexon, Inc.03589W102US03589W102706/11/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1661500.0000000FOR1661500.000000FORS000005321Annexon, Inc.03589W102US03589W102706/11/2026To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000.CAPITAL STRUCTUREISSUER1661500.0000000FOR1661500.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Robert BarrowDIRECTOR ELECTIONSISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D.DIRECTOR ELECTIONSISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D.DIRECTOR ELECTIONSISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: David GryskaDIRECTOR ELECTIONSISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Andreas KrebsDIRECTOR ELECTIONSISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Carol A. ValloneDIRECTOR ELECTIONSISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger AdsettDIRECTOR ELECTIONSISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders.AUDIT-RELATEDISSUER254100.0000000FOR254100.000000FORS000005321Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares.COMPENSATIONISSUER254100.0000000AGAINST254100.000000AGAINSTS000005321Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Natasha HerndayDIRECTOR ELECTIONSISSUER320385.0000000FOR320385.000000FORS000005321Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Eric DobmeierDIRECTOR ELECTIONSISSUER320385.0000000FOR320385.000000FORS000005321Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER320385.0000000FOR320385.000000FORS000005321Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER320385.0000000FOR320385.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Rowan ChapmanDIRECTOR ELECTIONSISSUER89400.0000000FOR89400.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Herm RosenmanDIRECTOR ELECTIONSISSUER89400.0000000FOR89400.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Jonathan SheenaDIRECTOR ELECTIONSISSUER89400.0000000FOR89400.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class I Nominee: Eric H. RubinDIRECTOR ELECTIONSISSUER89400.0000000FOR89400.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER89400.0000000FOR89400.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER89400.0000000FOR89400.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER89400.0000000ONE YEAR89400.000000FORS000005321Natera, Inc.632307104US632307104206/11/2026To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated.COMPENSATIONISSUER89400.0000000AGAINST89400.000000AGAINSTS000005321Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D.DIRECTOR ELECTIONSISSUER763629.0000000FOR763629.000000FORS000005321Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Halley Gilbert, J.D.DIRECTOR ELECTIONSISSUER763629.0000000FOR763629.000000FORS000005321Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Grant E. Pickering, M.B.A.DIRECTOR ELECTIONSISSUER763629.0000000FOR763629.000000FORS000005321Vaxcyte, Inc.92243G108US92243G108506/15/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER763629.0000000FOR763629.000000FORS000005321Vaxcyte, Inc.92243G108US92243G108506/15/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER763629.0000000FOR763629.000000FORS000005321Nuvalent, Inc.670703107US670703107506/16/2026Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D.DIRECTOR ELECTIONSISSUER412264.0000000FOR412264.000000FORS000005321Nuvalent, Inc.670703107US670703107506/16/2026Election of the following nominees as Class II directors: Ron SquarerDIRECTOR ELECTIONSISSUER412264.0000000FOR412264.000000FORS000005321Nuvalent, Inc.670703107US670703107506/16/2026To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER412264.0000000FOR412264.000000FORS000005321Nuvalent, Inc.670703107US670703107506/16/2026To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER412264.0000000FOR412264.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Matthew P. YoungDIRECTOR ELECTIONSISSUER2229051.0000000FOR2229051.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Elaine V. Jones, Ph.D.DIRECTOR ELECTIONSISSUER2229051.0000000FOR2229051.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER2229051.0000000FOR2229051.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares;CAPITAL STRUCTUREISSUER2229051.0000000FOR2229051.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan;COMPENSATIONISSUER2229051.0000000FOR2229051.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated Employee Stock Purchase Plan;COMPENSATIONISSUER2229051.0000000FOR2229051.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; andSECTION 14A SAY-ON-PAY VOTESISSUER2229051.0000000FOR2229051.000000FORS000005321CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2229051.0000000ONE YEAR2229051.000000FORS000005321Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026Election of Class III director nominees to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Michael LandsittelDIRECTOR ELECTIONSISSUER205542.00000092600.000000FOR205542.000000FORS000005321Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026Election of Class III director nominees to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Cameron Turtle, D. Phil.DIRECTOR ELECTIONSISSUER205542.00000092600.000000FOR205542.000000FORS000005321Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER205542.00000092600.000000FOR205542.000000FORS000005321Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026To conduct an advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER205542.00000092600.000000ONE YEAR205542.000000FORS000005321Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER205542.00000092600.000000FOR205542.000000FORS000005321Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Sean Bohen, M.D., Ph.D.DIRECTOR ELECTIONSISSUER777200.0000000FOR777200.000000FORS000005321Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Scott GarlandDIRECTOR ELECTIONSISSUER777200.0000000FOR777200.000000FORS000005321Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Yi LarsonDIRECTOR ELECTIONSISSUER777200.0000000FOR777200.000000FORS000005321Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Andrew RappaportDIRECTOR ELECTIONSISSUER777200.0000000FOR777200.000000FORS000005321Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER777200.0000000FOR777200.000000FORS000005321Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER777200.0000000FOR777200.000000FORS000005321Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Ted W. Love, M.D.DIRECTOR ELECTIONSISSUER481200.0000000FOR481200.000000FORS000005321Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Raymond Stevens, Ph.D.DIRECTOR ELECTIONSISSUER481200.0000000FOR481200.000000FORS000005321Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Daniel G. WelchDIRECTOR ELECTIONSISSUER481200.0000000FOR481200.000000FORS000005321Structure Therapeutics Inc.86366E106US86366E106406/17/2026To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER481200.0000000FOR481200.000000FORS000005321Structure Therapeutics Inc.86366E106US86366E106406/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER481200.0000000FOR481200.000000FORS000005321Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren DeardorfDIRECTOR ELECTIONSISSUER544470.0000000FOR544470.000000FORS000005321Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D.DIRECTOR ELECTIONSISSUER544470.0000000FOR544470.000000FORS000005321Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S.DIRECTOR ELECTIONSISSUER544470.0000000FOR544470.000000FORS000005321Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER544470.0000000FOR544470.000000FORS000005321Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; andSECTION 14A SAY-ON-PAY VOTESISSUER544470.0000000FOR544470.000000FORS000005321Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.DIRECTOR ELECTIONSISSUER142322.0000000FOR142322.000000FORS000005321Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D.DIRECTOR ELECTIONSISSUER142322.0000000FOR142322.000000FORS000005321Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D.DIRECTOR ELECTIONSISSUER142322.0000000FOR142322.000000FORS000005321Disc Medicine, Inc.254604101US254604101106/18/2026To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER142322.0000000FOR142322.000000FORS000005321Disc Medicine, Inc.254604101US254604101106/18/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER142322.0000000FOR142322.000000FORS000005321Revolution Medicines, Inc.76155X100US76155X100006/18/2026To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis BorisyDIRECTOR ELECTIONSISSUER299500.0000000FOR299500.000000FORS000005321Revolution Medicines, Inc.76155X100US76155X100006/18/2026To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Mark A. Goldsmith, M.D., Ph.D.DIRECTOR ELECTIONSISSUER299500.0000000FOR299500.000000FORS000005321Revolution Medicines, Inc.76155X100US76155X100006/18/2026To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER299500.0000000FOR299500.000000FORS000005321Revolution Medicines, Inc.76155X100US76155X100006/18/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER299500.0000000FOR299500.000000FORS000005321MapLight Therapeutics, Inc.56565P103US56565P103006/23/2026To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin BablerDIRECTOR ELECTIONSISSUER60500.000000142400.000000FOR60500.000000FORS000005321MapLight Therapeutics, Inc.56565P103US56565P103006/23/2026To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Troy CoxDIRECTOR ELECTIONSISSUER60500.000000142400.000000FOR60500.000000FORS000005321MapLight Therapeutics, Inc.56565P103US56565P103006/23/2026To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: George PavlovDIRECTOR ELECTIONSISSUER60500.000000142400.000000FOR60500.000000FORS000005321MapLight Therapeutics, Inc.56565P103US56565P103006/23/2026To ratify the appointment by the Audit Committee of our Board of Directors of RSM US LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER60500.000000142400.000000FOR60500.000000FORS000005321Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Bruce Booth, D.Phil.DIRECTOR ELECTIONSISSUER231700.0000000FOR231700.000000FORS000005321Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Nello Mainolfi, Ph.D.DIRECTOR ELECTIONSISSUER231700.0000000FOR231700.000000FORS000005321Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Maraganore, Ph.D.DIRECTOR ELECTIONSISSUER231700.0000000FOR231700.000000FORS000005321Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFADIRECTOR ELECTIONSISSUER231700.0000000FOR231700.000000FORS000005321Kymera Therapeutics, Inc.501575104US501575104406/24/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER231700.0000000FOR231700.000000FORS000005321Kymera Therapeutics, Inc.501575104US501575104406/24/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER231700.0000000FOR231700.000000FORS000005321Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirrDIRECTOR ELECTIONSISSUER126200.0000000FOR126200.000000FORS000005321Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David P. Meeker, M.D.DIRECTOR ELECTIONSISSUER126200.0000000FOR126200.000000FORS000005321Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER126200.0000000FOR126200.000000FORS000005321Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER126200.0000000FOR126200.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Harry H. Penner, Jr.DIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Anthony S. MarucciDIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Keith L. BrownlieDIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Cheryl L. CohenDIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Herbert J. ConradDIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Rita I. Jain, M.D.DIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: James J. MarinoDIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Garry A. Neil, M.D.DIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Denice TorresDIRECTOR ELECTIONSISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan.COMPENSATIONISSUER340152.0000000FOR340152.000000FORS000005321Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER340152.0000000FOR340152.000000FORS000005321Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: James B. Tananbaum, M.D.DIRECTOR ELECTIONSISSUER330600.0000000FOR330600.000000FORS000005321Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Lynn Tetrault, J.D.DIRECTOR ELECTIONSISSUER330600.0000000FOR330600.000000FORS000005321Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D.DIRECTOR ELECTIONSISSUER330600.0000000FOR330600.000000FORS000005321Alumis Inc.022307102US022307102006/30/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER330600.0000000FOR330600.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Consolidated Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Treatment of LossesCAPITAL STRUCTUREISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Non-Deductible ExpensesCAPITAL STRUCTUREISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Transaction with Samsara BioCapital, L.P. Re: Subscription of Shares Through Stock OptionsCORPORATE GOVERNANCEISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Compensation of Mark Pruzanski, Chairman of the BoardSECTION 14A SAY-ON-PAY VOTESISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Compensation of Frederic Cren, CEO until September 30, 2025SECTION 14A SAY-ON-PAY VOTESISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Compensation of Andrew Obenshain, CEO from October 1, 2025SECTION 14A SAY-ON-PAY VOTESISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Compensation of Pierre Broqua, Vice-CEO until June 30, 2025SECTION 14A SAY-ON-PAY VOTESISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Compensation Report of Corporate OfficersCOMPENSATIONISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Remuneration Policy of Mark Pruzanski, Chairman of the BoardCOMPENSATIONISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Remuneration Policy of Andrew Obenshain, CEOCOMPENSATIONISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Remuneration of Directors in the Aggregate Amount of EUR 1.5 MillionCOMPENSATIONISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Remuneration Policy of DirectorsCOMPENSATIONISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Reelect Renee Aguiar-Lucander as DirectorDIRECTOR ELECTIONSISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Reelect Heinz Maeusli as DirectorDIRECTOR ELECTIONSISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Elect Camilla Soenderby as DirectorDIRECTOR ELECTIONSISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Elect Anne Prener as DirectorDIRECTOR ELECTIONSISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Elect Barbara Krebs-Pohl as DirectorDIRECTOR ELECTIONSISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Repurchase of Up to 10 Percent of Issued Share CapitalCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Decrease in Share Capital via Cancellation of Repurchased SharesCAPITAL STRUCTUREISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 2 MillionCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 2 MillionCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Issuance of Equity or Equity-Linked Securities for Private Placements up to Aggregate Nominal Amount of EUR 1 MillionCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries up to Aggregate Nominal Amount of EUR 2 MillionCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Issuance of Equity or Equity-Linked Securities Reserved for One or More Specifically Designated Persons up to Aggregate Nominal Amount of EUR 1 MillionCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries in the Framework of an Equity Line on the American Market (ATM), up to Aggregate Nominal Amount of EUR 1 MillionCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 22-27CAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Capital Increase of Up to EUR 1 Million for Future Exchange OffersCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in KindCAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Capital Issuances for Use in Employee Stock Purchase PlansCOMPENSATIONISSUER685400.0000000FOR685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Capitalization of Reserves of Up to EUR 40,000 for Bonus Issue or Increase in Par ValueCAPITAL STRUCTUREISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize up to 8.1 Percent of Issued Capital for Use in Restricted Stock PlansCOMPENSATIONISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize up to 8.1 Percent of Issued Capital for Use in Stock Option PlansCOMPENSATIONISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Approve Issuance of Warrants (BSA 2026) without Preemptive Rights Reserved for Specific Beneficiaries, up to 8.1 Percent of Issued CapitalCOMPENSATIONISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Confirm Decline in Shareholder Equity to Below Half the Nominal Value of Company's Issued Capital; Oppose Liquidation of CompanyCAPITAL STRUCTUREISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Amend Article 26 of Bylaws to Incorporate Legal Changes Re: Record DateCORPORATE GOVERNANCEISSUER685400.0000000FOR685400.000000FORS000005321Inventiva SA46124U107US46124U107906/30/2026Amend Article 23 of Bylaws Re: Number of CensorsCORPORATE GOVERNANCEISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Issuance of Warrants without Preemptive Rights Reserved for the European Investment Bank, up to Aggregate Nominal Amount of EUR 156,775.73CAPITAL STRUCTUREISSUER685400.0000000AGAINST685400.000000AGAINSTS000005321Inventiva SA46124U107US46124U107906/30/2026Authorize Filing of Required Documents/Other FormalitiesCORPORATE GOVERNANCEISSUER685400.0000000FOR685400.000000FORS000005321Snowflake Inc.833445109US833445109807/02/2025Election of Class II Directors for terms expiring in 2028: Kelly A. KramerDIRECTOR ELECTIONSISSUER347833.0000000WITHHOLD347833.000000AGAINSTS000005322Snowflake Inc.833445109US833445109807/02/2025Election of Class II Directors for terms expiring in 2028: Frank SlootmanDIRECTOR ELECTIONSISSUER347833.0000000WITHHOLD347833.000000AGAINSTS000005322Snowflake Inc.833445109US833445109807/02/2025Election of Class II Directors for terms expiring in 2028: Michael L. SpeiserDIRECTOR ELECTIONSISSUER347833.0000000WITHHOLD347833.000000AGAINSTS000005322Snowflake Inc.833445109US833445109807/02/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER347833.0000000AGAINST347833.000000AGAINSTS000005322Snowflake Inc.833445109US833445109807/02/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2026.AUDIT-RELATEDISSUER347833.0000000FOR347833.000000FORS000005322Snowflake Inc.833445109US833445109807/02/2025To approve an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors.SHAREHOLDER RIGHTS AND DEFENSESISSUER347833.0000000FOR347833.000000FORS000005322Snowflake Inc.833445109US833445109807/02/2025To approve an amendment to our Amended and Restated Certificate of Incorporation to remove references to Class B common stock and rename Class A common stock to common stock.CAPITAL STRUCTURECORPORATE GOVERNANCEISSUER347833.0000000FOR347833.000000FORS000005322GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Tim BreenDIRECTOR ELECTIONSISSUER4102104.0000000WITHHOLD4102104.000000AGAINSTS000005322GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Thomas CaulfieldDIRECTOR ELECTIONSISSUER4102104.0000000WITHHOLD4102104.000000AGAINSTS000005322GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Glenda DorchakDIRECTOR ELECTIONSISSUER4102104.0000000FOR4102104.000000FORS000005322GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Camilla LanguilleDIRECTOR ELECTIONSISSUER4102104.0000000WITHHOLD4102104.000000AGAINSTS000005322GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Ratify PricewaterhouseCoopers LLP as AuditorsAUDIT-RELATEDISSUER4102104.0000000FOR4102104.000000FORS000005322monday.com Ltd.M7S64H106IL001176213007/31/2025Reelect Roy Mann as DirectorDIRECTOR ELECTIONSISSUER68524.0000000FOR68524.000000FORS000005322monday.com Ltd.M7S64H106IL001176213007/31/2025Reelect Gili Iohan as DirectorDIRECTOR ELECTIONSISSUER68524.0000000FOR68524.000000FORS000005322monday.com Ltd.M7S64H106IL001176213007/31/2025Reelect Ronen Faier as DirectorDIRECTOR ELECTIONSISSUER68524.0000000FOR68524.000000FORS000005322monday.com Ltd.M7S64H106IL001176213007/31/2025Reappoint Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER68524.0000000FOR68524.000000FORS000005322Pine Labs Ltd.09/29/2025Accept Financial Statements and Statutory ReportsOTHERPrivate company-related matterISSUER3056330.0000000FOR3056330.000000FORS000005322Pine Labs Ltd.09/29/2025Elect Bairavarasu Amrish Rau as DirectorOTHERPrivate company-related matterISSUER3056330.0000000FOR3056330.000000FORS000005322Pine Labs Ltd.09/29/2025Elect Shailendra Jit Singh as DirectorOTHERPrivate company-related matterISSUER3056330.0000000FOR3056330.000000FORS000005322Pine Labs Ltd.09/29/2025Approve Appointment of Bairavarasu Amrish Rau as Managing Director and CEOOTHERPrivate company-related matterISSUER3056330.0000000FOR3056330.000000FORS000005322Pine Labs Ltd.09/29/2025Approve Payment of Remuneration to Bairavarasu Amrish Rau as Managing Director and CEOOTHERPrivate company-related matterISSUER3056330.0000000FOR3056330.000000FORS000005322Meesho Limited09/30/2025Accept Standalone Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER3048996.0000000FOR3048996.000000FORS000005322Meesho Limited09/30/2025Accept Consolidated Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER3048996.0000000FOR3048996.000000FORS000005322Meesho Limited09/30/2025Reelect Sanjeev Kumar as DirectorDIRECTOR ELECTIONSISSUER3048996.0000000FOR3048996.000000FORS000005322Meesho Limited09/30/2025Approve Revision in Remuneration of Vidit Aatrey as Chairman, Managing Director & CEODIRECTOR ELECTIONSCOMPENSATIONISSUER3048996.0000000FOR3048996.000000FORS000005322Meesho Limited09/30/2025Approve Revision in Remuneration of Sanjeev Kumar as Whole-time Director & Chief Technology OfficerDIRECTOR ELECTIONSCOMPENSATIONISSUER3048996.0000000FOR3048996.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Mark W. AdamsDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Shankar ArumugaveluDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Prat S. BhattDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Michael R. CannonDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Richard L. ClemmerDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Yolanda L. ConyersDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Jay L. GeldmacherDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Dylan G. HaggartDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: William D. MosleyDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Thomas A. SzlosekDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Election of Directors: Stephanie TileniusDIRECTOR ELECTIONSISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Approve, in an Advisory, Non-binding Vote, the Compensation of the Company's Named Executive Officers ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Approve a Non-binding Ratification of the Appointment of Ernst & Young LLP as the Independent Auditors for the Fiscal Year Ending July 3, 2026 and Binding Authorization of the Audit and Finance Committee to Set Auditors' Remuneration.AUDIT-RELATEDISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Approve the Amended and Restated Employee Stock Purchase Plan.COMPENSATIONISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Approve the Amended and Restated 2022 Equity Incentive Plan.COMPENSATIONISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Grant the Board Authority to Allot and Issue Shares.CAPITAL STRUCTUREISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Grant the Board Authority to Opt-out of Statutory Pre-emption Rights.CAPITAL STRUCTUREISSUER401355.0000000FOR401355.000000FORS000005322Seagate Technology Holdings plcG7997R103IE00BKVD2N4910/25/2025Determine the Price Range for the Re-allotment of Treasury Shares.CAPITAL STRUCTUREISSUER401355.0000000FOR401355.000000FORS000005322CyberArk Software Ltd.M2682V108IL001133446811/13/2025Approve Merger AgreementEXTRAORDINARY TRANSACTIONSISSUER190000.0000000FOR190000.000000FORS000005322CyberArk Software Ltd.M2682V108IL001133446811/13/2025Approve 2024 Share Incentive PlanCOMPENSATIONISSUER190000.0000000FOR190000.000000FORS000005322CyberArk Software Ltd.M2682V108IL001133446811/13/2025Vote FOR if You Are NOT: A) PANW, Merger Sub or Holder of 25% or more of the Voting Power/CEO or Director Appointment Rights; B) Acting on Their Behalf; C) Their Family Member/Controlled Entity (Collectively "Bidco Affiliate")OTHERProcedural matterISSUER190000.0000000FOR190000.000000NONES000005322Sandisk Corporation80004C200US80004C200811/18/2025Election of Directors: Richard B. Cassidy IIDIRECTOR ELECTIONSISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Election of Directors: Thomas CaulfieldDIRECTOR ELECTIONSISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Election of Directors: David V. GoeckelerDIRECTOR ELECTIONSISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Election of Directors: Devinder KumarDIRECTOR ELECTIONSISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Election of Directors: Necip SayinerDIRECTOR ELECTIONSISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Election of Directors: Ellyn J. ShookDIRECTOR ELECTIONSISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Election of Directors: Miyuki SuzukiDIRECTOR ELECTIONSISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER437581.0000000FOR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Approval on an advisory basis of the frequency of future advisory votes on named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER437581.0000000ONE YEAR437581.000000FORS000005322Sandisk Corporation80004C200US80004C200811/18/2025Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2026.AUDIT-RELATEDISSUER437581.0000000FOR437581.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Kimberly E. AlexyDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Martin I. ColeDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Tunc DolucaDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Bruce E. KiddooDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Matthew E. MassengillDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Roxanne OulmanDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Stephanie A. StreeterDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Irving TanDIRECTOR ELECTIONSISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Approval of the amendment and restatement of our 2005 Employee Stock Purchase Plan to increase by 8 million the number of shares of our common stock available for issuance under that plan.COMPENSATIONISSUER1361143.0000000FOR1361143.000000FORS000005322Western Digital Corporation958102105US958102105511/20/2025Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2026.AUDIT-RELATEDISSUER1361143.0000000FOR1361143.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Reid G. HoffmanDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Hugh F. JohnstonDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Teri L. ListDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Catherine MacGregorDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Mark A. L. MasonDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Satya NadellaDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Sandra E. PetersonDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Penny S. PritzkerDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: John David RaineyDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Charles W. ScharfDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: John W. StantonDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Election of Directors: Emma N. WalmsleyDIRECTOR ELECTIONSISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote")SECTION 14A SAY-ON-PAY VOTESISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Ratification of the Selection of Deloitte & Touche LLP as our Independent Auditor for Fiscal Year 2026AUDIT-RELATEDISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Approval of the Microsoft Corporation 2026 Stock PlanCOMPENSATIONISSUER1869800.0000000FOR1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025European Security Program Censorship Risk AuditOTHER SOCIAL ISSUESSECURITY HOLDER1869800.0000000AGAINST1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Report on Risks of Censorship in Generative Artificial IntelligenceOTHER SOCIAL ISSUESSECURITY HOLDER1869800.0000000AGAINST1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Report on Al Data Usage OversightOTHER SOCIAL ISSUESSECURITY HOLDER1869800.0000000AGAINST1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Report on Data Operations in Human Rights HotspotsHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER1869800.0000000AGAINST1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Report on Human Rights Due DiligenceHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER1869800.0000000AGAINST1869800.000000FORS000005322Microsoft Corporation594918104US594918104512/05/2025Report on Al and Machine Learning Tools for Oil and Gas Development and ProductionOTHER SOCIAL ISSUESSECURITY HOLDER1869800.0000000AGAINST1869800.000000FORS000005322ServiceNow, Inc.81762P102US81762P102112/05/2025To approve an amended and restated certificate of incorporation to effect a 5-for-1 split of ServiceNow, Inc.'s common stock with a proportionate increase in authorized shares of common stock.CAPITAL STRUCTUREISSUER205234.0000000FOR205234.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Michael D. CapellasDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Mark GarrettDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: John D. Harris IIDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Dr. Kristina M. JohnsonDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Sarah Rae MurphyDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Charles H. RobbinsDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Daniel H. SchulmanDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Marianna TesselDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Election of Directors: Kevin WeilDIRECTOR ELECTIONSISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Approval of the amendment and restatement of the 2005 Stock Incentive Plan.COMPENSATIONISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Approval, on an advisory basis, of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Ratification of PricewaterhouseCoopers LLP as Cisco's independent registered public accounting firm for fiscal 2026.AUDIT-RELATEDISSUER5050500.0000000FOR5050500.000000FORS000005322Cisco Systems, Inc.17275R102US17275R102312/16/2025Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER5050500.0000000AGAINST5050500.000000FORS000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Cheng LuDIRECTOR ELECTIONSISSUER0.0000000S000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Mo ChenDIRECTOR ELECTIONSISSUER0.0000000S000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director James LuDIRECTOR ELECTIONSISSUER0.0000000S000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Zhen TaoDIRECTOR ELECTIONSISSUER0.0000000S000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Albert SchultzDIRECTOR ELECTIONSISSUER0.0000000S000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Jianan HaoDIRECTOR ELECTIONSISSUER0.0000000S000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Ratify UHY LLP as AuditorsAUDIT-RELATEDISSUER0.0000000S000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Carson MitchellDIRECTOR ELECTIONSSECURITY HOLDER86300.0000000FOR86300.000000AGAINSTS000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Douglas E. LuteDIRECTOR ELECTIONSSECURITY HOLDER86300.0000000FOR86300.000000AGAINSTS000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Danil KerimiDIRECTOR ELECTIONSSECURITY HOLDER86300.0000000FOR86300.000000AGAINSTS000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Abbot CooperDIRECTOR ELECTIONSSECURITY HOLDER86300.0000000FOR86300.000000AGAINSTS000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Elect Director Ben AppelDIRECTOR ELECTIONSSECURITY HOLDER86300.0000000FOR86300.000000AGAINSTS000005322CreateAI Holdings Inc.90089L108US90089L108912/29/2025Ratify UHY LLP as AuditorsAUDIT-RELATEDISSUER86300.0000000FOR86300.000000FORS000005322Zscaler, Inc.98980G102US98980G102201/12/2026To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, subject to their earlier death, resignation or removal: Andrew BrownDIRECTOR ELECTIONSISSUER164500.0000000FOR164500.000000FORS000005322Zscaler, Inc.98980G102US98980G102201/12/2026To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, subject to their earlier death, resignation or removal: Scott DarlingDIRECTOR ELECTIONSISSUER164500.0000000FOR164500.000000FORS000005322Zscaler, Inc.98980G102US98980G102201/12/2026To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, subject to their earlier death, resignation or removal: David SchneiderDIRECTOR ELECTIONSISSUER164500.0000000FOR164500.000000FORS000005322Zscaler, Inc.98980G102US98980G102201/12/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending July 31, 2026.AUDIT-RELATEDISSUER164500.0000000FOR164500.000000FORS000005322Zscaler, Inc.98980G102US98980G102201/12/2026To approve on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER164500.0000000FOR164500.000000FORS000005322Zscaler, Inc.98980G102US98980G102201/12/2026To approve on a non-binding, advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER164500.0000000ONE YEAR164500.000000FORS000005322Zscaler, Inc.98980G102US98980G102201/12/2026To vote on a non-binding stockholder proposal requesting the declassification of our board of directors.SHAREHOLDER RIGHTS AND DEFENSESSECURITY HOLDER164500.0000000FOR164500.000000AGAINSTS000005322Pine Labs Ltd.Y697DC105INE15B70101802/13/2026Ratification and Amendment of Pine Labs Employee Stock Option Plan 2025COMPENSATIONISSUER3056330.0000000AGAINST3056330.000000AGAINSTS000005322Pine Labs Ltd.Y697DC105INE15B70101802/13/2026Approve Extension of Benefits of Pine Labs Employee Stock Option Plan 2025 to Employees of the Subsidiary CompaniesCOMPENSATIONISSUER3056330.0000000AGAINST3056330.000000AGAINSTS000005322Pine Labs Ltd.Y697DC105INE15B70101802/13/2026Approve Appointment of Makarand M Joshi & Co. as Secretarial Auditor and Authorize the Board to Fix their RemunerationCOMPENSATIONCORPORATE GOVERNANCEISSUER3056330.0000000FOR3056330.000000FORS000005322Pine Labs Ltd.Y697DC105INE15B70101802/13/2026Approve Pledging of Assets for DebtCAPITAL STRUCTUREISSUER3056330.0000000FOR3056330.000000FORS000005322National Grid Plc636274409US636274409507/09/2025Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Approve Final DividendCAPITAL STRUCTUREISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Paula Reynolds as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect John Pettigrew as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Andy Agg as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Jacqui Ferguson as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Ian Livingston as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Iain Mackay as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Anne Robinson as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Earl Shipp as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Jonathan Silver as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Tony Wood as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Re-elect Martha Wyrsch as DirectorDIRECTOR ELECTIONSISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Reappoint Deloitte LLP as AuditorsAUDIT-RELATEDISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise the Audit & Risk Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Approve Remuneration PolicyCOMPENSATIONISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Approve Remuneration ReportCOMPENSATIONISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise UK Political Donations and ExpenditureOTHER SOCIAL ISSUESISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Approve Increase in Borrowing LimitCAPITAL STRUCTUREOTHERDebt RelatedISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Approve Scrip Dividend SchemeCAPITAL STRUCTUREISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise Directors to Capitalise the Appropriate Nominal Amounts of New Shares of the Company Allotted Pursuant to the Company's Scrip Dividend SchemeCAPITAL STRUCTUREISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise Issue of EquityCAPITAL STRUCTUREISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise Issue of Equity without Pre-emptive RightsCAPITAL STRUCTUREISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital InvestmentCAPITAL STRUCTUREISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise Market Purchase of Ordinary SharesCAPITAL STRUCTUREISSUER4693.000000121200.000000FOR4693.000000FORS000005323National Grid Plc636274409US636274409507/09/2025Authorise the Company to Call General Meeting with Two Weeks' NoticeCORPORATE GOVERNANCEISSUER4693.000000121200.000000FOR4693.000000FORS000005323TXNM Energy, Inc.69349H107US69349H107708/28/2025Approve the Agreement and Plan of Merger, dated as of May 18, 2025, (the merger agreement) by and among TXNM Energy, Inc. (TXNM), Troy ParentCo LLC, and Troy Merger Sub Inc.EXTRAORDINARY TRANSACTIONSISSUER317277.0000000FOR317277.000000FORS000005323TXNM Energy, Inc.69349H107US69349H107708/28/2025Approve, by non-binding, advisory vote, certain compensation arrangements for TXNM's named executive officers in connection with the merger contemplated by the merger agreement.SECTION 14A SAY-ON-PAY VOTESISSUER317277.0000000FOR317277.000000FORS000005323TXNM Energy, Inc.69349H107US69349H107708/28/2025Approve one or more adjournments of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the merger agreement.CORPORATE GOVERNANCEISSUER317277.0000000FOR317277.000000FORS000005323Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director Brian HillDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director Jennifer WongDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director John E. CurrieDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director Nicholas (Nick) DrakeDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director David LabistourDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director Frank Douglas (Doug) MackDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director Marni PayneDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director Glen SenkDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Elect Director Marcia SmithDIRECTOR ELECTIONSISSUER83300.0000000FOR83300.000000FORS000005324Aritzia Inc.04045U102CA04045U102107/08/2025Approve PricewaterhouseCoopers LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER83300.0000000FOR83300.000000FORS000005324Capri Holdings LimitedG1890L107VGG1890L107608/07/2025Election of Directors: Judy GibbonsDIRECTOR ELECTIONSISSUER71700.0000000FOR71700.000000FORS000005324Capri Holdings LimitedG1890L107VGG1890L107608/07/2025Election of Directors: Jane ThompsonDIRECTOR ELECTIONSISSUER71700.0000000FOR71700.000000FORS000005324Capri Holdings LimitedG1890L107VGG1890L107608/07/2025To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 28, 2026.AUDIT-RELATEDISSUER71700.0000000FOR71700.000000FORS000005324Capri Holdings LimitedG1890L107VGG1890L107608/07/2025To approve, on a non-binding advisory basis, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER71700.0000000FOR71700.000000FORS000005324Capri Holdings LimitedG1890L107VGG1890L107608/07/2025To approve, on a non-binding advisory basis, the frequency of future advisory votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER71700.0000000ONE YEAR71700.000000FORS000005324Capri Holdings LimitedG1890L107VGG1890L107608/07/2025To approve the Capri Holdings Limited Fourth Amended and Restated Omnibus Incentive Plan.COMPENSATIONISSUER71700.0000000FOR71700.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Cynthia (Cindy) L. DavisDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: David A. BurwickDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Stefano CarotiDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Nelson C. ChanDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Juan R. FiguereoDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Patrick J. GrismerDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Maha S. IbrahimDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Victor LuisDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Lauri M. ShanahanDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025Election of Directors: Bonita C. StewartDIRECTOR ELECTIONSISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025To ratify the selection of KPMG LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER40892.0000000FOR40892.000000FORS000005324Deckers Outdoor Corporation243537107US243537107309/08/2025To approve, on a non-binding advisory basis, the compensation of our Named Executive Officers, as described in the section of the Proxy Statement entitled "Compensation Discussion and Analysis."SECTION 14A SAY-ON-PAY VOTESISSUER40892.0000000FOR40892.000000FORS000005324NIKE, Inc.654106103US654106103109/09/2025Class B director nominees: To elect a Board of Directors for the ensuing year: Monica GilDIRECTOR ELECTIONSISSUER121972.0000000FOR121972.000000FORS000005324NIKE, Inc.654106103US654106103109/09/2025Class B director nominees: To elect a Board of Directors for the ensuing year: John Rogers, Jr.DIRECTOR ELECTIONSISSUER121972.0000000FOR121972.000000FORS000005324NIKE, Inc.654106103US654106103109/09/2025Class B director nominees: To elect a Board of Directors for the ensuing year: Robert SwanDIRECTOR ELECTIONSISSUER121972.0000000FOR121972.000000FORS000005324NIKE, Inc.654106103US654106103109/09/2025To approve executive compensation by an advisory vote.SECTION 14A SAY-ON-PAY VOTESISSUER121972.0000000FOR121972.000000FORS000005324NIKE, Inc.654106103US654106103109/09/2025To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm.AUDIT-RELATEDISSUER121972.0000000FOR121972.000000FORS000005324NIKE, Inc.654106103US654106103109/09/2025To approve the NIKE, Inc. Stock Incentive Plan, as amended and restated.COMPENSATIONISSUER121972.0000000FOR121972.000000FORS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER138632.0000000FOR138632.000000FORS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Approve the Remuneration ReportCOMPENSATIONISSUER138632.0000000AGAINST138632.000000AGAINSTS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Elect Gary Hendrickson as DirectorDIRECTOR ELECTIONSISSUER138632.0000000FOR138632.000000FORS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Elect Jesse Singh as DirectorDIRECTOR ELECTIONSISSUER138632.0000000FOR138632.000000FORS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Elect Howard Heckes as DirectorDIRECTOR ELECTIONSISSUER138632.0000000AGAINST138632.000000AGAINSTS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Elect Peter John Davis as DirectorDIRECTOR ELECTIONSISSUER138632.0000000AGAINST138632.000000AGAINSTS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Elect Anne Lloyd as DirectorDIRECTOR ELECTIONSISSUER138632.0000000AGAINST138632.000000AGAINSTS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Elect Rada Rodriguez as DirectorDIRECTOR ELECTIONSISSUER138632.0000000AGAINST138632.000000AGAINSTS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Authorize Board to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER138632.0000000FOR138632.000000FORS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Approve Grant of Return on Capital Employed Restricted Stock Units to Aaron ErterCOMPENSATIONISSUER138632.0000000FOR138632.000000FORS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Approve Grant of Relative Total Shareholder Return Restricted Stock Units to Aaron ErterCOMPENSATIONISSUER138632.0000000FOR138632.000000FORS000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Approve Issuance of Securities under the James Hardie 2020 Non-Executive Director Equity PlanCOMPENSATIONISSUER138632.0000000FOR138632.000000NONES000005324James Hardie Industries PlcG4253H119AU000000JHX110/29/2025Approve Increase in Non-Executive Director Fee PoolCOMPENSATIONISSUER138632.0000000FOR138632.000000NONES000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Ira EhrenpreisDIRECTOR ELECTIONSISSUER208970.0000000AGAINST208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Joe GebbiaDIRECTOR ELECTIONSISSUER208970.0000000AGAINST208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Kathleen Wilson-ThompsonDIRECTOR ELECTIONSISSUER208970.0000000AGAINST208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER208970.0000000AGAINST208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan.COMPENSATIONISSUER208970.0000000FOR208970.000000FORS000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for approval of the 2025 CEO Performance Award.COMPENSATIONISSUER208970.0000000AGAINST208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for the ratification of the appointment of PricewaterhouseCoopers LLP as Tesla's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER208970.0000000FOR208970.000000FORS000005324Tesla, Inc.88160R101US88160R101411/06/2025A Tesla proposal for adoption of amendments to certificate of formation and bylaws to eliminate applicable supermajority voting requirements.CORPORATE GOVERNANCEISSUER208970.0000000FOR208970.000000NONES000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal regarding Board authorization of an investment in xAl.CORPORATE GOVERNANCESECURITY HOLDER208970.0000000ABSTAIN208970.000000NONES000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal regarding adopting targets and reporting on metrics to assess the feasibility of integrating sustainability metrics into senior executive compensation plans.COMPENSATIONCORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER208970.0000000AGAINST208970.000000FORS000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal requesting a child labor audit.HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER208970.0000000AGAINST208970.000000FORS000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to amend the bylaws to repeal 3% derivative suit ownership threshold.CORPORATE GOVERNANCESECURITY HOLDER208970.0000000FOR208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to amend Article X of the bylaws.CORPORATE GOVERNANCESECURITY HOLDER208970.0000000FOR208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to elect each director annually.SHAREHOLDER RIGHTS AND DEFENSESSECURITY HOLDER208970.0000000FOR208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal regarding proposal that won 54% support at 2024 Tesla annual meeting.CORPORATE GOVERNANCESECURITY HOLDER208970.0000000FOR208970.000000AGAINSTS000005324Tesla, Inc.88160R101US88160R101411/06/2025A shareholder proposal to seek shareholder approval before adopting an amendment to the bylaws pursuant to Section 21.373 of the TBOC.CORPORATE GOVERNANCESECURITY HOLDER208970.0000000FOR208970.000000AGAINSTS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Darrell CavensDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Joanne CrevoiseratDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: David ElkinsDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Johanna (Hanneke) FaberDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Anne GatesDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Thomas GrecoDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Kevin HouricanDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Alan LauDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Pamela LiffordDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025To elect ten directors of Tapestry, Inc.: Annabelle Yu LongDIRECTOR ELECTIONSISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending June 27, 2026; andAUDIT-RELATEDISSUER68144.0000000FOR68144.000000FORS000005324Tapestry, Inc.876030107US876030107211/13/2025Advisory vote to approve the Company's executive compensation, as discussed and described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER68144.0000000FOR68144.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Barbara J. BeckDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Danielle M. BrownDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: William F. Dawson, Jr.DIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Scott D. FergusonDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Manuel A. FernandezDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Laura FlanaganDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Matthew C. FlaniganDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Kimberly S. GrantDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: George L. HolmDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Jeffrey M. OverlyDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: David V. SingerDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Randall N. SprattDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To elect the thirteen director nominees: Warren M. ThompsonDIRECTOR ELECTIONSISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal 2026.AUDIT-RELATEDISSUER9462.0000000FOR9462.000000FORS000005324Performance Food Group Company71377A103US71377A103411/19/2025To approve, in a non-binding advisory vote, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9462.0000000FOR9462.000000FORS000005324Eagle Materials Inc.26969P108US26969P108408/04/2025Election of Directors: George J. DamirisDIRECTOR ELECTIONSISSUER21600.0000000FOR21600.000000FORS000005325Eagle Materials Inc.26969P108US26969P108408/04/2025Election of Directors: Martin M. EllenDIRECTOR ELECTIONSISSUER21600.0000000FOR21600.000000FORS000005325Eagle Materials Inc.26969P108US26969P108408/04/2025Election of Directors: David RushDIRECTOR ELECTIONSISSUER21600.0000000FOR21600.000000FORS000005325Eagle Materials Inc.26969P108US26969P108408/04/2025Advisory resolution to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER21600.0000000FOR21600.000000FORS000005325Eagle Materials Inc.26969P108US26969P108408/04/2025Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors.SHAREHOLDER RIGHTS AND DEFENSESSECURITY HOLDER21600.0000000FOR21600.000000AGAINSTS000005325Eagle Materials Inc.26969P108US26969P108408/04/2025To approve the expected appointment of Ernst & Young LLP as independent auditors for fiscal year 2026.AUDIT-RELATEDISSUER21600.0000000FOR21600.000000FORS000005325Rocket Lab Corporation773121108US773121108908/27/2025Election of Class I Directors: Jon OlsonDIRECTOR ELECTIONSISSUER400.00000042000.000000FOR400.000000FORS000005325Rocket Lab Corporation773121108US773121108908/27/2025Election of Class I Directors: Merline SaintilDIRECTOR ELECTIONSISSUER400.00000042000.000000FOR400.000000FORS000005325Rocket Lab Corporation773121108US773121108908/27/2025Election of Class I Directors: Alex SluskyDIRECTOR ELECTIONSISSUER400.00000042000.000000FOR400.000000FORS000005325Rocket Lab Corporation773121108US773121108908/27/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER400.00000042000.000000FOR400.000000FORS000005325Rocket Lab Corporation773121108US773121108908/27/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER400.00000042000.000000FOR400.000000FORS000005325Rocket Lab Corporation773121108US773121108908/27/2025To approve an amendment to the Amended and Restated Certificate of Incorporation of Rocket Lab USA, Inc., our wholly owned subsidiary, to eliminate the recently added pass-through voting provision that requires approval by both us and our stockholders prior to certain actions being taken by or at Rocket Lab USA, Inc.CORPORATE GOVERNANCEISSUER400.00000042000.000000FOR400.000000FORS000005325RBC Bearings Incorporated75524B104US75524B104409/04/2025Election of Directors: Daniel A. Bergeron (Class I Director to serve a three-year term)DIRECTOR ELECTIONSISSUER3800.0000000FOR3800.000000FORS000005325RBC Bearings Incorporated75524B104US75524B104409/04/2025Election of Directors: Barry C. Boyan (Class I Director to serve a three-year term)DIRECTOR ELECTIONSISSUER3800.0000000FOR3800.000000FORS000005325RBC Bearings Incorporated75524B104US75524B104409/04/2025Election of Directors: Edward D. Stewart (Class I Director to serve a three-year term)DIRECTOR ELECTIONSISSUER3800.0000000FOR3800.000000FORS000005325RBC Bearings Incorporated75524B104US75524B104409/04/2025Election of Directors: Frederick J. Elmy (Class III Director to serve a one-year term)DIRECTOR ELECTIONSISSUER3800.0000000FOR3800.000000FORS000005325RBC Bearings Incorporated75524B104US75524B104409/04/2025To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2026.AUDIT-RELATEDISSUER3800.0000000FOR3800.000000FORS000005325RBC Bearings Incorporated75524B104US75524B104409/04/2025To consider a resolution regarding the stockholder advisory vote on named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3800.0000000FOR3800.000000FORS000005325Chart Industries, Inc.16115Q308US16115Q308310/06/2025To adopt the Agreement and Plan of Merger, dated as of July 28, 2025 (as it may be amended from time to time, the "Merger Agreement"), by and among Baker Hughes Company ("Baker Hughes"), Tango Merger Sub, Inc. ("Merger Sub"), and Chart Industries, Inc ("Chart"), providing for, among other things, the merger of Merger Sub with and into Chart (the "Merger"), with Chart surviving the Merger as a wholly owned subsidiary of Baker Hughes (the "Merger Proposal").EXTRAORDINARY TRANSACTIONSISSUER37600.0000000FOR37600.000000FORS000005325Chart Industries, Inc.16115Q308US16115Q308310/06/2025To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Chart's named executive officers that is based on or otherwise relates to the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER37600.0000000FOR37600.000000FORS000005325Chart Industries, Inc.16115Q308US16115Q308310/06/2025To approve one or more adjournments of the Chart special meeting to a later date or time, if necessary or appropriate, including adjournments to permit the solicitation of additional votes or proxies if there are not sufficient votes cast at the Chart special meeting to approve the Merger Proposal.CORPORATE GOVERNANCEISSUER37600.0000000FOR37600.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: Denise Russell FlemingDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: Lance M. FritzDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: Linda A. HartyDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: Kevin A. LoboDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: Jennifer A. ParmentierDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: E. Jean SavageDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: Laura K. ThompsonDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: James R. VerrierDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: James L. WainscottDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Election of the following individuals as Directors for a term expiring at the Annual Meeting of Shareholders in 2026: Beth A. WozniakDIRECTOR ELECTIONSISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Approval of, on a non-binding, advisory basis, the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER45413.0000000FOR45413.000000FORS000005325Parker-Hannifin Corporation701094104US701094104210/22/2025Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026.AUDIT-RELATEDISSUER45413.0000000FOR45413.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Melanie W. BarstadDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Beverly K. CarmichaelDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Karen L. CarnahanDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Robert E. ColettiDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Scott D. FarmerDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Martin MucciDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Joseph ScaminaceDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Todd M. SchneiderDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025Election of Directors: Ronald W. TysoeDIRECTOR ELECTIONSISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025To approve, on an advisory basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025To ratify Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER95300.0000000FOR95300.000000FORS000005325Cintas Corporation172908105US172908105910/28/2025A shareholder proposal regarding support for shareholder ability to call for a special shareholder meeting.CORPORATE GOVERNANCESECURITY HOLDER95300.0000000AGAINST95300.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: Neil M. AsheDIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: Marcia J. Avedon, Ph.D.DIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: W. Patrick BattleDIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: Michael J. BenderDIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: G. Douglas Dillard, Jr.DIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: James H. Hance, Jr.DIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: Maya LeibmanDIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: Laura G. O'ShaughnessyDIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026ELECTION OF DIRECTORS: Mark J. SachlebenDIRECTOR ELECTIONSISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2026.AUDIT-RELATEDISSUER49409.0000000FOR49409.000000FORS000005325Acuity Inc.00508Y102US00508Y102901/21/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER49409.0000000FOR49409.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: Leanne G. CaretDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: Tamra A. ErwinDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: R. Preston FeightDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: Alan C. HeubergerDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: L. Neil HunnDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: John C. MayDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: Gregory R. PageDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: Brian SikesDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: Dmitri L. StocktonDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Vote on Directors: Sheila G. TaltonDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Advisory vote to approve executive compensation ("say-on-pay")SECTION 14A SAY-ON-PAY VOTESISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Ratification of the appointment of Deloitte & Touche LLP as Deere's independent registered public accounting firm for fiscal 2026AUDIT-RELATEDISSUER68400.0000000FOR68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Shareholder proposal on a report on the return on investment of emission reduction goalsENVIRONMENT OR CLIMATESECURITY HOLDER68400.0000000AGAINST68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Shareholder proposal on shareholder right to act by written consentCORPORATE GOVERNANCESECURITY HOLDER68400.0000000AGAINST68400.000000FORS000005325Deere & Company244199105US244199105402/25/2026Shareholder proposal on a report on faith-based business resource groupsOTHER SOCIAL ISSUESSECURITY HOLDER68400.0000000AGAINST68400.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Timothy M. ArcherDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Jean BlackwellDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Pierre CohadeDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: W. Roy DunbarDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Gretchen R. HaggertyDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Ayesha KhannaDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Seetarama (Swamy) KotagiriDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Jurgen TinggrenDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Mark VergnanoDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: Joakim WeidemanisDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026By separate resolutions, to elect the following individuals as Directors for a period of one year, expiring at the end of the Company's Annual General Meeting of Shareholders in 2027: John D. YoungDIRECTOR ELECTIONSISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026To ratify the appointment of PricewaterhouseCoopers LLP as the independent auditors of the Company.AUDIT-RELATEDISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026To authorize the Audit Committee of the Board of Directors to set the auditors' remuneration.AUDIT-RELATEDISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026To authorize the Company and/or any subsidiary of the Company to make market purchases of Company shares.CAPITAL STRUCTUREISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026To determine the price range at which the Company can re-allot Shares that it holds as treasury shares (Special Resolution).CAPITAL STRUCTUREISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026To approve, in a non-binding advisory vote, the compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026To approve the Directors' authority to allot shares up to approximately 20% of issued share capital.CAPITAL STRUCTUREISSUER217657.0000000FOR217657.000000FORS000005325Johnson Controls International PlcG51502105IE00BY7QL61903/04/2026To approve the waiver of statutory preemption rights with respect to up to 20% of the issued share capital (Special Resolution).CAPITAL STRUCTUREISSUER217657.0000000FOR217657.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: David A. BarrDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Jane M. CroninDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Michael GraffDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Sean P. HennessyDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: W. Nicholas HowleyDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Michael J. LismanDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Gary E. McCulloughDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Peter J. PalmerDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Michele L. SantanaDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Election of Ten Director Nominees to our Board of Directors: Robert J. SmallDIRECTOR ELECTIONSISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER27251.0000000FOR27251.000000FORS000005325TransDigm Group Incorporated893641100US893641100303/05/2026Approval, on an advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER27251.0000000FOR27251.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Nanda Kumar CheruvatathDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Thomas M. CulliganDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Carol F. FineDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Adolfo HenriquesDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Mark H. HildebrandtDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Eric A. MendelsonDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Victor H. MendelsonDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Julie NeitzelDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Dr. Alan SchriesheimDIRECTOR ELECTIONSISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026ADVISORY APPROVAL OF THE COMPANY'S EXECUTIVE COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER77900.0000000FOR77900.000000FORS000005325HEICO Corporation422806208US422806208303/13/2026RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING OCTOBER 31, 2026AUDIT-RELATEDISSUER77900.0000000FOR77900.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Robert A. BradwayDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Mortimer "Tim" J. BuckleyDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Lynne M. DoughtieDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: David L. GitlinDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Lynn J. GoodDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Stayce D. HarrisDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Akhil JohriDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: David L. JoyceDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Steven M. MollenkopfDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Robert Kelly OrtbergDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: John M. RichardsonDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Election of Directors: Bradley D. TildenDIRECTOR ELECTIONSISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Approve, on an Advisory Basis, Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Ratify the Appointment of Deloitte & Touche LLP as Independent Auditor for 2026.AUDIT-RELATEDISSUER501822.0000000FOR501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Board Committee on Disability Access.CORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER501822.0000000AGAINST501822.000000FORS000005325The Boeing Company097023105US097023105804/17/2026Action by Written Consent.CORPORATE GOVERNANCESECURITY HOLDER501822.0000000AGAINST501822.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Gerald JohnsonDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Silvio NapoliDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Gregory R. PageDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Sandra PianaltoDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Robert V. PragadaDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Paulo RuizDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Lori J. RyerkerkDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Andre SchultenDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Karenann TerrellDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Dorothy C. ThompsonDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Electing the 11 director nominees: Darryl L. WilsonDIRECTOR ELECTIONSISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Approving the appointment of Ernst & Young LLP as independent auditor for 2026 and authorizing the Audit Committee of the Board of Directors to set auditor remuneration.AUDIT-RELATEDISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Approving, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Approving the Board of Directors' authority to issue shares under Irish law.CAPITAL STRUCTUREISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Approving the Board of Directors' authority to opt-out of pre-emption rights under Irish law.CAPITAL STRUCTUREISSUER170916.0000000FOR170916.000000FORS000005325Eaton Corporation plcG29183103IE00B8KQN82704/22/2026Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Company shares.CAPITAL STRUCTUREISSUER170916.0000000FOR170916.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Mark C. PigottDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Pierre R. BreberDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Dame Alison J. CarnwathDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: R. Preston FeightDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Kirk S. HachigianDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Brice A. HillDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Barbara B. HulitDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: John M. PigottDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Luiz A. S. PrettiDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Ganesh RamaswamyDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Dr. Dietmar A. ScheiterDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Election of director nominees to serve for one-year terms: Mark A. SchulzDIRECTOR ELECTIONSISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Advisory resolution to approve executive compensation ("Say on Pay")SECTION 14A SAY-ON-PAY VOTESISSUER314500.0000000FOR314500.000000FORS000005325PACCAR Inc693718108US693718108804/28/2026Advisory vote on the ratification of independent auditorsAUDIT-RELATEDISSUER314500.0000000FOR314500.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Richard F. AmbroseDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Lisa M. AthertonDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: R. Kerry ClarkDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Scott C. DonnellyDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Michael X. GarrettDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Deborah Lee JamesDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Thomas A. KennedyDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Cristina MendezDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Rob MionisDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Lionel L. Nowell IIIDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Election of Directors: Maria T. ZuberDIRECTOR ELECTIONSISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Ratification of appointment of independent registered public accounting firm.AUDIT-RELATEDISSUER148000.0000000FOR148000.000000FORS000005325Textron Inc.883203101US883203101204/29/2026Approval of the advisory (non-binding) resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER148000.0000000FOR148000.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Rodney C. AdkinsDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: George S. DavisDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Katherine D. JasponDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Christopher J. KleinDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: D.G. MacphersonDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Cindy J. MillerDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Neil S. NovichDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Beatriz R. PerezDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: E. Scott SantiDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Susan Slavik WilliamsDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Lucas E. WatsonDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To elect 12 Director nominees named in the proxy statement for the ensuing year: Steven A. WhiteDIRECTOR ELECTIONSISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To ratify the appointment of Ernst & Young LLP as the independent auditor for the year ending December 31, 2026.AUDIT-RELATEDISSUER18859.0000000FOR18859.000000FORS000005325W.W. Grainger, Inc.384802104US384802104004/29/2026To approve on a non-binding, advisory basis the compensation of Grainger's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER18859.0000000FOR18859.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Tracy A. AtkinsonDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Christopher T. CalioDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Leanne G. CaretDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Bernard A. Harris, Jr.DIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: George R. OliverDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Ellen M. PawlikowskiDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Denise L. RamosDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Fredric G. ReynoldsDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Brian C. RogersDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Election of Directors: Robert O. WorkDIRECTOR ELECTIONSISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Advisory Vote to Approve Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER224000.0000000FOR224000.000000FORS000005325RTX Corporation75513E101US75513E101004/30/2026Appointment of PricewaterhouseCoopers LLP to Serve as Independent Auditor for 2026AUDIT-RELATEDISSUER224000.0000000FOR224000.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Thomas A. BellDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Gregory R. DahlbergDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: David G. FubiniDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Noel B. GeerDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Tina W. JonasDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Harry M. J. Kraemer, Jr.DIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Gary S. MayDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Nancy A. NortonDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Patrick M. ShanahanDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Nominees: Robert S. ShapardDIRECTOR ELECTIONSISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Approve, by an advisory vote, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2027.AUDIT-RELATEDISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Approve the 2026 Omnibus Incentive Plan.COMPENSATIONISSUER71089.0000000FOR71089.000000FORS000005325Leidos Holdings, Inc.525327102US525327102805/01/2026Approve the 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER71089.0000000FOR71089.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Ronald SugarDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Revathi AdvaithiDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Turqi AlnowaiserDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Nikesh AroraDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Ursula BurnsDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Robert EckertDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Amanda GinsbergDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Dara KhosrowshahiDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: John ThainDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Election of Directors: Alexander WynaendtsDIRECTOR ELECTIONSISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Advisory vote to approve 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER452600.0000000FOR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Advisory vote on the frequency of future advisory votes on named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER452600.0000000ONE YEAR452600.000000FORS000005325Uber Technologies, Inc.90353T100US90353T100705/04/2026Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER452600.0000000FOR452600.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Sebastien BazinDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Margaret BillsonDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Wesley BushDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: H. Lawrence Culp, Jr.DIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Thomas EndersDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Isabella GorenDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Thomas HortonDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Catherine LesjakDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Election of Directors: Darren McDewDIRECTOR ELECTIONSISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Advisory Approval of Our Named Executives' CompensationSECTION 14A SAY-ON-PAY VOTESISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Approval of the Amendment and Restatement of the 2022 Long-Term Incentive PlanCOMPENSATIONISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Approval of the GE Aerospace Global Employee Stock Purchase PlanCOMPENSATIONISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Ratification of Deloitte as Independent Auditor for 2026AUDIT-RELATEDISSUER467040.0000000FOR467040.000000FORS000005325GE Aerospace369604301US369604301305/05/2026Shareholder Proposal Requesting Report on Defense-Related ProductsHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER467040.0000000AGAINST467040.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Richard D. ClarkeDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Rudy F. deLeonDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Cecil D. HaneyDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Charles W. HooperDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Mark M. MalcolmDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Phebe N. NovakovicDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: C. Howard NyeDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Catherine B. ReynoldsDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Laura J. SchumacherDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Robert K. SteelDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: John G. StrattonDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Election of Directors: Peter A. WallDIRECTOR ELECTIONSISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Advisory Vote on the Selection of Independent AuditorsAUDIT-RELATEDISSUER86200.0000000FOR86200.000000FORS000005325General Dynamics Corporation369550108US369550108605/06/2026Advisory Vote to Approve Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER86200.0000000FOR86200.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: James AndrasickDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: Chau BanksDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: Felica ConeyDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: Philip DonaldsonDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: Angela DrakeDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: Celeste Volz FordDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: Kenneth KnightDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Elect eight directors, each to hold office until the next annual meeting of the Company or until his or her successor has been duly elected and qualified: Michael OloskyDIRECTOR ELECTIONSISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER149459.0000000FOR149459.000000FORS000005325Simpson Manufacturing Co., Inc.829073105US829073105305/06/2026Ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER149459.0000000FOR149459.000000FORS000005325AMETEK, Inc.031100100US031100100405/07/2026Election of Directors for a term of three years: Thomas A. AmatoDIRECTOR ELECTIONSISSUER146354.0000000FOR146354.000000FORS000005325AMETEK, Inc.031100100US031100100405/07/2026Election of Directors for a term of three years: Anthony J. ContiDIRECTOR ELECTIONSISSUER146354.0000000FOR146354.000000FORS000005325AMETEK, Inc.031100100US031100100405/07/2026Election of Directors for a term of three years: Gretchen W. McClainDIRECTOR ELECTIONSISSUER146354.0000000FOR146354.000000FORS000005325AMETEK, Inc.031100100US031100100405/07/2026Approval, by advisory vote, of the compensation of AMETEK, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER146354.0000000FOR146354.000000FORS000005325AMETEK, Inc.031100100US031100100405/07/2026Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER146354.0000000FOR146354.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: David P. BozemanDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Kermit R. CrawfordDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Edward G. FeitzingerDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Timothy C. GokeyDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Mark A. GoodburnDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Mary J. Steele GuilfoileDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Jodee A. KozlakDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Michael H. McGarryDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Paige K. RobbinsDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Election of Directors: Paula C. TolliverDIRECTOR ELECTIONSISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026Ratification of the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER142150.0000000FOR142150.000000FORS000005325C.H. Robinson Worldwide, Inc.12541W209US12541W209805/07/2026To approve the Amended and Restated 1997 Employee Stock Purchase Plan.COMPENSATIONISSUER142150.0000000FOR142150.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Manny KadreDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Ian CraigDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Michael A. DuffyDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Thomas W. HandleyDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Jennifer M. KirkDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Michael LarsonDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Norman Thomas LinebargerDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Meg ReynoldsDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: James P. SneeDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Brian S. TylerDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Jon Vander ArkDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Sandra M. VolpeDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Election of Directors: Katharine B. WeymouthDIRECTOR ELECTIONSISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Advisory vote to approve our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER129600.0000000FOR129600.000000FORS000005325Republic Services, Inc.760759100US760759100205/07/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER129600.0000000FOR129600.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: D. L. DeHaasDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: H. J. Gilbertson, Jr.DIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: K. C. GrahamDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: M. A. HowzeDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: M. ManleyDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: D. K. OstlingDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: E. A. SpiegelDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: R. J. TobinDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026Election of Directors: K. E. WandellDIRECTOR ELECTIONSISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026To approve, on an advisory basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER217281.0000000FOR217281.000000FORS000005325Dover Corporation260003108US260003108005/08/2026To consider a shareholder proposal requesting an independent board chair.CORPORATE GOVERNANCESECURITY HOLDER217281.0000000AGAINST217281.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Julie M. Heuer BrandtDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Marc A. BrunoDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Larry D. De ShonDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Matthew J. FlanneryDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Kim Harris JonesDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Terri L. KellyDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Michael J. KneelandDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Francisco J. Lopez-BalboaDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Gracia C. MartoreDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Shiv SinghDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Election of Directors: Alexander R. TaussigDIRECTOR ELECTIONSISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Ratification of Appointment of Public Accounting FirmAUDIT-RELATEDISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Advisory Approval of Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER32550.0000000FOR32550.000000FORS000005325United Rentals, Inc.911363109US911363109005/08/2026Stockholder Proposal on Directors Who Fail to Obtain a Majority VoteCORPORATE GOVERNANCESECURITY HOLDER32550.0000000FOR32550.000000AGAINSTS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: David P. BozemanDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: Thomas "Tony" K. BrownDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: William M. BrownDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: Audrey ChoiDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: Anne H. ChowDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: James R. FitterlingDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: Suzan KereereDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: Neil G. Mitchill, Jr.DIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: Pedro J. PizarroDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To elect 10 members to the Board of Directors, each for a term of one year: Thomas W. SweetDIRECTOR ELECTIONSISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026To ratify the appointment of PricewaterhouseCoopers LLP as 3M's independent registered public accounting firm.AUDIT-RELATEDISSUER208600.0000000FOR208600.000000FORS0000053253M Company88579Y101US88579Y101005/12/2026Advisory approval of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER208600.0000000FOR208600.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Stephen F. AngelDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Ann D. BegemanDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Thomas P. BostickDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Anne H. ChowDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Steven T. HalversonDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Paul C. HilalDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: David M. MoffettDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Linda H. RieflerDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: Suzanne M. VautrinotDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: James L. WainscottDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: J. Steven WhislerDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Election of Directors: John J. ZillmerDIRECTOR ELECTIONSISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026The ratification of the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for 2026.AUDIT-RELATEDISSUER134452.0000000FOR134452.000000FORS000005325CSX Corporation126408103US126408103505/12/2026Advisory (non-binding) resolution to approve compensation for the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER134452.0000000FOR134452.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Jennifer W. RumseyDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Gary L. BelskeDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Bruno V. Di Leo AllenDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Daniel W. FisherDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Carla A. HarrisDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Thomas J. LynchDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: William I. MillerDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Kimberly A. NelsonDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Karen H. QuintosDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: John H. StoneDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Election of Directors: Matthew TsienDIRECTOR ELECTIONSISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Advisory vote to approve the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Proposal to approve the 2026 Omnibus Incentive Plan.COMPENSATIONISSUER80537.0000000FOR80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Shareholder proposal to adopt a policy for separation of the roles of Chairperson and Chief Executive Officer.CORPORATE GOVERNANCESECURITY HOLDER80537.0000000AGAINST80537.000000FORS000005325Cummins Inc.231021106US231021106305/12/2026Shareholder proposal requesting a report on the Company's charitable support.OTHER SOCIAL ISSUESSECURITY HOLDER80537.0000000AGAINST80537.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Douglas ColDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Reid DoveDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Michael GarnreiterDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Louis HobsonDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Gary KnightDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Kevin KnightDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Adam MillerDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Kathryn MunroDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Jessica PowellDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: Roberta Roberts ShankDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Elect eleven directors, each such director to serve until the 2027 Annual Meeting: David Vander PloegDIRECTOR ELECTIONSISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Conduct an advisory, non-binding vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER386500.0000000FOR386500.000000FORS000005325Knight-Swift Transportation Holdings Inc.499049104US499049104905/12/2026Vote on a stockholder proposal regarding support for transparency in political spending.OTHER SOCIAL ISSUESSECURITY HOLDER386500.0000000FOR386500.000000AGAINSTS000005325Westinghouse Air Brake Technologies Corporation929740108US929740108805/12/2026Elect three directors for a term of three years expiring in 2029: Rafael SantanaDIRECTOR ELECTIONSISSUER180200.0000000FOR180200.000000FORS000005325Westinghouse Air Brake Technologies Corporation929740108US929740108805/12/2026Elect three directors for a term of three years expiring in 2029: Lee C. BanksDIRECTOR ELECTIONSISSUER180200.0000000FOR180200.000000FORS000005325Westinghouse Air Brake Technologies Corporation929740108US929740108805/12/2026Elect three directors for a term of three years expiring in 2029: Byron S. FosterDIRECTOR ELECTIONSISSUER180200.0000000FOR180200.000000FORS000005325Westinghouse Air Brake Technologies Corporation929740108US929740108805/12/2026Approve an advisory (non-binding) resolution to approve the 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER180200.0000000FOR180200.000000FORS000005325Westinghouse Air Brake Technologies Corporation929740108US929740108805/12/2026Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER180200.0000000FOR180200.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Stuart J. B. BradieDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Joseph DominguezDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Lynn A. DugleDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Nchacha E. EttaDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Sir John A. Manzoni KCBDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Lt. General Wendy M. Masiello, USAF (Ret.)DIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Jack B. MooreDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Ann D. PickardDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Carlos A. SabaterDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Huibert H. VigevenoDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Election of Directors: Lewis F. Von ThaerDIRECTOR ELECTIONSISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Advisory vote to approve KBR's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER255571.000000429.000000FOR255571.000000FORS000005325KBR, Inc.48242W106US48242W106205/14/2026Ratify the appointment of KPMG LLP as the independent registered public accounting firm to audit the consolidated financial statements for KBR, Inc. as of and for the fiscal year ending January 1, 2027.AUDIT-RELATEDISSUER255571.000000429.000000FOR255571.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Darcy G. AndersonDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Herman E. BullsDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Rhoman J. HardyDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Gaurav KapoorDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Brian E. LaneDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Pablo G. MercadoDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Franklin MyersDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: William J. SandbrookDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Constance E. SkidmoreDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ELECTION OF TEN DIRECTORS FOR TERMS EXPIRING AT THE 2027 ANNUAL MEETING: Cindy L. Wallis-LageDIRECTOR ELECTIONSISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026RATIFICATION OF APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.AUDIT-RELATEDISSUER16802.0000000FOR16802.000000FORS000005325Comfort Systems USA, Inc.199908104US199908104505/18/2026ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER16802.0000000FOR16802.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: James F. AlbaughDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: Amy E. AlvingDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: Sharon R. BarnerDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: Joseph S. CantieDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: Robert F. LeducDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: Jody G. MillerDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: John C. PlantDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: Ulrich R. SchmidtDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Election of Directors: Gunner S. SmithDIRECTOR ELECTIONSISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER378095.0000000FOR378095.000000FORS000005325Howmet Aerospace Inc.443201108US443201108205/19/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER378095.0000000FOR378095.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Election of Directors: Mario HarikDIRECTOR ELECTIONSISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Election of Directors: Bella AllaireDIRECTOR ELECTIONSISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Election of Directors: J. Wes FryeDIRECTOR ELECTIONSISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Election of Directors: Michael G. JesselsonDIRECTOR ELECTIONSISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Election of Directors: Allison LandryDIRECTOR ELECTIONSISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Election of Directors: Irene MoshourisDIRECTOR ELECTIONSISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Election of Directors: Johnny C. Taylor, Jr.DIRECTOR ELECTIONSISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Ratification of the appointment of KPMG as our independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER103103.0000000FOR103103.000000FORS000005325XPO, Inc.983793100US983793100805/19/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER103103.0000000FOR103103.000000FORS000005325GE Vernova Inc.36828A101US36828A101605/20/2026Election of Class II Directors for Three Year Terms: Matthew HarrisDIRECTOR ELECTIONSISSUER153709.0000000FOR153709.000000FORS000005325GE Vernova Inc.36828A101US36828A101605/20/2026Election of Class II Directors for Three Year Terms: Martina Hund-MejeanDIRECTOR ELECTIONSISSUER153709.0000000FOR153709.000000FORS000005325GE Vernova Inc.36828A101US36828A101605/20/2026Election of Class II Directors for Three Year Terms: Paula Rosput ReynoldsDIRECTOR ELECTIONSISSUER153709.0000000FOR153709.000000FORS000005325GE Vernova Inc.36828A101US36828A101605/20/2026Approve the compensation of our named executive officers in an advisory voteSECTION 14A SAY-ON-PAY VOTESISSUER153709.0000000FOR153709.000000FORS000005325GE Vernova Inc.36828A101US36828A101605/20/2026Ratify the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026AUDIT-RELATEDISSUER153709.0000000FOR153709.000000FORS000005325GE Vernova Inc.36828A101US36828A101605/20/2026Stockholder proposal requesting report assessing sustainability goals on the basis of net-present-value and return-on-investment calculationENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER153709.0000000AGAINST153709.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Sherry A. AaholmDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: David S. CongdonDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: John R. Congdon, Jr.DIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Andrew S. DavisDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Kevin M. FreemanDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Bradley R. GaboschDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Greg C. GanttDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: John D. KasardaDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Cheryl S. MillerDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: A. Randolph Smith, IIDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Wendy T. StallingsDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Election of twelve directors named below to the Company's Board of Directors for one-year terms and until their respective successors have been elected and qualified, as set forth in the accompanying proxy statement: Thomas A. Stith, IIIDIRECTOR ELECTIONSISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER164000.0000000FOR164000.000000FORS000005325Old Dominion Freight Line, Inc.679580100US679580100905/20/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER164000.0000000FOR164000.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Kevin BerrymanDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Maggie ChuDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Donald DeFosset, Jr.DIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Douglas G. DelGrossoDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Mary LaschingerDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Nazzic S. KeeneDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Rebecca A. McDonaldDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Christopher O'SheaDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Luca SaviDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Election of Directors: Sharon SzafranskiDIRECTOR ELECTIONSISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the 2026 fiscal yearAUDIT-RELATEDISSUER278209.0000000FOR278209.000000FORS000005325ITT Inc.45073V108US45073V108905/21/2026Approval of a non-binding advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER278209.0000000FOR278209.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Earl C. (Duke) Austin, Jr.DIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Warner L. BaxterDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Doyle N. BenebyDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Bernard FriedDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Worthing F. JackmanDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Joseph KimDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Holli C. LadhaniDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Jo-ann M. dePass OlsovskyDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: R. Scott RoweDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Election of ten directors nominated by Quanta's Board of Directors: Martha B. WyrschDIRECTOR ELECTIONSISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Approval, by non-binding advisory vote, of the compensation of Quanta's named executive officers for fiscal year 2025;SECTION 14A SAY-ON-PAY VOTESISSUER100.00000089300.000000FOR100.000000FORS000005325Quanta Services, Inc.74762E102US74762E102905/21/2026Ratification of the appointment of PricewaterhouseCoopers LLP as Quanta's independent registered public accounting firm for fiscal year 2026; andAUDIT-RELATEDISSUER100.00000089300.000000FOR100.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Erika Ayers BadanDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Adriane BrownDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Michael GarnreiterDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Caitlin KalinowskiDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Todd MorgenfeldDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Hadi PartoviDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Graham SmithDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Patrick SmithDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Election of nine directors of the Company named in the proxy statement: Jeri WilliamsDIRECTOR ELECTIONSISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER44900.0000000FOR44900.000000FORS000005325Axon Enterprise, Inc.05464C101US05464C101805/28/2026Proposal No. 3 requests that shareholders vote to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER44900.0000000FOR44900.000000FORS000005325GPGI, Inc.20459V105US20459V105206/04/2026To approve the reincorporation of GPGI, Inc. from the State of Delaware to the State of Nevada by conversion (the "Nevada Reincorporation"), and to adopt the resolutions of GPGI, Inc.'s Board of Directors approving the Nevada Reincorporation (the "Nevada Reincorporation Proposal").EXTRAORDINARY TRANSACTIONSCORPORATE GOVERNANCEISSUER448090.0000000AGAINST448090.000000AGAINSTS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: Kirk E. ArnoldDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: Ana P. AssisDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: Ann C. BerzinDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: April Miller BoiseDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: Mark R. GeorgeDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: John A. HayesDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: Myles P. LeeDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: Matthew F. PineDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: David S. RegneryDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: Melissa N. SchaefferDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Election of Directors: John P. SurmaDIRECTOR ELECTIONSISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Advisory approval of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Approval of the appointment of independent auditors of the Company and authorization of the Audit Committee of the Board of Directors to set the auditors' remuneration.AUDIT-RELATEDISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Approval of the renewal of the Directors' existing authority to issue shares.CAPITAL STRUCTUREISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Approval of the renewal of the Directors' existing authority to issue shares for cash without first offering shares to existing shareholders. (Special Resolution)CAPITAL STRUCTUREISSUER212935.0000000FOR212935.000000FORS000005325Trane Technologies plcG8994E103IE00BK9ZQ96706/04/2026Determination of the price range at which the Company can reallot shares that it holds as treasury shares. (Special Resolution)CAPITAL STRUCTUREISSUER212935.0000000FOR212935.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Timothy D. BoswellDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Erika T. DavisDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Gerard E. HolthausDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Worthing JackmanDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Natalia JohnsonDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Rebecca L. OwenDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Jeff SaganskyDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Michael W. UpchurchDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026If Proposal 1 is approved, the election as directors of all nominees listed to serve a one-year term: Dominick ZarconeDIRECTOR ELECTIONSISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026To ratify the appointment of Ernst & Young LLP as independent registered public accounting firm of WillScot Holdings Corporation for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026To approve, on an advisory and non-binding basis, the compensation of the named executive officers of WillScot Holdings Corporation.SECTION 14A SAY-ON-PAY VOTESISSUER598300.0000000FOR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026To vote, on an advisory and non-binding basis, how often WillScot Holdings Corporation will conduct a stockholder advisory vote to approve the compensation of its named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER598300.0000000ONE YEAR598300.000000FORS000005325WillScot Holdings Corporation971378104US971378104806/05/2026To approve the WillScot Holdings Corporation 2026 Incentive Award Plan.COMPENSATIONISSUER598300.0000000FOR598300.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Joseph E. CreedDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: James C. Fish, Jr.DIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Lynn J. GoodDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Gerald JohnsonDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Nazzic S. KeeneDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: David W. MacLennanDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Judith F. MarksDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Debra L. Reed-KlagesDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Susan C. SchwabDIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Election of Directors: Rayford Wilkins, Jr.DIRECTOR ELECTIONSISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Ratification of our Independent Registered Public Accounting FirmAUDIT-RELATEDISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Advisory Vote to Approve Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER68400.0000000FOR68400.000000FORS000005325Caterpillar, Inc.149123101US149123101506/10/2026Shareholder Proposal - Shareholder Right to Act by Written ConsentCORPORATE GOVERNANCESECURITY HOLDER68400.0000000AGAINST68400.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Victor D. GrizzleDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Mark A. HersheyDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Richard D. HolderDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Kevin P. HolleranDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Barbara L. LoughranDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: William H. OsborneDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Kathleen E. PitreDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Wayne R. ShurtsDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026Election of Directors: Roy W. TemplinDIRECTOR ELECTIONSISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026To approve the 2026 Directors Stock Unit Plan.COMPENSATIONISSUER92600.0000000FOR92600.000000FORS000005325Armstrong World Industries, Inc.04247X102US04247X102806/11/2026To approve, on an advisory basis, our executive compensation program.SECTION 14A SAY-ON-PAY VOTESISSUER92600.0000000FOR92600.000000FORS000005325BETA Technologies, Inc.086921103US086921103906/11/2026Election of Directors: John AbeleDIRECTOR ELECTIONSISSUER5851.0000002549.000000FOR5851.000000FORS000005325BETA Technologies, Inc.086921103US086921103906/11/2026Election of Directors: General (RET) James McConvilleDIRECTOR ELECTIONSISSUER5851.0000002549.000000FOR5851.000000FORS000005325BETA Technologies, Inc.086921103US086921103906/11/2026Election of Directors: John SlatteryDIRECTOR ELECTIONSISSUER5851.0000002549.000000FOR5851.000000FORS000005325BETA Technologies, Inc.086921103US086921103906/11/2026Ratification of appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026AUDIT-RELATEDISSUER5851.0000002549.000000FOR5851.000000FORS000005325GPGI, Inc.20459V105US20459V105206/11/2026Election of Directors: Joseph J. DeAngeloDIRECTOR ELECTIONSISSUER448090.0000000FOR448090.000000FORS000005325GPGI, Inc.20459V105US20459V105206/11/2026Election of Directors: Brian F. HughesDIRECTOR ELECTIONSISSUER448090.0000000FOR448090.000000FORS000005325GPGI, Inc.20459V105US20459V105206/11/2026Election of Directors: Mark R. JamesDIRECTOR ELECTIONSISSUER448090.0000000FOR448090.000000FORS000005325GPGI, Inc.20459V105US20459V105206/11/2026Election of Directors: Thomas R. KnottDIRECTOR ELECTIONSISSUER448090.0000000FOR448090.000000FORS000005325GPGI, Inc.20459V105US20459V105206/11/2026A proposal to approve, on an advisory basis, the 2025 compensation of the Company's named executive officers as disclosed in the Company's 2026 proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER448090.0000000FOR448090.000000FORS000005325GPGI, Inc.20459V105US20459V105206/11/2026A proposal to approve, on an advisory basis, the frequency (i.e., every one, two or three years) of future advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER448090.0000000ONE YEAR448090.000000FORS000005325GPGI, Inc.20459V105US20459V105206/11/2026A proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER448090.0000000FOR448090.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: Vicente ReynalDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: William P. DonnellyDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: Jerome GuillenDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: Jennifer HartsockDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: John HumphreyDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: Marc E. JonesDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: Aurobind SatpathyDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: JoAnna L. SohovichDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: Mark P. StevensonDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Election of Directors: Michelle SwanenburgDIRECTOR ELECTIONSISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Ratification of appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Non-binding vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER700007.0000000FOR700007.000000FORS000005325Ingersoll Rand Inc.45687V106US45687V106106/11/2026Approval of Ingersoll Rand Inc. 2026 Omnibus Incentive Plan.COMPENSATIONISSUER700007.0000000FOR700007.000000FORS000005325StandardAero, Inc.85423L103US85423L103506/25/2026Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholder, and until their respective successors shall have been duly elected and qualified: Douglas V. BrandelyDIRECTOR ELECTIONSISSUER846930.00000082300.000000FOR846930.000000FORS000005325StandardAero, Inc.85423L103US85423L103506/25/2026Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholder, and until their respective successors shall have been duly elected and qualified: Wendy M. MasielloDIRECTOR ELECTIONSISSUER846930.00000082300.000000FOR846930.000000FORS000005325StandardAero, Inc.85423L103US85423L103506/25/2026Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholder, and until their respective successors shall have been duly elected and qualified: Stefan WeingartnerDIRECTOR ELECTIONSISSUER846930.00000082300.000000FOR846930.000000FORS000005325StandardAero, Inc.85423L103US85423L103506/25/2026Ratification of the appointment of PricewaterhouseCoopers LLP, United States as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER846930.00000082300.000000FOR846930.000000FORS000005325StandardAero, Inc.85423L103US85423L103506/25/2026Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER846930.00000082300.000000FOR846930.000000FORS000005325GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Tim BreenDIRECTOR ELECTIONSISSUER3067483.0000000WITHHOLD3067483.000000AGAINSTS000005327GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Thomas CaulfieldDIRECTOR ELECTIONSISSUER3067483.0000000WITHHOLD3067483.000000AGAINSTS000005327GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Glenda DorchakDIRECTOR ELECTIONSISSUER3067483.0000000FOR3067483.000000FORS000005327GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Elect Director Camilla LanguilleDIRECTOR ELECTIONSISSUER3067483.0000000WITHHOLD3067483.000000AGAINSTS000005327GLOBALFOUNDRIES Inc.G39387108KYG39387108507/29/2025Ratify PricewaterhouseCoopers LLP as AuditorsAUDIT-RELATEDISSUER3067483.0000000FOR3067483.000000FORS000005327Allegro MicroSystems, Inc.01749D105US01749D105408/07/2025To elect three individuals to the Board of Directors for three-year terms expiring in 2028: Michael C. DoogueDIRECTOR ELECTIONSISSUER1745414.0000000FOR1745414.000000FORS000005327Allegro MicroSystems, Inc.01749D105US01749D105408/07/2025To elect three individuals to the Board of Directors for three-year terms expiring in 2028: Katsumi KawashimaDIRECTOR ELECTIONSISSUER1745414.0000000FOR1745414.000000FORS000005327Allegro MicroSystems, Inc.01749D105US01749D105408/07/2025To elect three individuals to the Board of Directors for three-year terms expiring in 2028: Yoshihiro (Zen) SuzukiDIRECTOR ELECTIONSISSUER1745414.0000000FOR1745414.000000FORS000005327Allegro MicroSystems, Inc.01749D105US01749D105408/07/2025To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending March 27, 2026.AUDIT-RELATEDISSUER1745414.0000000FOR1745414.000000FORS000005327Allegro MicroSystems, Inc.01749D105US01749D105408/07/2025To approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1745414.0000000FOR1745414.000000FORS000005327Silicon Motion Technology Corp.82706C108US82706C108009/23/2025Elect Han-Ping D. Shieh and Shii-Tyng Duann as DirectorDIRECTOR ELECTIONSISSUER418000.0000000FOR418000.000000FORS000005327Silicon Motion Technology Corp.82706C108US82706C108009/23/2025Approve Appointment of Deloitte & Touche as Independent AuditorAUDIT-RELATEDISSUER418000.0000000FOR418000.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal for the Election of Directors: Jeffrey D. BuchananDIRECTOR ELECTIONSISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal for the Election of Directors: Keith B. GeeslinDIRECTOR ELECTIONSISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal for the Election of Directors: Patricia KummrowDIRECTOR ELECTIONSISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal for the Election of Directors: Vivie LeeDIRECTOR ELECTIONSISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal for the Election of Directors: Rahul PatelDIRECTOR ELECTIONSISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal for the Election of Directors: James L. WhimsDIRECTOR ELECTIONSISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal to ratify the appointment of KPMG LLP, an independent registered public accounting firm, as the Company's independent auditor for the fiscal year ending June 27, 2026.AUDIT-RELATEDISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal to approve the Company's amended and restated 2019 Equity and Incentive Compensation Plan.COMPENSATIONISSUER140821.0000000AGAINST140821.000000AGAINSTS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal to approve the Company's amended and restated 2019 Employee Stock Purchase Plan.COMPENSATIONISSUER140821.0000000FOR140821.000000FORS000005327Synaptics Incorporated87157D109US87157D109010/28/2025Proposal to approve, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER140821.0000000FOR140821.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Sohail U. AhmedDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Timothy M. ArcherDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Eric K. BrandtDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Ita M. BrennanDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Michael R. CannonDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: John M. DineenDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Mark FieldsDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Ho Kyu KangDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Bethany J. MayerDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Jyoti K. MehraDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Election of Directors: Abhijit Y. TalwalkarDIRECTOR ELECTIONSISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Advisory vote to approve the compensation of the named executive officers of Lam Research, or "Say on Pay."SECTION 14A SAY-ON-PAY VOTESISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Approval of the adoption of the Lam 2025 Stock Incentive Plan.COMPENSATIONISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Ratification of the appointment of the independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Approval of an amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law.CORPORATE GOVERNANCEISSUER1585774.0000000FOR1585774.000000FORS000005327Lam Research Corporation512807306US512807306211/04/2025Stockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented.CORPORATE GOVERNANCESECURITY HOLDER1585774.0000000AGAINST1585774.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Kimberly E. AlexyDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Martin I. ColeDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Tunc DolucaDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Bruce E. KiddooDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Matthew E. MassengillDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Roxanne OulmanDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Stephanie A. StreeterDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Election of Directors: Irving TanDIRECTOR ELECTIONSISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Approval of the amendment and restatement of our 2005 Employee Stock Purchase Plan to increase by 8 million the number of shares of our common stock available for issuance under that plan.COMPENSATIONISSUER881368.0000000FOR881368.000000FORS000005327Western Digital Corporation958102105US958102105511/20/2025Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2026.AUDIT-RELATEDISSUER881368.0000000FOR881368.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ELECTION OF DIRECTORS: Anthony M. AbateDIRECTOR ELECTIONSISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ELECTION OF DIRECTORS: Michael W. BokanDIRECTOR ELECTIONSISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ELECTION OF DIRECTORS: Robert A. FeurleDIRECTOR ELECTIONSISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ELECTION OF DIRECTORS: Hong Q. HouDIRECTOR ELECTIONSISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ELECTION OF DIRECTORS: Mark E. JensenDIRECTOR ELECTIONSISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ELECTION OF DIRECTORS: Eric S. MusserDIRECTOR ELECTIONSISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ELECTION OF DIRECTORS: Paul V. Walsh, Jr.DIRECTOR ELECTIONSISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025ADVISORY (NONBINDING) VOTE TO APPROVE EXECUTIVE COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER457.0000000FOR457.000000FORS000005327Wolfspeed, Inc.97785W106US97785W106212/16/2025RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING JUNE 28, 2026AUDIT-RELATEDISSUER457.0000000FOR457.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: Lynn A. DugleDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: Steven J. GomoDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: Linnie M. HaynesworthDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: T. Mark LiuDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: Sanjay MehrotraDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: A. Christine SimonsDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: Robert H. SwanDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026ELECTION OF DIRECTORS: MaryAnn WrightDIRECTOR ELECTIONSISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026PROPOSAL BY THE COMPANY TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT.SECTION 14A SAY-ON-PAY VOTESISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026PROPOSAL BY THE COMPANY TO APPROVE THE AMENDMENT OF THE RESTATED CERTIFICATE OF INCORPORATION TO REFLECT DELAWARE LAW PROVISIONS REGARDING EXCULPATION OF OFFICERS.CORPORATE GOVERNANCEISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026PROPOSAL BY THE COMPANY TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING SEPTEMBER 3, 2026.AUDIT-RELATEDISSUER1329701.0000000FOR1329701.000000FORS000005327Micron Technology, Inc.595112103US595112103801/15/2026SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT.CORPORATE GOVERNANCESECURITY HOLDER1329701.0000000AGAINST1329701.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: Charles BlandDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: Stephen DalyDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: Peter ChungDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: Bryan IngramDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: Geoffrey RibarDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: John RitchieDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: Jihye Whang RosenbandDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026The election of eight directors nominated by our board of directors and named in the accompanying proxy materials to serve until the 2027 annual meeting of stockholders: Murugesan "Raj" ShanmugarajDIRECTOR ELECTIONSISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026Advisory vote to approve the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER481492.0000000FOR481492.000000FORS000005327MACOM Technology Solutions Holdings, Inc.55405Y100US55405Y100103/05/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending October 2, 2026.AUDIT-RELATEDISSUER481492.0000000FOR481492.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Vincent RocheDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Stephen M. JenningsDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Andre AndonianDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Edward H. FrankDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Karen M. GolzDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Peter B. HenryDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Mercedes JohnsonDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Yoky MatsuokaDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Ray StataDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026The election to Analog Devices' Board of Directors of the ten nominees named in our Proxy Statement: Andrea F. WainerDIRECTOR ELECTIONSISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026Advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026Approve the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan.COMPENSATIONISSUER182300.0000000FOR182300.000000FORS000005327Analog Devices, Inc.032654105US032654105103/11/2026To consider a shareholder proposal, if properly presented at the Annual Meeting.CORPORATE GOVERNANCESECURITY HOLDER182300.0000000AGAINST182300.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Diane M. BryantDIRECTOR ELECTIONSISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Gayla J. DellyDIRECTOR ELECTIONSISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Kenneth Y. HaoDIRECTOR ELECTIONSISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Check Kian LowDIRECTOR ELECTIONSISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Justine F. PageDIRECTOR ELECTIONSISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Henry SamueliDIRECTOR ELECTIONSISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Hock E. TanDIRECTOR ELECTIONSISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Election of Directors: Harry L. YouDIRECTOR ELECTIONSISSUER1682873.0000000AGAINST1682873.000000AGAINSTS000005327Broadcom Inc.11135F101US11135F101204/20/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Broadcom for the fiscal year ending November 1, 2026.AUDIT-RELATEDISSUER1682873.0000000FOR1682873.000000FORS000005327Broadcom Inc.11135F101US11135F101204/20/2026Advisory vote to approve the named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1682873.0000000FOR1682873.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Approve Remuneration ReportCOMPENSATIONISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Approve DividendsCAPITAL STRUCTUREISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Approve Discharge of Management BoardCORPORATE GOVERNANCEISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Approve Discharge of Supervisory BoardCORPORATE GOVERNANCEISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Approve Number of Shares for Management BoardCOMPENSATIONISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Reelect T.L. Kelly to Supervisory BoardDIRECTOR ELECTIONSISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Reelect A.L. Steegen to Supervisory BoardDIRECTOR ELECTIONSISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Elect B. Loh to Supervisory BoardDIRECTOR ELECTIONSISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Appoint PricewaterhouseCoopers Accountants N.V. as AuditorsAUDIT-RELATEDISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Appoint PricewaterhouseCoopers Accountants N.V. as Auditor for Sustainability ReportingAUDIT-RELATEDISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Grant Board Authority to Issue Shares Up to 5 Percent of Issued Capital Plus Additional 5 Percent in Case of Merger, Acquisition or AlliancesCAPITAL STRUCTUREISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Authorize Board to Exclude Preemptive Rights from Share IssuancesCAPITAL STRUCTUREISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Authorize Repurchase of Up to 10 Percent of Issued Share CapitalcCAPITAL STRUCTUREISSUER138848.0000000FOR138848.000000FORS000005327ASML Holding NVN07059210USN07059210004/22/2026Authorize Cancellation of Ordinary SharesCAPITAL STRUCTUREISSUER138848.0000000FOR138848.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: Rodney ClarkDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: James F. GentilcoreDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: Yvette KanouffDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: James P. LedererDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: Bertrand LoyDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: Mary PumaDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: David ReederDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Election of Directors: Azita Saleki-GerhardtDIRECTOR ELECTIONSISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Approval, by non-binding vote, of the compensation paid to Entegris, Inc.'s named executive officers (advisory vote).SECTION 14A SAY-ON-PAY VOTESISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Ratify the appointment of KPMG LLP as Entegris, Inc.'s Independent Registered Public Accounting Firm for 2026.AUDIT-RELATEDISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Approval of amendments to Entegris, Inc.'s Amended and Restated Certificate of Incorporation to eliminate supermajority voting requirements.CORPORATE GOVERNANCEISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026To approve, on an advisory basis, providing stockholders the right to call special meetings of stockholders.CORPORATE GOVERNANCEISSUER247200.0000000FOR247200.000000FORS000005327Entegris, Inc.29362U104US29362U104305/06/2026Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders.CORPORATE GOVERNANCESECURITY HOLDER247200.0000000AGAINST247200.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To elect seven directors nominated by our Board of Directors: Susan K. CarterDIRECTOR ELECTIONSISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To elect seven directors nominated by our Board of Directors: Thomas L. DeitrichDIRECTOR ELECTIONSISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To elect seven directors nominated by our Board of Directors: Hassane El-KhouryDIRECTOR ELECTIONSISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To elect seven directors nominated by our Board of Directors: Bruce E. KiddooDIRECTOR ELECTIONSISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To elect seven directors nominated by our Board of Directors: Paul A. MascarenasDIRECTOR ELECTIONSISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To elect seven directors nominated by our Board of Directors: Gregory L. WatersDIRECTOR ELECTIONSISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To elect seven directors nominated by our Board of Directors: Christine Y. YanDIRECTOR ELECTIONSISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To vote on an advisory (non-binding) resolution to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER3797719.0000000FOR3797719.000000FORS000005327ON Semiconductor Corporation682189105US682189105705/14/2026To vote on a stockholder proposal regarding simple majority voting, if properly presented at the annual meeting.CORPORATE GOVERNANCESECURITY HOLDER3797719.0000000FOR3797719.000000NONES000005327Impinj, Inc.453204109US453204109605/28/2026Election of Directors: Chris DiorioDIRECTOR ELECTIONSISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026Election of Directors: Daniel GibsonDIRECTOR ELECTIONSISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026Election of Directors: Umesh PadvalDIRECTOR ELECTIONSISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026Election of Directors: Steve SanghiDIRECTOR ELECTIONSISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026Election of Directors: Meera RaoDIRECTOR ELECTIONSISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026Election of Directors: Arthur Valdez, Jr.DIRECTOR ELECTIONSISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026Election of Directors: Miron WashingtonDIRECTOR ELECTIONSISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER152359.0000000FOR152359.000000FORS000005327Impinj, Inc.453204109US453204109605/28/2026To approve the 2026 Equity Incentive Plan.COMPENSATIONISSUER152359.0000000FOR152359.000000FORS000005327Astera Labs, Inc.04626A103US04626A103406/04/2026To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Sanjay GajendraDIRECTOR ELECTIONSISSUER1284945.0000000FOR1284945.000000FORS000005327Astera Labs, Inc.04626A103US04626A103406/04/2026To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Craig BarrattDIRECTOR ELECTIONSISSUER1284945.0000000FOR1284945.000000FORS000005327Astera Labs, Inc.04626A103US04626A103406/04/2026To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Michael HurlstonDIRECTOR ELECTIONSISSUER1284945.0000000FOR1284945.000000FORS000005327Astera Labs, Inc.04626A103US04626A103406/04/2026To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1284945.0000000FOR1284945.000000FORS000005327Astera Labs, Inc.04626A103US04626A103406/04/2026To approve, on an advisory basis, the compensation of our named executive officers ("NEOs") as disclosed in our proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER1284945.0000000FOR1284945.000000FORS000005327Astera Labs, Inc.04626A103US04626A103406/04/2026To approve, on an advisory basis, the frequency of holding future advisory votes to approve the compensation of our NEOs.SECTION 14A SAY-ON-PAY VOTESISSUER1284945.0000000ONE YEAR1284945.000000FORS000005327Taiwan Semiconductor Manufacturing Co., Ltd.874039100US874039100306/04/2026Approve Business Report and Financial StatementsCORPORATE GOVERNANCEISSUER70658.0000000FOR70658.000000FORS000005327Taiwan Semiconductor Manufacturing Co., Ltd.874039100US874039100306/04/2026Approve Amendments to Articles of AssociationCORPORATE GOVERNANCEISSUER70658.0000000FOR70658.000000FORS000005327Taiwan Semiconductor Manufacturing Co., Ltd.874039100US874039100306/04/2026Approve Amendments to Procedures Governing the Acquisition or Disposal of AssetsCORPORATE GOVERNANCEISSUER70658.0000000FOR70658.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Adoption of the 2025 Statutory Annual AccountsCORPORATE GOVERNANCEISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Discharge of the members of the Company's Board of Directors (the "Board") for their responsibilities in the financial year ended December 31, 2025CORPORATE GOVERNANCEISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Rafael Sotomayor as executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Annette Clayton as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Anthony Foxx as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Moshe Gavrielov as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Chunyuan Gu as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Lena Olving as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Julie Southern as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Jasmin Staiblin as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Gregory Summe as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Appoint Karl-Henrik Sundstrom as non-executive directorDIRECTOR ELECTIONSISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Authorization of the Board to issues ordinary shares of the Company ("ordinary shares") and grant rights to acquire ordinary sharesCAPITAL STRUCTUREISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Authorization of the Board to restrict or exclude preemption rights accruing in the connection with an issue of shares or grant of rightsCAPITAL STRUCTUREISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Authorization of the Board to repurchase ordinary sharesCAPITAL STRUCTUREISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Authorization of the Board to cancel ordinary shares held or to be acquired by the CompanyCAPITAL STRUCTUREISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Re-appointment of EY Accountants B.V. as our independent auditors for the fiscal year ending December 31, 2026AUDIT-RELATEDISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Amended remuneration of the non-executive directorsCOMPENSATIONISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Non-binding, advisory vote to approve Named Executive Officer compensationSECTION 14A SAY-ON-PAY VOTESISSUER1527881.0000000FOR1527881.000000FORS000005327NXP Semiconductors N.V.N6596X109NL000953878406/10/2026Non-binding, advisory vote on the frequency of future shareholder advisory votes on Named Executive Officer compensationSECTION 14A SAY-ON-PAY VOTESISSUER1527881.0000000ONE YEAR1527881.000000FORS000005327Monolithic Power Systems, Inc.609839105US609839105406/11/2026Election of Directors: Victor K. LeeDIRECTOR ELECTIONSISSUER280572.0000000FOR280572.000000FORS000005327Monolithic Power Systems, Inc.609839105US609839105406/11/2026Election of Directors: Jeff ZhouDIRECTOR ELECTIONSISSUER280572.0000000FOR280572.000000FORS000005327Monolithic Power Systems, Inc.609839105US609839105406/11/2026Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER280572.0000000FOR280572.000000FORS000005327Monolithic Power Systems, Inc.609839105US609839105406/11/2026Approve, on an advisory basis, the 2025 executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER280572.0000000FOR280572.000000FORS000005327Aeva Technologies, Inc.00835Q202US00835Q202106/18/2026Election of Class II Directors: Hrach SimonianDIRECTOR ELECTIONSISSUER5620.00000018000.000000WITHHOLD5620.000000AGAINSTS000005327Aeva Technologies, Inc.00835Q202US00835Q202106/18/2026Election of Class II Directors: Stephen ZadeskyDIRECTOR ELECTIONSISSUER5620.00000018000.000000WITHHOLD5620.000000AGAINSTS000005327Aeva Technologies, Inc.00835Q202US00835Q202106/18/2026Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm.AUDIT-RELATEDISSUER5620.00000018000.000000FOR5620.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Reelect Eitan Oppenhaim as DirectorDIRECTOR ELECTIONSISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Reelect Avi Cohen as DirectorDIRECTOR ELECTIONSISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Reelect Raanan Cohen as DirectorDIRECTOR ELECTIONSISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Reelect Sarit Sagiv as DirectorDIRECTOR ELECTIONSISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Reelect Zehava Simon as DirectorDIRECTOR ELECTIONSISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Reelect Yaniv Garty as DirectorDIRECTOR ELECTIONSISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Elect Rami Hadar as DirectorDIRECTOR ELECTIONSISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Approve Amended Employment Terms of Gabriel Waisman, President and CEOCOMPENSATIONISSUER36432.000000277300.000000FOR36432.000000FORS000005327Nova Ltd.M7516K103IL001084557106/18/2026Reappoint Kost Forer Gabbay & Kasierer as AuditorsAUDIT-RELATEDISSUER36432.000000277300.000000FOR36432.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Tench CoxeDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: John O. DabiriDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Jen-Hsun HuangDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Dawn HudsonDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Harvey C. JonesDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Melissa B. LoraDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Stephen C. NealDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: A. Brooke SeawellDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Aarti ShahDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Election of Directors: Mark A. StevensDIRECTOR ELECTIONSISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Advisory approval of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2027.AUDIT-RELATEDISSUER7598536.0000000FOR7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard.CORPORATE GOVERNANCESECURITY HOLDER7598536.0000000FOR7598536.000000AGAINSTS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups.OTHER SOCIAL ISSUESSECURITY HOLDER7598536.0000000AGAINST7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Approval of a non-binding stockholder proposal requesting a report on workforce civil liberties.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER7598536.0000000AGAINST7598536.000000FORS000005327NVIDIA Corporation67066G104US67066G104006/24/2026Approval of a non-binding stockholder proposal requesting reporting on greenhouse gas emissions from the use of our sold products.ENVIRONMENT OR CLIMATESECURITY HOLDER7598536.0000000AGAINST7598536.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Amend Articles to Remove Provisions on Non-Common SharesCORPORATE GOVERNANCEISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Elect Director Ota, HiroDIRECTOR ELECTIONSISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Elect Director Stacy J. SmithDIRECTOR ELECTIONSISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Elect Director Sugimoto, YujiDIRECTOR ELECTIONSISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Elect Director Suekane, MasashiDIRECTOR ELECTIONSISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Elect Director Suzuki, HiroshiDIRECTOR ELECTIONSISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Elect Director Michael R. SplinterDIRECTOR ELECTIONSISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Elect Director Higashi, EmikoDIRECTOR ELECTIONSISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Appoint Statutory Auditor Yamamoto, ChizukoCOMPENSATIONCORPORATE GOVERNANCEISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Approve Compensation Ceiling for DirectorsCOMPENSATIONISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Approve Restricted Stock PlanCOMPENSATIONISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Approve Performance Share PlanCOMPENSATIONISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Approve Restricted Stock PlanCOMPENSATIONISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Approve Restricted Stock PlanCOMPENSATIONISSUER166300.0000000FOR166300.000000FORS000005327Kioxia Holdings Corp.J3343A10706/25/2026Approve Performance Share PlanCOMPENSATIONISSUER166300.0000000FOR166300.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026Election of Directors: Sara AndrewsDIRECTOR ELECTIONSISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026Election of Directors: Brad W. BussDIRECTOR ELECTIONSISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026Election of Directors: Rebecca W. HouseDIRECTOR ELECTIONSISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026Election of Directors: Marachel L. KnightDIRECTOR ELECTIONSISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026Election of Directors: Matthew J. MurphyDIRECTOR ELECTIONSISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026Election of Directors: Rajiv RamaswamiDIRECTOR ELECTIONSISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026Election of Directors: Richard P. WallaceDIRECTOR ELECTIONSISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026An advisory (non-binding) vote to approve compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026To ratify the appointment of Deloitte and Touche LLP as our independent registered public accounting firm for the fiscal year ending January 30, 2027.AUDIT-RELATEDISSUER3795123.0000000FOR3795123.000000FORS000005327Marvell Technology, Inc.573874104US573874104106/25/2026To consider and act on one stockholder proposal, entitled "Independent Board Chairman", if properly presented at the Annual Meeting.CORPORATE GOVERNANCESECURITY HOLDER3795123.0000000AGAINST3795123.000000FORS000005327Corebridge Financial, Inc.21871X109US21871X109007/09/2025An amendment to Corebridge's Amended and Restated Certificate of Incorporation (the "Existing Charter") to expressly authorize the Board of Directors to approve amendments to Corebridge's By-laws.CORPORATE GOVERNANCEISSUER139801.0000000FOR139801.000000FORS000005328Corebridge Financial, Inc.21871X109US21871X109007/09/2025An Amendment to the Existing Charter to implement provisions governing stockholder action by written consent, including a requirement that stockholders owning at least 25% of the voting power of the outstanding shares of Corebridge capital stock entitled to consent on the action sought to be taken by written consent must submit a written request before the Board of Directors is required to fix a record date for stockholders entitled to take action by written consent without Board support (together with the amendment contemplated by Proposal 1, the "Charter Amendments").CORPORATE GOVERNANCEISSUER139801.0000000FOR139801.000000FORS000005328Corebridge Financial, Inc.21871X109US21871X109007/09/2025The adjournment of the Special Meeting, from time to time, if necessary or appropriate, as determined in good faith by the Board, including to solicit additional proxies if there are not sufficient votes in favor of any of the Charter Amendments.CORPORATE GOVERNANCEISSUER139801.0000000FOR139801.000000FORS000005328Patria Investments LimitedG69451105KYG69451105909/10/2025Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER376200.00000049100.000000FOR376200.000000FORS000005328Patria Investments LimitedG69451105KYG69451105909/10/2025Elect Daniel Rizardi Sorrentino as DirectorDIRECTOR ELECTIONSISSUER376200.00000049100.000000AGAINST376200.000000AGAINSTS000005328AUB Group LimitedQ0647P113AU000000AUB911/13/2025Approve Remuneration ReportCOMPENSATIONISSUER290105.0000000FOR290105.000000FORS000005328AUB Group LimitedQ0647P113AU000000AUB911/13/2025Elect Tonianne Dwyer as DirectorDIRECTOR ELECTIONSISSUER290105.0000000FOR290105.000000FORS000005328AUB Group LimitedQ0647P113AU000000AUB911/13/2025Approve Issuance of Performance Share Rights to Michael EmmettCOMPENSATIONISSUER290105.0000000FOR290105.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Mark W. BegorDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Marlene DebelDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Jeffrey N. EdwardsDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Benjamin C. EstyDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Art A. GarciaDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Anne GatesDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Raymond W. McDaniel, Jr.DIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Roderick C. McGearyDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Cecily M. MistarzDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Paul C. ReillyDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Raj SeshadriDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026ELECTION OF DIRECTORS: Paul M. ShoukryDIRECTOR ELECTIONSISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026To approve the Amended and Restated 2012 Stock Incentive Plan.COMPENSATIONISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026To approve the Amended and Restated 2003 Employee Stock Purchase Plan.COMPENSATIONISSUER4350.00000040200.000000FOR4350.000000FORS000005328Raymond James Financial, Inc.754730109US754730109002/19/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm.AUDIT-RELATEDISSUER4350.00000040200.000000FOR4350.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Jorge A. BermudezDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Sumit DhawanDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Therese EsperdyDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Robert FauberDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Vincent A. ForlenzaDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Jose M. MinayaDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Lisa P. SawickiDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Leslie F. SeidmanDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Zig SerafinDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Election of Directors: Bruce Van SaunDIRECTOR ELECTIONSISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Ratification of the appointment of KPMG LLP as independent registered public accounting firm of the Company for 2026.AUDIT-RELATEDISSUER22400.0000000FOR22400.000000FORS000005328Moody's Corporation615369105US615369105904/14/2026Advisory resolution approving executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER22400.0000000FOR22400.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Louis M. AltmanDIRECTOR ELECTIONSISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: John L. BookmyerDIRECTOR ELECTIONSISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Todd F. ClossinDIRECTOR ELECTIONSISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Denise Knouse-SnyderDIRECTOR ELECTIONSISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: F. Eric Nelson, Jr.DIRECTOR ELECTIONSISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (b) For a term of one (1) year expiring at the annual stockholders meeting in 2027: Joseph R. RobinsonDIRECTOR ELECTIONSISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers in 2025.SECTION 14A SAY-ON-PAY VOTESISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To approve an advisory (non-binding) vote ratifying the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER130200.0000000FOR130200.000000FORS000005328Wesbanco, Inc.950810101US950810101404/15/2026To approve the Wesbanco, Inc. 2026 Equity Incentive Plan.COMPENSATIONISSUER130200.0000000FOR130200.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: John P. BarnesDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Carlton J. CharlesDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Jane ChwickDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: William F. Cruger, Jr.DIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Leslie V. GodridgeDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Rene F. JonesDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Richard H. Ledgett, Jr.DIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Melinda R. RichDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Denis J. SalamoneDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Rudina SeseriDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Kirk W. WaltersDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO ELECT 12 DIRECTORS FOR ONE-YEAR TERMS AND UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED: Herbert L. WashingtonDIRECTOR ELECTIONSISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE 2025 COMPENSATION OF M&T BANK CORPORATION'S NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE M&T BANK CORPORATION 2019 EQUITY INCENTIVE COMPENSATION PLAN.COMPENSATIONISSUER56688.0000000FOR56688.000000FORS000005328M&T Bank Corporation55261F104US55261F104904/21/2026TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF M&T BANK CORPORATION FOR THE YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER56688.0000000FOR56688.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Susan CrownDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Chandra DhandapaniDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Dean M. HarrisonDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Jay L. HendersonDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Marcy S. KlevornDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Siddharth N. (Bobby) MehtaDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Robert E. MoritzDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Michael G. O'GradyDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Richard M. PetrinoDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Martin P. SlarkDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: David H. B. Smith, Jr.DIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Donald ThompsonDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Election of 13 Directors: Charles A. Tribbett IIIDIRECTOR ELECTIONSISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Approval, by an advisory vote, of the 2025 compensation of the Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Approval of the Corporation's 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER54500.0000000FOR54500.000000FORS000005328Northern Trust Corporation665859104US665859104404/21/2026Ratification of the appointment of KPMG LLP as the Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER54500.0000000FOR54500.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Warner L. BaxterDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Dorothy BridgesDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Elizabeth L. BuseDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Alan B. ColbergDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Kimberly N. Ellison-TaylorDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Aleem GillaniDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Roland A. HernandezDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Gunjan KediaDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Richard P. McKenneyDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Yusuf I. MehdiDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: Loretta E. ReynoldsDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The election of each of the 12 directors named in the proxy statement: John P. WiehoffDIRECTOR ELECTIONSISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026An advisory vote to approve the compensation of our executives disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER246000.0000000FOR246000.000000FORS000005328U.S. Bancorp902973304US902973304804/21/2026The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER246000.0000000FOR246000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: Tertia M. FreasDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: Michael K. FujimotoDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: Robert S. HarrisonDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: James S. MoffattDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: Mark M. MugiishiDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: Kelly A. ThompsonDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: Vanessa L. WashingtonDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Election of Directors: C. Scott WoDIRECTOR ELECTIONSISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026An advisory vote on the compensation of the Company's named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER163000.0000000FOR163000.000000FORS000005328First Hawaiian, Inc.32051X108US32051X108104/22/2026Ratification of the appointment of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER163000.0000000FOR163000.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve CEO's Report and External Auditor's ReportCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Board's Report on Operations and Results of CompanyCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Board's Opinion on CEO's ReportCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve to Add Copy of Reports Mentioned in Previous Items and Opinion to Minutes of MeetingCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Board's Report on Policies and Accounting Information and Criteria Followed in Preparation of Financial InformationCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Report on Activities and Operations Undertaken by BoardCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Individual and Consolidated Financial StatementsCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Chair's Report of Audit CommitteeCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Chair's Report of Corporate Practices CommitteeCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Reports of Other CommitteesCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Discharge of BoardCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Discharge of Audit CommitteeCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Discharge of Corporate Practices CommitteeCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Report of Statutory AuditorsCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Accept Report on Compliance with Fiscal ObligationsCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Allocation of MXN 1.6 Billion; Maintain Legal ReserveCAPITAL STRUCTUREISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Allocation of MXN 2.19 Billion to Reserve of Accumulated Earnings Pending to be AppliedCAPITAL STRUCTUREISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Cash Dividends of MXN 2.05 Per ShareCAPITAL STRUCTUREISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Discharge of BoardCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Marcos Alejandro Martinez Gavica as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Eduardo Cepeda Fernandez as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000AGAINST1749841.000000AGAINSTS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Gina Diez Barroso Azcarraga as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Felipe Garcia Ascencio as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Claudia Janez Sanchez as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Jose Kaun Nader as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Ernesto Ortega Arellano as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Tania Ortiz Mena Lopez Negrete as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Eduardo Osuna Osuna as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000AGAINST1749841.000000AGAINSTS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Marcos Ramirez Miguel as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000AGAINST1749841.000000AGAINSTS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Clemente Ismael Reyes-Retana Valdes as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Alberto Torrado Martinez as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Blanca Avelina Trevino de Vega as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Eduardo Valdes Acra as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Alvaro Vaqueiro Ussel as DirectorDIRECTOR ELECTIONSISSUER1749841.0000000AGAINST1749841.000000AGAINSTS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Tomas Christian Ehrenberg Aldford as Alternate DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Felipe Garcia-Moreno Rodriguez as Alternate DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Elect or Ratify Jose Armando Rodal Espinosa as Alternate DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Any Alternate Director Can Replace DirectorDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Independence Classification of Independent DirectorsDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Accept Resignation of Each Person Who do not Ratify themselves as DirectorDIRECTOR ELECTIONSAUDIT-RELATEDCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Marcos Alejandro Martinez Gavica as Board ChairDIRECTOR ELECTIONSISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Rafael Robles Miaja as Secretary of BoardCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Maria Luisa Petricioli Castellon as Deputy Secretary of BoardCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify J. Luis Garcia Ramirez as Statutory AuditorCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Clemente Ismael Reyes-Retana Valdes as Chair of Audit CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Claudia Janez Sanchez as Member of Audit CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Marcos Alejandro Martinez Gavica as Member of Audit CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Eduardo Valdes Acra as Member of Audit CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Tania Ortiz Mena Lopez Negrete as Chair of Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Gina Diez Barroso Azcarraga as Member of Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Alberto Torrado Martinez as Member of Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Ratify Marcos Alejandro Martinez Gavica as Member of Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Authorize Board to Elect Rest of Members and Chairs of CommitteesDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Remuneration of Directors and Company SecretaryCOMPENSATIONISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Remuneration of Members of Audit Committee in the Amount of MXN 60,000COMPENSATIONISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Remuneration of Members of Corporate Practices Committees in the Amount of MXN 60,000COMPENSATIONISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Report of Policies Related to Repurchase of SharesCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Approve Report on Company Has 38.75 Million Series A Class I Repurchase SharesCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Set Amount of Share Repurchase ReserveCAPITAL STRUCTUREISSUER1749841.0000000FOR1749841.000000FORS000005328Bolsa Mexicana de Valores SAB de CVP17330104MX01BM1B000004/27/2026Authorize Rafael Robles Miaja, Maria Luisa Petricioli Castellon and Clementina Ramirez de Arellano Moreno to Ratify and Execute Approved ResolutionsCORPORATE GOVERNANCEISSUER1749841.0000000FOR1749841.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Judith P. GreffinDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Michael J. HaddadDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Andrew J. HarmeningDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Rodney Jones-TysonDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Eileen A. KamerickDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Kristen M. LudgateDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Cory L. NettlesDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Owen J. SullivanDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: Karen T. van LithDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Election of Directors: John (Jay) B. WilliamsDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026Advisory approval of Associated Banc-Corp's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026The ratification of the selection of KPMG LLP as the independent registered public accounting firm for Associated Banc-Corp for the year ending December 31, 2026.AUDIT-RELATEDISSUER241847.0000000FOR241847.000000FORS000005328Associated Banc-Corp045487105US045487105604/28/2026To elect Wende Kotouc as a DirectorDIRECTOR ELECTIONSISSUER241847.0000000FOR241847.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Jennifer S. BannerDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: K. David Boyer, Jr.DIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Agnes Bundy ScanlanDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Dallas S. ClementDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Linnie M. HaynesworthDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Donna S. MoreaDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Charles A. PattonDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Jonathan M. PruzanDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: William H. Rogers, Jr.DIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Thomas E. SkainsDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Laurence SteinDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026The election of twelve directors, each for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Bruce L. TannerDIRECTOR ELECTIONSISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026Advisory vote to approve Truist's executive compensation program.SECTION 14A SAY-ON-PAY VOTESISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026Ratification of the appointment of PricewaterhouseCoopers LLP as Truist's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026Approval of the amendment and restatement of the Truist Financial Corporation 2022 Incentive Plan.COMPENSATIONISSUER291900.0000000FOR291900.000000FORS000005328Truist Financial Corporation89832Q109US89832Q109404/28/2026Shareholder proposal regarding a report on risks from misalignment between Company policies and customer base, if properly presented.OTHER SOCIAL ISSUESSECURITY HOLDER291900.0000000AGAINST291900.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Robin C. BeeryDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Janine A. DavidsonDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Kevin C. GallagherDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Greg M. GravesDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Bradley J. HendersonDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Jennifer K. HopkinsDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: J. Mariner KemperDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Gordon E. Lansford IIIDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Margaret LazoDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Susan G. MurphyDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Tamara M. PetermanDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Kris A. RobbinsDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: L. Joshua SoslandDIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026Election of Directors: Leroy J. Williams, Jr.DIRECTOR ELECTIONSISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026An advisory vote (non-binding) on the compensation paid to UMB's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026The ratification of the Corporate Audit Committee's engagement of KPMG LLP as UMB's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER68445.0000000FOR68445.000000FORS000005328UMB Financial Corporation902788108US902788108804/28/2026The approval of the Amended and Restated UMB Financial Corporation Omnibus Incentive Compensation Plan as presented.COMPENSATIONISSUER68445.0000000FOR68445.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Steven D. BlackDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Mark A. ChancyDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Theodore F. Craver, Jr.DIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Richard K. DavisDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Fabian T. GarciaDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Wayne M. HewettDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: CeCelia G. MorkenDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Maria R. MorrisDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Felicia F. NorwoodDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Ronald L. SargentDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Charles W. ScharfDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Election of Directors: Suzanne M. VautrinotDIRECTOR ELECTIONSISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Advisory resolution to approve executive compensation (Say on Pay).SECTION 14A SAY-ON-PAY VOTESISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Proposal to amend and restate the Company's 2022 Long-Term Incentive Plan.COMPENSATIONISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Proposal to ratify KPMG as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER523528.0000000FOR523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair.CORPORATE GOVERNANCESECURITY HOLDER523528.0000000AGAINST523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Shareholder Proposal - Govern by Majority Vote.CORPORATE GOVERNANCESECURITY HOLDER523528.0000000FOR523528.000000AGAINSTS000005328Wells Fargo & Company949746101US949746101504/28/2026Shareholder Proposal - Energy Supply Ratio.ENVIRONMENT OR CLIMATESECURITY HOLDER523528.0000000AGAINST523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Shareholder Proposal - Report on High-Carbon Financing Litigation Risks.ENVIRONMENT OR CLIMATESECURITY HOLDER523528.0000000AGAINST523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Shareholder Proposal - Board Committee on Indigenous Peoples' Rights.CORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER523528.0000000AGAINST523528.000000FORS000005328Wells Fargo & Company949746101US949746101504/28/2026Shareholder Proposal - Report on Respecting Vendor Civil Liberties.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER523528.0000000AGAINST523528.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Approve Remuneration PolicyCOMPENSATIONISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Approve Remuneration ReportCOMPENSATIONISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Approve Final DividendCAPITAL STRUCTUREISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Philip Broadley as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Bob Cox as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Paul Gregory as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Jack Gressier as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Bryan Joseph as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Natalie Kershaw as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Alex Maloney as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Irene McDermott Brown as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Nathalie Rachou as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Linda Ventresca as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Re-elect Sally Williams as DirectorDIRECTOR ELECTIONSISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Reappoint KPMG LLP as AuditorsAUDIT-RELATEDISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Authorise Board to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Approve Restricted Share SchemeCOMPENSATIONISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Authorise Issue of EquityCAPITAL STRUCTUREISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Authorise Issue of Equity without Pre-emptive RightsCAPITAL STRUCTUREISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital InvestmentCAPITAL STRUCTUREISSUER538766.0000000FOR538766.000000FORS000005328Lancashire Holdings Ltd.G5361W104BMG5361W104704/29/2026Authorise Market Purchase of Common SharesCAPITAL STRUCTUREISSUER538766.0000000FOR538766.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: AINAR D. AIJALA, JR.DIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: LISA ROJAS BACUSDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: TERRENCE W. CAVANAUGHDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: ROBERT KELLY DOHERTYDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: JOHN J. MARCHIONIDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: THOMAS A. MCCARTHYDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: STEPHEN C. MILLSDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: H. ELIZABETH MITCHELLDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: CYNTHIA S. NICHOLSONDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: JULIE PARSONSDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: KATE E. R. SAMPSONDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026ELECTION OF DIRECTORS: JOHN S. SCHEIDDIRECTOR ELECTIONSISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026APPROVAL ON AN ADVISORY BASIS OF THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERSSECTION 14A SAY-ON-PAY VOTESISSUER94200.0000000FOR94200.000000FORS000005328Selective Insurance Group, Inc.816300107US816300107104/29/2026RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMAUDIT-RELATEDISSUER94200.0000000FOR94200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Maria Contreras-SweetDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Gary L. CrittendenDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Suren K. GuptaDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Claire A. HuangDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Vivian S. LeeDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Scott J. McLeanDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Edward F. MurphyDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Stephen D. QuinnDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Harris H. SimmonsDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Aaron B. SkonnardDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To elect 11 director nominees for a one-year term (Proposal 1): Barbara A. YastineDIRECTOR ELECTIONSISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To ratify the appointment of our independent registered public accounting firm for our fiscal year ending Dec. 31, 2026 (Proposal 2);AUDIT-RELATEDISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To approve, on a nonbinding advisory basis, the compensation paid to our named executive officers with respect to the fiscal year ended Dec. 31, 2025 (Proposal 3); andSECTION 14A SAY-ON-PAY VOTESISSUER60200.0000000FOR60200.000000FORS000005328Zions Bancorporation, N.A.989701107US989701107105/01/2026To consider a shareholder proposal regarding "Report on Risks from Misalignment Between Company Policies and Customer Base."OTHER SOCIAL ISSUESSECURITY HOLDER60200.0000000AGAINST60200.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Sharon L. AllenDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Jose (Joe) E. AlmeidaDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Arnold W. DonaldDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Monica C. LozanoDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Maria N. MartinezDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Brian T. MoynihanDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Lionel L. Nowell IIIDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Denise L. RamosDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Clayton S. RoseDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Michael D. WhiteDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Thomas D. WoodsDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Electing Directors: Maria T. ZuberDIRECTOR ELECTIONSISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Approving our executive compensation (an advisory, non-binding "Say on Pay" resolution)SECTION 14A SAY-ON-PAY VOTESISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Ratifying the appointment of our independent registered public accounting firm for 2026AUDIT-RELATEDISSUER798756.0000000FOR798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Shareholder proposal requesting independent board chairCORPORATE GOVERNANCESECURITY HOLDER798756.0000000AGAINST798756.000000FORS000005328Bank of America Corporation060505104US060505104605/04/2026Shareholder proposal requesting report on board oversight of risks related to animal welfareOTHER SOCIAL ISSUESSECURITY HOLDER798756.0000000AGAINST798756.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Alan S. ArmstrongDIRECTOR ELECTIONSISSUER66900.0000000WITHHOLD66900.000000AGAINSTS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Steven BangertDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: John W. CoffeyDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Joseph W. Craft, IIIDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: David F. GriffinDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: E. Carey Joullian, IVDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: George B. KaiserDIRECTOR ELECTIONSISSUER66900.0000000WITHHOLD66900.000000AGAINSTS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Stacy C. KymesDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Steven J. MalcolmDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Emmet C. RichardsDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Claudia S. San PedroDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Kayse M. ShrumDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Michael C. TurpenDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Robert A. WaldoDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Election of Directors: Rose M. Washington-JonesDIRECTOR ELECTIONSISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Ratification of the selection of Ernst & Young LLP as BOK Financial Corporation's independent auditors for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER66900.0000000FOR66900.000000FORS000005328BOK Financial Corporation05561Q201US05561Q201205/05/2026Advisory approval of the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER66900.0000000FOR66900.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: J. Hyatt BrownDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: J. Powell BrownDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Lawrence L. Gellerstedt IIIDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Theodore J. HoepnerDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: James S. HuntDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Toni JenningsDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Joia M. JohnsonDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Paul J. KrumpDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Timothy R.M. MainDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Bronislaw E. MasojadaDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Jaymin B. PatelDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: H. Palmer Proctor, Jr.DIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Wendell S. ReillyDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026Election of Directors: Kathleen A. SavioDIRECTOR ELECTIONSISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026To ratify the appointment of Deloitte & Touche LLP as Brown & Brown, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026To approve, on an advisory basis, the compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER113400.0000000FOR113400.000000FORS000005328Brown & Brown, Inc.115236101US115236101005/06/2026To approve an amendment to Brown & Brown, Inc.'s 2019 Stock Incentive Plan to increase the number of shares available for issuance under the plan and extend the term.COMPENSATIONISSUER113400.0000000FOR113400.000000FORS000005328Essent Group Ltd.G3198U102BMG3198U102705/06/2026ELECTION OF DIRECTORS: Mark Casale Class III DirectorDIRECTOR ELECTIONSISSUER569.0000000FOR569.000000FORS000005328Essent Group Ltd.G3198U102BMG3198U102705/06/2026ELECTION OF DIRECTORS: Douglas J. Pauls Class III DirectorDIRECTOR ELECTIONSISSUER569.0000000FOR569.000000FORS000005328Essent Group Ltd.G3198U102BMG3198U102705/06/2026ELECTION OF DIRECTORS: William Spiegel Class III DirectorDIRECTOR ELECTIONSISSUER569.0000000FOR569.000000FORS000005328Essent Group Ltd.G3198U102BMG3198U102705/06/2026REAPPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDED DECEMBER 31, 2026 AND UNTIL THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS, AND TO REFER THE DETERMINATION OF THE AUDITORS' COMPENSATION TO THE BOARD OF DIRECTORS.AUDIT-RELATEDISSUER569.0000000FOR569.000000FORS000005328Essent Group Ltd.G3198U102BMG3198U102705/06/2026PROVIDE A NON-BINDING, ADVISORY VOTE ON OUR EXECUTIVE COMPENSATION.SECTION 14A SAY-ON-PAY VOTESISSUER569.0000000FOR569.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Annabelle BexigaDIRECTOR ELECTIONSISSUER29300.0000000AGAINST29300.000000AGAINSTS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: David L. BunchDIRECTOR ELECTIONSISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Ronald F. ClarkeDIRECTOR ELECTIONSISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Joseph W. FarrellyDIRECTOR ELECTIONSISSUER29300.0000000AGAINST29300.000000AGAINSTS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Rahul GuptaDIRECTOR ELECTIONSISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Thomas M. HagertyDIRECTOR ELECTIONSISSUER29300.0000000AGAINST29300.000000AGAINSTS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Archie L. Jones, Jr.DIRECTOR ELECTIONSISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Richard MacchiaDIRECTOR ELECTIONSISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Hala G. ModdelmogDIRECTOR ELECTIONSISSUER29300.0000000AGAINST29300.000000AGAINSTS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Jeffrey S. SloanDIRECTOR ELECTIONSISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Steven T. StullDIRECTOR ELECTIONSISSUER29300.0000000AGAINST29300.000000AGAINSTS000005328Corpay, Inc.219948106US219948106805/07/2026Elect Directors nominated by the Board of Directors for a one-year term: Gerald ThroopDIRECTOR ELECTIONSISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Ratify the re-appointment of Ernst & Young LLP as Corpay's independent public accounting firm for 2026.AUDIT-RELATEDISSUER29300.0000000FOR29300.000000FORS000005328Corpay, Inc.219948106US219948106805/07/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER29300.0000000AGAINST29300.000000AGAINSTS000005328Corpay, Inc.219948106US219948106805/07/2026Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting.CORPORATE GOVERNANCESECURITY HOLDER29300.0000000AGAINST29300.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Richard D. FairbankDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Ime ArchibongDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Christine DetrickDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Suni P. HarfordDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Peter Thomas KillaleaDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Cornelis ("Eli") LeenaarsDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Francois Locoh-DonouDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Peter E. RaskindDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Eileen SerraDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Mayo A. Shattuck IIIDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: J. Michael ShepherdDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Craig Anthony WilliamsDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Election of Directors: Jennifer L. WongDIRECTOR ELECTIONSISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Advisory vote on our Named Executive Officer compensation ("Say on Pay").SECTION 14A SAY-ON-PAY VOTESISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER80957.0000000FOR80957.000000FORS000005328Capital One Financial Corporation14040H105US14040H105905/08/2026Stockholder proposal to require a shareholder vote on golden parachute arrangements.COMPENSATIONSECURITY HOLDER80957.0000000AGAINST80957.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Alejandro M. BallesterDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Robert CarradyDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Richard L. CarrionDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Bertil E. ChappuisDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Betty DeVitaDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Maria Luisa Ferre RangelDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Javier D. FerrerDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: C. Kim GoodwinDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Jose R. RodriguezDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Alejandro M. SanchezDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Carlos A. UnanueDIRECTOR ELECTIONSISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026To approve an amendment to Popular's Restated Certificate of Incorporation to modernize indemnification provisions.CORPORATE GOVERNANCEISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026To approve an amendment to Popular's Restated Certificate of Incorporation to provide for director and officer exculpation to the extent permitted by Puerto Rico law.CORPORATE GOVERNANCEISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Approve, on an advisory basis, the Corporation's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER60371.0000000FOR60371.000000FORS000005328Popular, Inc.733174700PR733174700105/08/2026Ratify the appointment of PricewaterhouseCoopers LLP as the Corporation's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER60371.0000000FOR60371.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: Deborah CaplanDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: Teresa ClarkeDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: John ColdmanDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: Richard HarriesDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: Pat GallagherDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: David JohnsonDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: Chris MiskelDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: Ralph NicolettiDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Election of Directors: Norman RosenthalDIRECTOR ELECTIONSISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Ratification of the Appointment of Ernst & Young LLP as our Independent Auditor for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER45800.0000000FOR45800.000000FORS000005328Arthur J. Gallagher & Co.363576109US363576109705/12/2026Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER45800.0000000FOR45800.000000FORS000005328First American Financial Corporation31847R102US31847R102305/12/2026Election of Class I director nominees: Mark E. SeatonDIRECTOR ELECTIONSISSUER128900.0000000FOR128900.000000FORS000005328First American Financial Corporation31847R102US31847R102305/12/2026Election of Class I director nominees: Marsha A. SpenceDIRECTOR ELECTIONSISSUER128900.0000000FOR128900.000000FORS000005328First American Financial Corporation31847R102US31847R102305/12/2026Election of Class I director nominees: Deborah L. WahlDIRECTOR ELECTIONSISSUER128900.0000000FOR128900.000000FORS000005328First American Financial Corporation31847R102US31847R102305/12/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER128900.0000000FOR128900.000000FORS000005328First American Financial Corporation31847R102US31847R102305/12/2026To approve amendments to eliminate supermajority voting requirements in the Certificate of Incorporation.CORPORATE GOVERNANCEISSUER128900.0000000FOR128900.000000FORS000005328First American Financial Corporation31847R102US31847R102305/12/2026To approve amendments to the Certificate of Incorporation to declassify the board and phase-in annual director elections.SHAREHOLDER RIGHTS AND DEFENSESISSUER128900.0000000FOR128900.000000FORS000005328First American Financial Corporation31847R102US31847R102305/12/2026To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER128900.0000000FOR128900.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: George M. AwadDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Christopher A. CartwrightDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Sayan ChakrabortyDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Suzanne P. ClarkDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Hamidou DiaDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Russell P. FradinDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Charles E. GottdienerDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Pamela A. JosephDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Thomas L. Monahan, IIIDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Ravi Kumar SingisettiDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Charlotte B. YarkoniDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Election of Directors: Linda K. ZukauckasDIRECTOR ELECTIONSISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Ratification of appointment of PricewaterhouseCoopers LLP as TransUnion's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026To approve, on a non-binding advisory basis, the compensation of TransUnion's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER100200.0000000FOR100200.000000FORS000005328TransUnion89400J107US89400J107905/12/2026Advisory vote on a stockholder proposal requesting a stockholder right to call a special meeting.CORPORATE GOVERNANCESECURITY HOLDER100200.0000000AGAINST100200.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Barbara A. BoigegrainDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Thomas L. BrownDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Kathryn J. HayleyDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Peter J. HenselerDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Daniel S. HermannDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Ryan C. KitchellDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Daniel C. ReardonDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: James C. Ryan, IIIDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Thomas E. SalmonDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Michael J. SmallDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Derrick J. StewartDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Election of Directors: Katherine E. WhiteDIRECTOR ELECTIONSISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Approval of a non-binding advisory proposal on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026.AUDIT-RELATEDISSUER417233.0000000FOR417233.000000FORS000005328Old National Bancorp680033107US680033107505/13/2026Approval of the Company's 2026 Equity Compensation Plan.COMPENSATIONISSUER417233.0000000FOR417233.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: Jennifer M. BazanteDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: George B. BellDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: James P. ClementsDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: Kenneth L. DanielsDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: Sally Pope DavisDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: Lance F. DrummondDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: H. Lynn HartonDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: John M. JamesDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: Jennifer K. MannDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: Thomas A. RichlovskyDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: Tim R. WallisDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026Election of Directors: David H. WilkinsDIRECTOR ELECTIONSISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026To approve, on an advisory basis, the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER129100.0000000FOR129100.000000FORS000005328United Community Banks, Inc.90984P303US90984P303805/13/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER129100.0000000FOR129100.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Approve Remuneration ReportCOMPENSATIONISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Approve Remuneration PolicyCOMPENSATIONISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Approve UK Sharesave Scheme and International Sharesave SchemeCOMPENSATIONISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Approve Share Award PlanCOMPENSATIONISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Approve Final DividendCAPITAL STRUCTUREISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Elect Peter Clarke as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Lynne Biggar as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Beth Boucher as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Paul Cooper as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Donna DeMaio as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect June Yee Felix as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Michael Goodwin as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Jane Guyett as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Thomas Huerlimann as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Hamayou Akbar Hussain as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Constantinos Miranthis as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Re-elect Joanne Musselle as DirectorDIRECTOR ELECTIONSISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Reappoint PricewaterhouseCoopers LLP as AuditorsAUDIT-RELATEDISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Authorise the Audit Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Authorise Issue of EquityCAPITAL STRUCTUREISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Authorise Issue of Equity without Pre-emptive RightsCAPITAL STRUCTUREISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital InvestmentCAPITAL STRUCTUREISSUER388400.0000000FOR388400.000000FORS000005328Hiscox Ltd.G4593F138BMG4593F138905/14/2026Authorise Market Purchase of Ordinary SharesCAPITAL STRUCTUREISSUER388400.0000000FOR388400.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Jacqueline L. AllardDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Alexander M. CutlerDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: H. James DallasDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Antonio DeSpiritoDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Elizabeth R. GileDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Christopher M. GormanDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Robin N. HayesDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Christopher L. HensonDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Richard J. HippleDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Somesh KhannaDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Devina A. RankinDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Barbara R. SnyderDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Richard J. TobinDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Election of Directors: Todd J. VasosDIRECTOR ELECTIONSISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Ratification of the appointment of independent auditor.AUDIT-RELATEDISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Advisory approval of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER327600.0000000FOR327600.000000FORS000005328KeyCorp493267108US493267108805/14/2026Approval of the 2026 Equity Compensation Plan.COMPENSATIONISSUER327600.0000000FOR327600.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Megan ButlerDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Thomas H. GlocerDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Lynn J. GoodDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Robert H. HerzDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Yasushi ItagakiDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Erika H. JamesDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Hironori KamezawaDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Shelley B. LeibowitzDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Jami MiscikDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Dennis M. NallyDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Douglas L. PetersonDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Edward PickDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Mary L. SchapiroDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Perry M. TraquinaDIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Election of Directors: Rayford Wilkins, Jr.DIRECTOR ELECTIONSISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026To ratify the appointment of Deloitte & Touche LLP as independent auditorAUDIT-RELATEDISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026To approve the compensation of executives as disclosed in the proxy statement (non-binding advisory vote)SECTION 14A SAY-ON-PAY VOTESISSUER101800.0000000FOR101800.000000FORS000005328Morgan Stanley617446448US617446448605/14/2026Shareholder proposal requesting an independent Board ChairmanCORPORATE GOVERNANCESECURITY HOLDER101800.0000000AGAINST101800.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Manuel P. AlvarezDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Peter BabejDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Molly CampbellDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Archana DeskusDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Serge DumontDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Mark HutchinsDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Paul H. IrvingDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Sabrina KayDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Jack C. LiuDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Dominic NgDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To elect 11 directors to serve until the next annual meeting of stockholders and to serve until their successors are duly elected and qualified: Lester M. SussmanDIRECTOR ELECTIONSISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2025.SECTION 14A SAY-ON-PAY VOTESISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To approve the amendment and restatement of the East West Bancorp, Inc. 2021 Stock Incentive Plan.COMPENSATIONISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To approve the adoption of the East West Bancorp, Inc. Employee Stock Purchase Plan.COMPENSATIONISSUER48900.0000000FOR48900.000000FORS000005328East West Bancorp, Inc.27579R104US27579R104105/18/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER48900.0000000FOR48900.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To elect six directors for a one-year term: Luis A. BorgenDIRECTOR ELECTIONSISSUER361800.0000000FOR361800.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To elect six directors for a one-year term: Diane S. HessanDIRECTOR ELECTIONSISSUER361800.0000000FOR361800.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To elect six directors for a one-year term: Leon A. PalandjianDIRECTOR ELECTIONSISSUER361800.0000000FOR361800.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To elect six directors for a one-year term: Robert F. RiversDIRECTOR ELECTIONSISSUER361800.0000000FOR361800.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To elect six directors for a one-year term: Cathleen A. SchmidtDIRECTOR ELECTIONSISSUER361800.0000000FOR361800.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To elect six directors for a one-year term: Michael J. SullivanDIRECTOR ELECTIONSISSUER361800.0000000FOR361800.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To approve, in an advisory vote, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER361800.0000000FOR361800.000000FORS000005328Eastern Bankshares, Inc.27627N105US27627N105405/18/2026To ratify the appointment of Ernst & Young LLP by the Audit Committee of our Board of Directors as the Company's independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER361800.0000000FOR361800.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Joy ChikDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Jonathan ChristodoroDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Carmine Di SibioDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: David W. DormanDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Alyssa H. HenryDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Enrique LoresDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Deborah M. MessemerDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: David M. MoffettDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Ann M. SarnoffDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Deirdre StanleyDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Election of the 11 Director Nominees Named in the Proxy Statement: Frank D. YearyDIRECTOR ELECTIONSISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Approval of the PayPal Holdings, Inc. 2026 Equity Incentive Award Plan.COMPENSATIONISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Ratification of the Appointment of PricewaterhouseCoopers LLP as Our Independent Auditor for 2026.AUDIT-RELATEDISSUER400.0000000FOR400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Stockholder Proposal - Policy on Provision of Services in Conflict Zones.HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER400.0000000AGAINST400.000000FORS000005328PayPal Holdings, Inc.70450Y103US70450Y103805/19/2026Stockholder Proposal - Reduce Threshold to Call Special Meetings of Stockholders.CORPORATE GOVERNANCESECURITY HOLDER400.0000000AGAINST400.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: Carl H. Lindner IIIDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: S. Craig LindnerDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: John B. BerdingDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: Gregory G. JosephDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: Craig Lindner, Jr.DIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: Mary Beth MartinDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: Amy Y. MurrayDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: Roger K. NewportDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: Evans N. NwankwoDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: David L. ThompsonDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: William W. VerityDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Election of Directors: John I. Von LehmanDIRECTOR ELECTIONSISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Proposal to ratify the Audit Committee's appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for 2026.AUDIT-RELATEDISSUER63000.0000000FOR63000.000000FORS000005328American Financial Group, Inc.025932104US025932104205/20/2026Advisory vote on compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER63000.0000000FOR63000.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Titi ColeDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Ellen M. CostelloDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Grace E. DaileyDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: John C. DuganDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Jane FraserDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Duncan P. HennesDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Peter B. HenryDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Renee J. JamesDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Jonathan P. MouldsDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Gary M. ReinerDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Diana L. TaylorDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: James S. TurleyDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to elect 13 Directors: Casper W. von KoskullDIRECTOR ELECTIONSISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Proposal to ratify the selection of KPMG LLP as Citi's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Advisory vote to approve our 2025 Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER218005.0000000FOR218005.000000FORS000005328Citigroup Inc.172967424US172967424205/20/2026Approval of additional shares for the Citigroup 2019 Stock Incentive Plan.COMPENSATIONISSUER218005.0000000FOR218005.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Pina AlboDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Peter BabejDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Michele BangDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Tony ChengDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: John J. GauthierDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Patricia L. GuinnDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Hazel M. McNeilageDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Stephen O'HearnDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Alison RandDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Shundrawn ThomasDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Khanh T. TranDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Election of Directors: Steven C. Van WykDIRECTOR ELECTIONSISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026To approve an amended and restated Employee Stock Purchase Plan.COMPENSATIONISSUER116600.0000000FOR116600.000000FORS000005328Reinsurance Group of America, Incorporated759351604US759351604705/20/2026Ratify the appointment of Deloitte & Touche LLP as the Company's independent auditor for the year ending December 31, 2026.AUDIT-RELATEDISSUER116600.0000000FOR116600.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: M. ChandohaDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: D. DeMaioDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: A. FawcettDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: W. FredaDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: S. GordonDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: P. HallidayDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: S. MathewDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: W. MeaneyDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: R. O'HanleyDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: S. O'SullivanDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: J. PortalatinDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: B. PorterDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To elect 13 directors. Nominees for Director: J. RheaDIRECTOR ELECTIONSISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To approve an advisory proposal on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026To ratify the selection of Ernst & Young LLP as State Street's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER168900.0000000FOR168900.000000FORS000005328State Street Corporation857477103US857477103105/20/2026Shareholder proposal requesting the adoption of a policy and amendment to the by-laws requiring the Chair of the Board be an independent member of the Board in the next CEO transition, if properly presented.CORPORATE GOVERNANCESECURITY HOLDER168900.0000000AGAINST168900.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Elaine D. RosenDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Rajiv BasuDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Lynn S. BlakeDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: J. Braxton CarterDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Keith W. DemmingsDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Harriet EdelmanDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Sari GranatDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Ognjen (Ogi) RedzicDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Paul J. ReillyDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Election of Directors: Kevin M. WarrenDIRECTOR ELECTIONSISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Ratification of the appointment of PricewaterhouseCoopers LLP as Assurant's independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Advisory approval of the fiscal year 2025 compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Approval of an amendment to the Assurant, Inc. 2017 long term equity incentive plan.COMPENSATIONISSUER41100.0000000FOR41100.000000FORS000005328Assurant, Inc.04621X108US04621X108105/21/2026Stockholder proposal regarding action by written consent.CORPORATE GOVERNANCESECURITY HOLDER41100.0000000AGAINST41100.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Approval of the management report, standalone financial statements and consolidated financial statements of Chubb Limited for the year ended December 31, 2025CORPORATE GOVERNANCEISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Allocation of disposable profit and distribution of a dividend out of legal reserves Allocation of disposable profitCAPITAL STRUCTUREISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Distribution of a dividend out of legal reserves (by way of release and allocation to a dividend reserve)CAPITAL STRUCTUREISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Discharge of the Board of DirectorsCORPORATE GOVERNANCEISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of Auditors Election of PricewaterhouseCoopers AG (Zurich) as our statutory auditorAUDIT-RELATEDISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Ratification of appointment of PricewaterhouseCoopers LLP (United States) as independent registered public accounting firm for purposes of U.S. securities law reportingAUDIT-RELATEDISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of BDO AG (Zurich) as special audit firmEXTRAORDINARY TRANSACTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Evan G. GreenbergDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Michael P. ConnorsDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Michael G. AtiehDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Nancy K. BueseDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Nelson J. ChaiDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Michael L. CorbatDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Fred HuDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Robert J. HuginDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Robert W. ScullyDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Theodore E. ShastaDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: David H. SidwellDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Olivier SteimerDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Board of Directors: Frances F. TownsendDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of Evan G. Greenberg as Chairman of the Board of DirectorsDIRECTOR ELECTIONSISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Compensation Committee of the Board of Directors: Michael P. ConnorsDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Compensation Committee of the Board of Directors: Michael L. CorbatDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Compensation Committee of the Board of Directors: David H. SidwellDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of the Compensation Committee of the Board of Directors: Frances F. TownsendDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Election of Homburger AG as independent proxyCORPORATE GOVERNANCEISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Renewal of a capital band for authorized share capital increases and reductionsCAPITAL STRUCTUREISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Approval of the Chubb Limited 2016 Long-Term Incentive Plan, as amended and restatedCOMPENSATIONISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Approval of the compensation of the Board of Directors and Executive Management under Swiss law requirements Maximum compensation of the Board of Directors until the next annual general meetingCOMPENSATIONISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Maximum compensation of Executive Management for the 2027 calendar yearCOMPENSATIONISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Advisory vote to approve the Swiss compensation reportCOMPENSATIONISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Advisory vote to approve executive compensation under U.S. securities law requirementsSECTION 14A SAY-ON-PAY VOTESISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026Approval of the Sustainability Report of Chubb Limited for the year ended December 31, 2025CORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESISSUER57900.0000000FOR57900.000000FORS000005328Chubb LimitedH1467J104CH004432874505/21/2026If a new agenda item or a new proposal for an existing agenda item is put before the meeting, I/we hereby authorize and instruct the independent proxy to vote as follows: For = In accordance with the position of the Board of Directors Against = Against new items and proposals Abstain = Abstain on new items and proposalsCORPORATE GOVERNANCEISSUER57900.0000000AGAINST57900.000000AGAINSTS000005328KKR & Co. Inc.48251W104US48251W104505/21/2026An amendment to the Company's Second Amended and Restated Certificate of Incorporation (the "Existing Charter") to remove the supermajority voting requirements for stockholders to amend certain provisions of the Company's Existing Charter.CORPORATE GOVERNANCEISSUER153000.0000000FOR153000.000000FORS000005328KKR & Co. Inc.48251W104US48251W104505/21/2026An amendment to the Existing Charter to establish stockholders' meetings as the sole mechanism for approval of matters on which holders of common stock are required or permitted to vote.CORPORATE GOVERNANCEISSUER153000.0000000FOR153000.000000FORS000005328KKR & Co. Inc.48251W104US48251W104505/21/2026An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships.CORPORATE GOVERNANCEISSUER153000.0000000FOR153000.000000FORS000005328KKR & Co. Inc.48251W104US48251W104505/21/2026Other amendments to the Existing Charter to modernize and streamline the Existing Charter.CORPORATE GOVERNANCEISSUER153000.0000000AGAINST153000.000000AGAINSTS000005328KKR & Co. Inc.48251W104US48251W104505/21/2026The adjournment of the Special Meeting, from time to time, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of any of the amendments to the Existing Charter.CORPORATE GOVERNANCEISSUER153000.0000000AGAINST153000.000000AGAINSTS000005328Lazard, Inc.52110M109US52110M109905/21/2026Election of Directors: Peter R. OrszagDIRECTOR ELECTIONSISSUER52.000000161000.000000FOR52.000000FORS000005328Lazard, Inc.52110M109US52110M109905/21/2026Election of Directors: Michelle JarrardDIRECTOR ELECTIONSISSUER52.000000161000.000000FOR52.000000FORS000005328Lazard, Inc.52110M109US52110M109905/21/2026Election of Directors: Iris KnoblochDIRECTOR ELECTIONSISSUER52.000000161000.000000FOR52.000000FORS000005328Lazard, Inc.52110M109US52110M109905/21/2026Non-binding advisory vote regarding executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER52.000000161000.000000FOR52.000000FORS000005328Lazard, Inc.52110M109US52110M109905/21/2026Approval of the amendment of Lazard, Inc.'s Certificate of Incorporation to declassify the Board of Directors.SHAREHOLDER RIGHTS AND DEFENSESISSUER52.000000161000.000000FOR52.000000FORS000005328Lazard, Inc.52110M109US52110M109905/21/2026Approval of the amendment to the Lazard Inc. 2018 Incentive Compensation Plan.COMPENSATIONISSUER52.000000161000.000000AGAINST52.000000AGAINSTS000005328Lazard, Inc.52110M109US52110M109905/21/2026Ratification of the appointment of Deloitte & Touche LLP as Lazard, Inc.'s independent registered public accounting firm for 2026 and authorization of Lazard, Inc.'s Board of Directors, acting by its Audit Committee, to set their remuneration.AUDIT-RELATEDISSUER52.000000161000.000000FOR52.000000FORS000005328The Charles Schwab Corporation808513105US808513105505/21/2026Election of directors for three-year terms: Marianne C. BrownDIRECTOR ELECTIONSISSUER218300.0000000FOR218300.000000FORS000005328The Charles Schwab Corporation808513105US808513105505/21/2026Election of directors for three-year terms: Frank C. HerringerDIRECTOR ELECTIONSISSUER218300.0000000FOR218300.000000FORS000005328The Charles Schwab Corporation808513105US808513105505/21/2026Election of directors for three-year terms: Richard A. WursterDIRECTOR ELECTIONSISSUER218300.0000000FOR218300.000000FORS000005328The Charles Schwab Corporation808513105US808513105505/21/2026Election of directors for three-year terms: Carolyn Schwab-PomerantzDIRECTOR ELECTIONSISSUER218300.0000000FOR218300.000000FORS000005328The Charles Schwab Corporation808513105US808513105505/21/2026Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for 2026AUDIT-RELATEDISSUER218300.0000000FOR218300.000000FORS000005328The Charles Schwab Corporation808513105US808513105505/21/2026Advisory approval of named executive officer compensationSECTION 14A SAY-ON-PAY VOTESISSUER218300.0000000FOR218300.000000FORS000005328The Charles Schwab Corporation808513105US808513105505/21/2026Approval of Amendments to the Certificate of Incorporation and Bylaws to declassify the Board of DirectorsSHAREHOLDER RIGHTS AND DEFENSESISSUER218300.0000000FOR218300.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Kirsten E. GarenDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Cory W. GieseDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: John S. A. HasbrookDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Margaret L. KaneDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Michael W. KoehnenDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Anthony L. LeggioDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Martin A. MarianiDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Thomas C. McGrawDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Jon Y. NakamuraDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Richard P. SmithDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Election of Directors: Kimberley H. VogelDIRECTOR ELECTIONSISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Advisory approval of the company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026Amendment to the Company's Bylaws to eliminate cumulative voting rights.SHAREHOLDER RIGHTS AND DEFENSESISSUER107100.0000000FOR107100.000000FORS000005328TriCo Bancshares896095106US896095106405/21/2026To ratify the selection of Baker Tilly US, LLP as the company's independent auditor for 2026.AUDIT-RELATEDISSUER107100.0000000FOR107100.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Lynne BiggarDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: S. Biff BowmanDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Yvette S. ButlerDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Jane P. ChwickDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Kathleen DeRoseDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Hikmet ErsekDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Ruth Ann M. GillisDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Heather LavalleeDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Robert G. LearyDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Aylwin B. LewisDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: William J. MullaneyDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Election of Directors: Joseph V. TripodiDIRECTOR ELECTIONSISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Approval, on an advisory basis, of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER134600.0000000FOR134600.000000FORS000005328Voya Financial, Inc.929089100US929089100405/21/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER134600.0000000FOR134600.000000FORS000005328First Interstate BancSystem, Inc.32055Y201US32055Y201905/27/2026Election of Class II Director Nominees: Alice S. ChoDIRECTOR ELECTIONSISSUER109252.0000000FOR109252.000000FORS000005328First Interstate BancSystem, Inc.32055Y201US32055Y201905/27/2026Election of Class II Director Nominees: Dennis L. JohnsonDIRECTOR ELECTIONSISSUER109252.0000000FOR109252.000000FORS000005328First Interstate BancSystem, Inc.32055Y201US32055Y201905/27/2026Election of Class II Director Nominees: Daniel A. RykhusDIRECTOR ELECTIONSISSUER109252.0000000FOR109252.000000FORS000005328First Interstate BancSystem, Inc.32055Y201US32055Y201905/27/2026Approval of an amendment to our Certificate of Incorporation to provide for plurality voting in contested director elections.CORPORATE GOVERNANCEISSUER109252.0000000FOR109252.000000FORS000005328First Interstate BancSystem, Inc.32055Y201US32055Y201905/27/2026Adoption of non-binding, advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER109252.0000000FOR109252.000000FORS000005328First Interstate BancSystem, Inc.32055Y201US32055Y201905/27/2026Ratification of appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER109252.0000000FOR109252.000000FORS000005328Perella Weinberg Partners71367G102US71367G102205/27/2026To elect three Class directors to our Board of Directors: Robert K. SteelDIRECTOR ELECTIONSISSUER138000.0000000WITHHOLD138000.000000AGAINSTS000005328Perella Weinberg Partners71367G102US71367G102205/27/2026To elect three Class directors to our Board of Directors: R. Edwin BennettDIRECTOR ELECTIONSISSUER138000.0000000FOR138000.000000FORS000005328Perella Weinberg Partners71367G102US71367G102205/27/2026To elect three Class directors to our Board of Directors: Houda DabboussiDIRECTOR ELECTIONSISSUER138000.0000000FOR138000.000000FORS000005328Perella Weinberg Partners71367G102US71367G102205/27/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER138000.0000000FOR138000.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Elizabeth H. ConnellyDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Timothy S. CraneDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Peter D. CristDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Marla F. GlabeDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Brian A. KenneyDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Laura A. KohlDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Deborah L. Hall LefevreDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Suzet M. McKinneyDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: David S. RichterDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Gregory A. SmithDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Karin Gustafson TegliaDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Election of Directors: Alex E. Washington, IIIDIRECTOR ELECTIONSISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Proposal to approve, on an advisory (non-binding) basis, the Company's executive compensation as described in the 2026 Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER41766.0000000FOR41766.000000FORS000005328Wintrust Financial Corporation97650W108US97650W108005/28/2026Proposal to ratify the appointment of Ernst & Young LLP to serve as the independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER41766.0000000FOR41766.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Consolidated Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Allocation of Income and Dividends of EUR 4.25 per ShareCAPITAL STRUCTUREISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New TransactionsCORPORATE GOVERNANCEISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Compensation ReportCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Compensation of Philippe Brassac, Chairman of the Board From January 1, 2025 to May 27, 2025COMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Compensation of Olivier Gavalda, Chairman of the Board Since May 27, 2025COMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Compensation of Valerie Baudson, CEOCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Compensation of Nicolas Calcoen, Vice-CEOCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Remuneration Policy of DirectorsCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Remuneration Policy of Chairman of the BoardCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Remuneration Policy of CEOCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Remuneration Policy of Vice-CEOCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Advisory Vote on the Aggregate Remuneration Granted in 2025 to Senior Management, Responsible Officers and Regulated Risk-TakersCOMPENSATIONISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Ratify Appointment of Pierre Cambefort as DirectorDIRECTOR ELECTIONSISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Ratify Appointment of Clotilde L Angevin as DirectorDIRECTOR ELECTIONSISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Ratify Appointment of Nicolas Maure as DirectorDIRECTOR ELECTIONSISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Reelect Pierre Cambefort as DirectorDIRECTOR ELECTIONSISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Reelect Laurence Danon-Arnaud as DirectorDIRECTOR ELECTIONSISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Reelect Nicolas Maure as DirectorDIRECTOR ELECTIONSISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Elect Dominique Potiron as DirectorDIRECTOR ELECTIONSISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Approve Report on Progress of Company's Climate Transition Plan (Advisory)ENVIRONMENT OR CLIMATEISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Authorize Repurchase of Up to 10 Percent of Issued Share CapitalCAPITAL STRUCTUREISSUER82500.0000000FOR82500.000000FORS000005328Amundi SAF0300Q103FR000412592006/02/2026Authorize Filing of Required Documents/Other FormalitiesCORPORATE GOVERNANCEISSUER82500.0000000FOR82500.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: William E. Conway, Jr.DIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: David M. RubensteinDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Daniel A. D'AnielloDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Harvey M. SchwartzDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Afsaneh BeschlossDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Sharda CherwooDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Linda H. FillerDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Lawton W. FittDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: James H. Hance, Jr.DIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Mark S. OrdanDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Derica W. RiceDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: William J. ShawDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Election of Directors: Anthony WeltersDIRECTOR ELECTIONSISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Ratification of Ernst & Young LLP as Independent Registered Public Accounting Firm for 2026AUDIT-RELATEDISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Approval of The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive PlanCOMPENSATIONISSUER82600.0000000FOR82600.000000FORS000005328The Carlyle Group Inc.14316J108US14316J108806/03/2026Non-Binding Vote to Approve Named Executive Officer Compensation ("Say-on-Pay")SECTION 14A SAY-ON-PAY VOTESISSUER82600.0000000FOR82600.000000FORS000005328Blue Owl Capital Inc.09581B103US09581B103506/04/2026Election of Directors: Claudia HolzDIRECTOR ELECTIONSISSUER100.000000648500.000000AGAINST100.000000AGAINSTS000005328Blue Owl Capital Inc.09581B103US09581B103506/04/2026Election of Directors: Marc S. LipschultzDIRECTOR ELECTIONSISSUER100.000000648500.000000AGAINST100.000000AGAINSTS000005328Blue Owl Capital Inc.09581B103US09581B103506/04/2026Election of Directors: Michael D. ReesDIRECTOR ELECTIONSISSUER100.000000648500.000000AGAINST100.000000AGAINSTS000005328Blue Owl Capital Inc.09581B103US09581B103506/04/2026The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for our 2026 fiscal year.AUDIT-RELATEDISSUER100.000000648500.000000FOR100.000000FORS000005328The Baldwin Insurance Group, Inc.05589G102US05589G102206/04/2026Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Lowry BaldwinDIRECTOR ELECTIONSISSUER4.000000285800.000000FOR4.000000FORS000005328The Baldwin Insurance Group, Inc.05589G102US05589G102206/04/2026Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sathish MuthukrishnanDIRECTOR ELECTIONSISSUER4.000000285800.000000FOR4.000000FORS000005328The Baldwin Insurance Group, Inc.05589G102US05589G102206/04/2026Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sunita ParasuramanDIRECTOR ELECTIONSISSUER4.000000285800.000000FOR4.000000FORS000005328The Baldwin Insurance Group, Inc.05589G102US05589G102206/04/2026Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Ellyn ShookDIRECTOR ELECTIONSISSUER4.000000285800.000000FOR4.000000FORS000005328The Baldwin Insurance Group, Inc.05589G102US05589G102206/04/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4.000000285800.000000FOR4.000000FORS000005328The Baldwin Insurance Group, Inc.05589G102US05589G102206/04/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER4.000000285800.000000FOR4.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Marc BeilinsonDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: James BelardiDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Jessica BibliowiczDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Gary CohnDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Kerry Murphy HealeyDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Mitra HormoziDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Pamela JoynerDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Scott KleinmanDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Brian LeachDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Marc RowanDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Lynn SwannDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Patrick ToomeyDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: James ZelterDIRECTOR ELECTIONSISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026An advisory vote to approve the compensation of AGM's named executive officers (Say on Pay);SECTION 14A SAY-ON-PAY VOTESISSUER109609.0000000FOR109609.000000FORS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026An advisory vote on the frequency of future advisory votes to approve the compensation of AGM's named executive officers (Say on Frequency); andSECTION 14A SAY-ON-PAY VOTESISSUER109609.0000000ONE YEAR109609.000000AGAINSTS000005328Apollo Global Management, Inc.03769M106US03769M106206/08/2026The ratification of the appointment of Deloitte & Touche LLP as AGM's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER109609.0000000FOR109609.000000FORS000005328FirstCash Holdings, Inc.33768G107US33768G107606/09/2026Election of Directors: Daniel E. BerceDIRECTOR ELECTIONSISSUER39371.0000000FOR39371.000000FORS000005328FirstCash Holdings, Inc.33768G107US33768G107606/09/2026Election of Directors: Mikel D. FaulknerDIRECTOR ELECTIONSISSUER39371.0000000FOR39371.000000FORS000005328FirstCash Holdings, Inc.33768G107US33768G107606/09/2026Election of Directors: Randel G. OwenDIRECTOR ELECTIONSISSUER39371.0000000FOR39371.000000FORS000005328FirstCash Holdings, Inc.33768G107US33768G107606/09/2026To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026.AUDIT-RELATEDISSUER39371.0000000FOR39371.000000FORS000005328FirstCash Holdings, Inc.33768G107US33768G107606/09/2026Approve, by non-binding vote, the compensation of named executive officers as described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER39371.0000000FOR39371.000000FORS000005328FirstCash Holdings, Inc.33768G107US33768G107606/09/2026Approve the reincorporation of the Company to the State of Texas by conversion.EXTRAORDINARY TRANSACTIONSCORPORATE GOVERNANCEISSUER39371.0000000AGAINST39371.000000AGAINSTS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Carlos M. HernandezDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Christopher R. ConcannonDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Nancy AltobelloDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Steven L. BegleiterDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Jane ChwickDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Douglas A. CifuDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: William F. CrugerDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Kourtney GibsonDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Roberto HoornwegDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Richard G. KetchumDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Emily H. PortneyDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026Election of Directors: Kenneth T. SchicianoDIRECTOR ELECTIONSISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the 2026 Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER37600.0000000FOR37600.000000FORS000005328MarketAxess Holdings Inc.57060D108US57060D108106/10/2026If properly presented, a stockholder proposal regarding changes to existing stockholder special meeting right.CORPORATE GOVERNANCESECURITY HOLDER37600.0000000AGAINST37600.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election 12 Directors: Melissa M. ArnoldiDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election 12 Directors: Charlene T. BegleyDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Adena T. FriedmanDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Essa KazimDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Thomas A. KloetDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Kathryn A. KochDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Holden SpahtDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Michael R. SplinterDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Johan TorgebyDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Toni Townes-WhitleyDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Jeffery W. YabukiDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Election of 12 Directors: Alfred W. ZollarDIRECTOR ELECTIONSISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Advisory vote to approve the Company's executive compensation as presented in the Proxy StatementSECTION 14A SAY-ON-PAY VOTESISSUER98100.0000000FOR98100.000000FORS000005328Nasdaq, Inc.631103108US631103108106/10/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026AUDIT-RELATEDISSUER98100.0000000FOR98100.000000FORS000005328Virtu Financial, Inc.928254101US928254101306/10/2026Election of Directors: Aaron SimonsDIRECTOR ELECTIONSISSUER236060.0000000FOR236060.000000FORS000005328Virtu Financial, Inc.928254101US928254101306/10/2026Election of Directors: Joseph J. Grano, Jr.DIRECTOR ELECTIONSISSUER236060.0000000FOR236060.000000FORS000005328Virtu Financial, Inc.928254101US928254101306/10/2026Election of Directors: Joanne M. MinieriDIRECTOR ELECTIONSISSUER236060.0000000FOR236060.000000FORS000005328Virtu Financial, Inc.928254101US928254101306/10/2026Advisory Vote to Approve Compensation of Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER236060.0000000FOR236060.000000FORS000005328Virtu Financial, Inc.928254101US928254101306/10/2026Proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER236060.0000000FOR236060.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Merit E. JanowDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Candido BracherDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Richard K. DavisDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Julius GenachowskiDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Choon Phong GohDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Oki MatsumotoDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Michael MiebachDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Youngme MoonDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Gabrielle SulzbergerDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Harit TalwarDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026ELECTION OF DIRECTORS TO SERVE ON THE BOARD OF DIRECTORS: Lance UgglaDIRECTOR ELECTIONSISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026Advisory approval of Mastercard's executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Mastercard for 2026AUDIT-RELATEDISSUER105400.0000000FOR105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026Consideration of a stockholder proposal regarding shareholder right to act by written consentCORPORATE GOVERNANCESECURITY HOLDER105400.0000000AGAINST105400.000000FORS000005328Mastercard Incorporated57636Q104US57636Q104006/16/2026Consideration of a stockholder proposal to adopt cumulative voting for the election of directorsSHAREHOLDER RIGHTS AND DEFENSESSECURITY HOLDER105400.0000000AGAINST105400.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Janaki AkellaDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: R. Scott BlackleyDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Mary Carter Warren FrankeDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Daniel GreensteinDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Henry F. GreigDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Mark L. LavelleDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Christopher T. LeechDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Ted ManvitzDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Jim MathesonDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Gary MillerchipDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Vivian C. Schneck-LastDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Jonathan W. WitterDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Election of Directors: Kirsten O. WolbergDIRECTOR ELECTIONSISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Advisory approval of SLM Corporation's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER276800.0000000FOR276800.000000FORS000005328SLM Corporation78442P106US78442P106606/16/2026Ratification of the appointment of KPMG LLP as SLM Corporation's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER276800.0000000FOR276800.000000FORS000005328Wealthfront Corporation947002101US947002101806/23/2026Election of Class I Directors: David FortunatoDIRECTOR ELECTIONSISSUER28200.00000053700.000000FOR28200.000000FORS000005328Wealthfront Corporation947002101US947002101806/23/2026Election of Class I Directors: Andrew S. RachleffDIRECTOR ELECTIONSISSUER28200.00000053700.000000FOR28200.000000FORS000005328Wealthfront Corporation947002101US947002101806/23/2026Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending January 31, 2027.AUDIT-RELATEDISSUER28200.00000053700.000000FOR28200.000000FORS000005328Kardium Inc.07/23/2025Approve Reorganization PlanEXTRAORDINARY TRANSACTIONSISSUER2614967.0000000FOR2614967.000000FORS000005329Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jacob BauerDIRECTOR ELECTIONSISSUER225534.0000000FOR225534.000000FORS000005329Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas HughesDIRECTOR ELECTIONSISSUER225534.0000000FOR225534.000000FORS000005329Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Robert SusmanDIRECTOR ELECTIONSISSUER225534.0000000FOR225534.000000FORS000005329Immunovant, Inc.45258J102US45258J102508/27/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER225534.0000000FOR225534.000000FORS000005329Immunovant, Inc.45258J102US45258J102508/27/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER225534.0000000FOR225534.000000FORS000005329Kestra Medical Technologies, Ltd.G52441105BMG52441105209/03/2025The election of Conor Hanley and Elizabeth Kwo to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Conor HanleyDIRECTOR ELECTIONSISSUER250000.0000000AGAINST250000.000000AGAINSTS000005329Kestra Medical Technologies, Ltd.G52441105BMG52441105209/03/2025The election of Conor Hanley and Elizabeth Kwo to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Elizabeth KwoDIRECTOR ELECTIONSISSUER250000.0000000AGAINST250000.000000AGAINSTS000005329Kestra Medical Technologies, Ltd.G52441105BMG52441105209/03/2025The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered accounting firm for the fiscal year ending April 30, 2026.AUDIT-RELATEDISSUER250000.0000000FOR250000.000000FORS000005329Kestra Medical Technologies, Ltd.G52441105BMG52441105209/03/2025The approval of the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan.COMPENSATIONISSUER250000.0000000FOR250000.000000FORS000005329argenx SE04016X101US04016X101911/18/2025Approve Remuneration PolicyCOMPENSATIONISSUER146000.0000000FOR146000.000000FORS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Nevan Charles ElamDIRECTOR ELECTIONSISSUER1600000.0000000FOR1600000.000000FORS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Gil LabrucherieDIRECTOR ELECTIONSISSUER1600000.0000000FOR1600000.000000FORS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Philippe FauchetDIRECTOR ELECTIONSISSUER1600000.0000000FOR1600000.000000FORS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Nerissa KreherDIRECTOR ELECTIONSISSUER1600000.0000000WITHHOLD1600000.000000AGAINSTS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Wladimir HogenhuisDIRECTOR ELECTIONSISSUER1600000.0000000WITHHOLD1600000.000000AGAINSTS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Young-Jin KimDIRECTOR ELECTIONSISSUER1600000.0000000FOR1600000.000000FORS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Erik HarrisDIRECTOR ELECTIONSISSUER1600000.0000000WITHHOLD1600000.000000AGAINSTS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accountants for the fiscal year ending on June 30, 2026.AUDIT-RELATEDISSUER1600000.0000000FOR1600000.000000FORS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1600000.0000000AGAINST1600000.000000AGAINSTS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To approve an amendment to the 2021 Equity Incentive Plan, as amended, to increase the number of shares available for issuance thereunder from 14,450,000 shares of common stock to an aggregate of 21,950,000 shares of common stock (the "2021 Equity Plan Amendment Proposal").COMPENSATIONISSUER1600000.0000000FOR1600000.000000FORS000005329Rezolute, Inc.76200L309US76200L309611/19/2025To authorize an adjournment of the meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the Plan Amendment Proposal.CORPORATE GOVERNANCEISSUER1600000.0000000FOR1600000.000000FORS000005329Galecto, Inc.G2646Y104KYG2646Y104402/09/2026Approve, in accordance with Nasdaq Listing Rule 5635(a), the issuance of shares of the Company's Common Stock upon conversion of the Company's Series B Non-Voting Convertible Preferred Stock and the Company's Series C Non-Voting Convertible Preferred Stock.CAPITAL STRUCTUREISSUER50000.0000000FOR50000.000000FORS000005329Galecto, Inc.G2646Y104KYG2646Y104402/09/2026Approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of the Common Stock from 300,000,000 to 500,000,000.CAPITAL STRUCTUREISSUER50000.0000000AGAINST50000.000000AGAINSTS000005329Galecto, Inc.G2646Y104KYG2646Y104402/09/2026Approve (A) the redomestication of the Company from the State of Delaware to the Cayman Islands by conversion and (B)(i) the redomestication of the Company from the State of Delaware to the Cayman Islands by way of continuation and (ii) the adoption of the memorandum and articles of association of the Company.EXTRAORDINARY TRANSACTIONSCORPORATE GOVERNANCEISSUER50000.0000000AGAINST50000.000000AGAINSTS000005329Galecto, Inc.G2646Y104KYG2646Y104402/09/2026Approve the Galecto, Inc. 2026 Equity Incentive Plan.COMPENSATIONISSUER50000.0000000AGAINST50000.000000AGAINSTS000005329Galecto, Inc.G2646Y104KYG2646Y104402/09/2026Approve the Galecto, Inc. 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER50000.0000000AGAINST50000.000000AGAINSTS000005329Galecto, Inc.G2646Y104KYG2646Y104402/09/2026Approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposal Nos. 1, 2, 3, 4 and/or 5.CORPORATE GOVERNANCEISSUER50000.0000000AGAINST50000.000000AGAINSTS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Elect Chair of MeetingCORPORATE GOVERNANCEISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Accept Financial Statements and Statutory Reports; Approve Discharge of Management and BoardCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Approve Treatment of Net LossCAPITAL STRUCTUREISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Albert Cha as DirectorDIRECTOR ELECTIONSISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Lars Holtug as DirectorDIRECTOR ELECTIONSISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Jan Moller Mikkelsen as DirectorDIRECTOR ELECTIONSISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Lisa Jane Morrison as DirectorDIRECTOR ELECTIONSISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect William Carl Fairey Jr as DirectorDIRECTOR ELECTIONSISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Siham Imani as DirectorDIRECTOR ELECTIONSISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Elect Jean-Jacques Bienaime as New DirectorDIRECTOR ELECTIONSISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Ratify Deloitte as AuditorAUDIT-RELATEDISSUER370000.0000000FOR370000.000000FORS000005329Ascendis Pharma A/SK08588103DK006061575503/23/2026Authorize Share Repurchase ProgramCAPITAL STRUCTUREISSUER370000.0000000FOR370000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: David M. CordaniDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Brian C. EvankoDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Eric J. FossDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Neesha HathiDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Michael J. HenniganDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: George KurianDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Kathleen M. MazzarellaDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Mark B. McClellan, M.D., Ph.D.DIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Philip O. Ozuah, M.D., Ph.D.DIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Kimberly A. RossDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Eric C. WisemanDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Election of Directors: Donna F. ZarconeDIRECTOR ELECTIONSISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Advisory approval of executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026AUDIT-RELATEDISSUER55000.0000000FOR55000.000000FORS000005329The Cigna Group125523100US125523100304/22/2026Shareholder Proposal - Shareholder Right to Act by Written ConsentCORPORATE GOVERNANCESECURITY HOLDER55000.0000000AGAINST55000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): Ari BousbibDIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): Carol J. BurtDIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): John G. DanhaklDIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): James A. FasanoDIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): Colleen A. GogginsDIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): William G. Kaelin Jr., M.D.DIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): John M. Leonard, M.D.DIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): Leslie Wims MorrisDIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026The election of each of the director nominees listed below (a through i): Sheila A. StampsDIRECTOR ELECTIONSISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan.COMPENSATIONISSUER50000.0000000FOR50000.000000FORS000005329IQVIA Holdings Inc.46266C105US46266C105304/23/2026If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles.CORPORATE GOVERNANCESECURITY HOLDER50000.0000000AGAINST50000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Mary C. BeckerleDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Jennifer A. DoudnaDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Joaquin DuatoDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Marillyn A. HewsonDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Paula A. JohnsonDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Hubert JolyDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Mark B. McClellanDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: John G. MorikisDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Daniel E. PintoDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Mark A. WeinbergerDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Nadja Y. WestDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Election of Directors: Eugene A. WoodsDIRECTOR ELECTIONSISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Advisory Vote to Approve Named Executive Officer CompensationSECTION 14A SAY-ON-PAY VOTESISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting FirmAUDIT-RELATEDISSUER690000.0000000FOR690000.000000FORS000005329Johnson & Johnson478160104US478160104604/23/2026Independent Board ChairCORPORATE GOVERNANCESECURITY HOLDER690000.0000000AGAINST690000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: David C. HabigerDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Edward J. LudwigDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Michael F. MahoneyDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Jessica L. MegaDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Susan E. MoranoDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Cheryl PegusDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Cathy R. SmithDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Christophe P. WeberDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: David S. WichmannDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Proposal to elect ten Directors: Ellen M. ZaneDIRECTOR ELECTIONSISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.COMPENSATIONISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026To amend our Certificate of Incorporation to remove supermajority voting provisions.CORPORATE GOVERNANCEISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.CORPORATE GOVERNANCEISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders.CORPORATE GOVERNANCEISSUER2480000.0000000FOR2480000.000000FORS000005329Boston Scientific Corporation101137107US101137107704/30/2026Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."CORPORATE GOVERNANCESECURITY HOLDER2480000.0000000AGAINST2480000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.DIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.DIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.DIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. KramerDIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.DIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish ManwaniDIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'DayDIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. RodriguezDIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony WeltersDIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan.COMPENSATIONISSUER540000.0000000FOR540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.CORPORATE GOVERNANCESECURITY HOLDER540000.0000000AGAINST540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting.OTHER SOCIAL ISSUESSECURITY HOLDER540000.0000000AGAINST540000.000000FORS000005329Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER540000.0000000AGAINST540000.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Craig H. Barratt, Ph.D.DIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Joseph C. BeeryDIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Lewis ChewDIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Gary S. Guthart, Ph.D.DIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Sreelakshmi KolliDIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Amy L. Ladd, M.D.DIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Keith R. Leonard, Jr.DIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Jami Dover NachtsheimDIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: Monica P. Reed, M.D.DIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026Election of Directors: David J. RosaDIRECTOR ELECTIONSISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026To approve, by advisory vote, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER52800.0000000FOR52800.000000FORS000005329Intuitive Surgical, Inc.46120E602US46120E602304/30/2026To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan.COMPENSATIONISSUER52800.0000000FOR52800.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Approve Financial Statements, Allocation of Income, and Dividends of EUR 1.45 per ShareCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Approve Remuneration ReportCOMPENSATIONISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Approve Discharge of AuditorsAUDIT-RELATEDCORPORATE GOVERNANCEISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Reelect Jean-Christophe Tellier as DirectorDIRECTOR ELECTIONSISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Reelect Cedric van Rijckevorsel as DirectorDIRECTOR ELECTIONSISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Approve Renewal of Change-of-Control Clause Re: EMTN Program - Art. 7:151 of the BCCASHAREHOLDER RIGHTS AND DEFENSESCAPITAL STRUCTUREISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Renew Authorization to Increase Share Capital within the Framework of Authorized CapitalCAPITAL STRUCTUREISSUER225000.0000000FOR225000.000000FORS000005329UCB SAB93562120BE000373953004/30/2026Authorize Share Repurchase Program and Reissuance of Repurchased SharesCAPITAL STRUCTUREISSUER225000.0000000FOR225000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Election of the following directors, each to serve a three-year term: Carolyn BertozziDIRECTOR ELECTIONSISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Election of the following directors, each to serve a three-year term: William Kaelin, Jr.DIRECTOR ELECTIONSISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Election of the following directors, each to serve a three-year term: Jon MoellerDIRECTOR ELECTIONSISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Election of the following directors, each to serve a three-year term: David RicksDIRECTOR ELECTIONSISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Approval, on an advisory basis, of the compensation paid to the company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026.AUDIT-RELATEDISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Approval of amendments to the company's articles of incorporation to eliminate the classified board structure.SHAREHOLDER RIGHTS AND DEFENSESISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions.CORPORATE GOVERNANCEISSUER208000.0000000FOR208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.CORPORATE GOVERNANCESECURITY HOLDER208000.0000000AGAINST208000.000000FORS000005329Eli Lilly and Company532457108US532457108305/04/2026Shareholder proposal to prepare an annual lobbying report.OTHER SOCIAL ISSUESSECURITY HOLDER208000.0000000AGAINST208000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. BlairDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz DewanDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda FillerDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. LamannaDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. ListDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. RalesDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. RalesDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane SandersDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. SpoonDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D.DIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MDDIRECTOR ELECTIONSISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To approve on an advisory basis the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER960000.0000000FOR960000.000000FORS000005329Danaher Corporation235851102US235851102805/05/2026To approve the Company's Amended and Restated Omnibus Incentive Plan.COMPENSATIONISSUER960000.0000000FOR960000.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Approve Remuneration ReportCOMPENSATIONISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Approve Allocation of Income to the Retained Earnings of the CompanyCAPITAL STRUCTUREISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Approve Discharge of Executive DirectorsCORPORATE GOVERNANCEISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Approve Discharge of Non-Executive DirectorsCORPORATE GOVERNANCEISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Elect Karen Massey as Executive DirectorDIRECTOR ELECTIONSISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Elect Tim Van Hauwermeiren as Non-Executive DirectorDIRECTOR ELECTIONSISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Reelect Ana Cespedes as Non-Executive DirectorDIRECTOR ELECTIONSISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Reelect Camilla Sylvest as Non-Executive DirectorDIRECTOR ELECTIONSISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Reelect Pamela Klein as Non-Executive DirectorDIRECTOR ELECTIONSISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Grant Board Authority to Issue Shares Up to 10 Percent of Issued Capital and Limit/Exclude Preemptive RightsCAPITAL STRUCTUREISSUER72800.0000000FOR72800.000000FORS000005329argenx SE04016X101US04016X101905/06/2026Ratify Ernst & Young Accountants LLP as AuditorsAUDIT-RELATEDISSUER72800.0000000FOR72800.000000FORS000005329Moderna, Inc.60770K107US60770K107905/06/2026To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Sandra Horning, M.D.DIRECTOR ELECTIONSISSUER740000.0000000FOR740000.000000FORS000005329Moderna, Inc.60770K107US60770K107905/06/2026To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Abbas HussainDIRECTOR ELECTIONSISSUER740000.0000000FOR740000.000000FORS000005329Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER740000.0000000FOR740000.000000FORS000005329Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER740000.0000000ONE YEAR740000.000000FORS000005329Moderna, Inc.60770K107US60770K107905/06/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER740000.0000000FOR740000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Mary K. BrainerdDIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Giovanni Caforio, M.D.DIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Kevin A. LoboDIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Emmanuel P. MacedaDIRECTOR ELECTIONSISSUER76000.0000000AGAINST76000.000000AGAINSTS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Sherilyn S. McCoyDIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Rachel M. RuggeriDIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Andrew K. SilvernailDIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Lisa M. Skeete TatumDIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Ronda E. StrykerDIRECTOR ELECTIONSISSUER76000.0000000AGAINST76000.000000AGAINSTS000005329Stryker Corporation863667101US863667101305/06/2026Election Directors: Rajeev SuriDIRECTOR ELECTIONSISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026.AUDIT-RELATEDISSUER76000.0000000FOR76000.000000FORS000005329Stryker Corporation863667101US863667101305/06/2026Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER76000.0000000FOR76000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Leslie C. DavisDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: David T. Feinberg, MDDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Kieran T. GallahueDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Leslie S. HeiszDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Paul A. LaVioletteDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Steven R. LorangerDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Ramona SequeiraDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Nicholas J. ValerianiDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Election of Directors: Bernard ZovighianDIRECTOR ELECTIONSISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Advisory Vote to Approve Named Executive Officer CompensationSECTION 14A SAY-ON-PAY VOTESISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Ratification of Appointment of Independent Registered Public Accounting FirmAUDIT-RELATEDISSUER785000.0000000FOR785000.000000FORS000005329Edwards Lifesciences Corporation28176E108US28176E108205/07/2026Approval of the Amended and Restated Long-Term Stock Incentive Compensation ProgramCOMPENSATIONISSUER785000.0000000FOR785000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Jennifer L. DavisDIRECTOR ELECTIONSISSUER545000.0000000FOR545000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Melody B. MeyerDIRECTOR ELECTIONSISSUER545000.0000000FOR545000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Robert A. MichaelDIRECTOR ELECTIONSISSUER545000.0000000FOR545000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Election of Class II Directors: Frederick H. WaddellDIRECTOR ELECTIONSISSUER545000.0000000FOR545000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026AUDIT-RELATEDISSUER545000.0000000FOR545000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Say on Pay - An advisory vote on the approval of executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER545000.0000000FOR545000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority votingCORPORATE GOVERNANCEISSUER545000.0000000FOR545000.000000FORS000005329AbbVie Inc.00287Y109US00287Y109105/08/2026Stockholder Proposal - to Adopt a Policy to Require an Independent ChairCORPORATE GOVERNANCESECURITY HOLDER545000.0000000AGAINST545000.000000FORS000005329Zenas BioPharma, Inc.05/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James BoylanDIRECTOR ELECTIONSISSUER122099.0000000FOR122099.000000FORS000005329Zenas BioPharma, Inc.05/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick EnrightDIRECTOR ELECTIONSISSUER122099.0000000FOR122099.000000FORS000005329Zenas BioPharma, Inc.05/11/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER122099.0000000FOR122099.000000FORS000005329Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James BoylanDIRECTOR ELECTIONSISSUER500000.0000000FOR500000.000000FORS000005329Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick EnrightDIRECTOR ELECTIONSISSUER500000.0000000FOR500000.000000FORS000005329Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER500000.0000000FOR500000.000000FORS000005329Insmed Incorporated457669307US457669307505/13/2026Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee AndersonDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Insmed Incorporated457669307US457669307505/13/2026Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D.DIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Insmed Incorporated457669307US457669307505/13/2026An advisory vote on the 2025 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER285000.0000000FOR285000.000000FORS000005329Insmed Incorporated457669307US457669307505/13/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER285000.0000000FOR285000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Fernando AguirreDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Jeffrey R. Balser, M.D., Ph.D.DIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: C. David Brown IIDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Alecia A. DeCoudreauxDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Anne M. FinucaneDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: John E. GallinaDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: J. David JoynerDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: J. Scott KirbyDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Michael F. MahoneyDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Leslie V. NorwalkDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Larry M. RobbinsDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Guy P. SansoneDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Election of Directors: Douglas H. ShulmanDIRECTOR ELECTIONSISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026.AUDIT-RELATEDISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Proposal to Approve the Company's 2026 Incentive Compensation Plan.COMPENSATIONISSUER485000.0000000FOR485000.000000FORS000005329CVS Health Corporation126650100US126650100605/14/2026Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.CORPORATE GOVERNANCESECURITY HOLDER485000.0000000AGAINST485000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Olivier LoeillotDIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Karen A. DawesDIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Nicolas M. BarthelemyDIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Carrie Eglinton MannerDIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Konstantin Konstantinov, Ph.D.DIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Martin D. Madaus, D.V.M., Ph.D.DIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Rohin Mhatre, Ph.D.DIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Glenn P. MuirDIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Election of Directors: Margaret A. PaxDIRECTOR ELECTIONSISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER228000.0000000FOR228000.000000FORS000005329Repligen Corporation759916109US759916109505/14/2026Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER228000.0000000FOR228000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Allocation of Income and Omission of DividendsCAPITAL STRUCTUREISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Discharge of Management Board for Fiscal Year 2025CORPORATE GOVERNANCEISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Discharge of Supervisory Board for Fiscal Year 2025CORPORATE GOVERNANCEISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Ratify EY GmbH & Co. KG as Auditors for Fiscal Year 2026 and for the Review of Interim Financial Statements for the Fiscal Year 2026 and the First Quarter of Fiscal Year 2027AUDIT-RELATEDISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Remuneration ReportCOMPENSATIONISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Increase in Size of Board to Eight MembersCORPORATE GOVERNANCEISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Reelect Helmut Jeggle to the Supervisory BoardDIRECTOR ELECTIONSISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Reelect Anja Morawietz to the Supervisory BoardDIRECTOR ELECTIONSISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Reelect Rudolf Staudigl to the Supervisory BoardDIRECTOR ELECTIONSISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Elect Susanne Schaffert to the Supervisory BoardDIRECTOR ELECTIONSISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Elect Iris Loew-Friedrich to the Supervisory BoardDIRECTOR ELECTIONSISSUER85000.0000000AGAINST85000.000000AGAINSTS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Virtual-Only Shareholder Meetings Until 2028CORPORATE GOVERNANCEISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Creation of EUR 129.5 Million Pool of Authorized Capital with or without Exclusion of Preemptive RightsCAPITAL STRUCTUREISSUER85000.0000000FOR85000.000000FORS000005329BioNTech SE09075V102US09075V102605/15/2026Approve Affiliation Agreement with BioNTech Discovery GmbHEXTRAORDINARY TRANSACTIONSISSUER85000.0000000FOR85000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Roy BaynesDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Suzanne BruhnDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Timothy CoughlinDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Eric DubeDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Gary LyonsDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Jeffrey MecklerDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: John OrwinDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Sandra PooleDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ron SquarerDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ruth Williams-BrinkleyDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares.COMPENSATIONISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER285000.0000000FOR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER285000.0000000ONE YEAR285000.000000FORS000005329Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER285000.0000000FOR285000.000000FORS000005329Viking Therapeutics, Inc.92686J106US92686J106005/19/2026ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): J. Matthew SingletonDIRECTOR ELECTIONSISSUER147800.000000152200.000000WITHHOLD147800.000000AGAINSTS000005329Viking Therapeutics, Inc.92686J106US92686J106005/19/2026ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): S. Kathryn Rouan, Ph.D.DIRECTOR ELECTIONSISSUER147800.000000152200.000000WITHHOLD147800.000000AGAINSTS000005329Viking Therapeutics, Inc.92686J106US92686J106005/19/2026TO RATIFY THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER147800.000000152200.000000FOR147800.000000FORS000005329Viking Therapeutics, Inc.92686J106US92686J106005/19/2026TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER147800.000000152200.000000FOR147800.000000FORS000005329Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Stuart A. ArbuckleDIRECTOR ELECTIONSISSUER174000.0000000FOR174000.000000FORS000005329Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Yvonne L. Greenstreet, M.D.DIRECTOR ELECTIONSISSUER174000.0000000FOR174000.000000FORS000005329Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Elliott Sigal, M.D., Ph.D.DIRECTOR ELECTIONSISSUER174000.0000000FOR174000.000000FORS000005329Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER174000.0000000FOR174000.000000FORS000005329Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER174000.0000000FOR174000.000000FORS000005329Insulet Corporation45784P101US45784P101205/20/2026Election of Directors: Luciana BorioDIRECTOR ELECTIONSISSUER128000.0000000FOR128000.000000FORS000005329Insulet Corporation45784P101US45784P101205/20/2026Election of Directors: Michael R. MinogueDIRECTOR ELECTIONSISSUER128000.0000000FOR128000.000000FORS000005329Insulet Corporation45784P101US45784P101205/20/2026Election of Directors: Timothy C. StonesiferDIRECTOR ELECTIONSISSUER128000.0000000FOR128000.000000FORS000005329Insulet Corporation45784P101US45784P101205/20/2026To approve, on a non-binding, advisory basis, the compensation of certain executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER128000.0000000FOR128000.000000FORS000005329Insulet Corporation45784P101US45784P101205/20/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER128000.0000000FOR128000.000000FORS000005329Privia Health Group, Inc.74276R102US74276R102305/20/2026To elect the three nominees listed in the accompanying proxy statement as Class I directors to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Nancy CocozzaDIRECTOR ELECTIONSISSUER1180000.0000000FOR1180000.000000FORS000005329Privia Health Group, Inc.74276R102US74276R102305/20/2026To elect the three nominees listed in the accompanying proxy statement as Class I directors to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: David KingDIRECTOR ELECTIONSISSUER1180000.0000000FOR1180000.000000FORS000005329Privia Health Group, Inc.74276R102US74276R102305/20/2026To elect the three nominees listed in the accompanying proxy statement as Class I directors to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Francis SoistmanDIRECTOR ELECTIONSISSUER1180000.0000000FOR1180000.000000FORS000005329Privia Health Group, Inc.74276R102US74276R102305/20/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs").SECTION 14A SAY-ON-PAY VOTESISSUER1180000.0000000FOR1180000.000000FORS000005329Privia Health Group, Inc.74276R102US74276R102305/20/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1180000.0000000FOR1180000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Marc N. CasperDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Nelson J. ChaiDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Ruby R. ChandyDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: C. Martin HarrisDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Tyler JacksDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Jennifer M. JohnsonDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: R. Alexandra KeithDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Karen S. LynchDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Debora L. SparDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Scott M. SperlingDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Election of Directors: Dion J. WeislerDIRECTOR ELECTIONSISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026An advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER108000.0000000FOR108000.000000FORS000005329Thermo Fisher Scientific Inc.883556102US883556102305/20/2026Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026.AUDIT-RELATEDISSUER108000.0000000FOR108000.000000FORS000005329BrightSpring Health Services, Inc.10950A106US10950A106005/21/2026Election of Class II directors: Olivia KirtleyDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329BrightSpring Health Services, Inc.10950A106US10950A106005/21/2026Election of Class II directors: Max LinDIRECTOR ELECTIONSISSUER1000000.0000000WITHHOLD1000000.000000AGAINSTS000005329BrightSpring Health Services, Inc.10950A106US10950A106005/21/2026Election of Class II directors: Steve MillerDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329BrightSpring Health Services, Inc.10950A106US10950A106005/21/2026Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026AUDIT-RELATEDISSUER1000000.0000000FOR1000000.000000FORS000005329BrightSpring Health Services, Inc.10950A106US10950A106005/21/2026Advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1000000.0000000FOR1000000.000000FORS000005329Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay KangoDIRECTOR ELECTIONSISSUER85000.0000000FOR85000.000000FORS000005329Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeDIRECTOR ELECTIONSISSUER85000.0000000FOR85000.000000FORS000005329Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D.DIRECTOR ELECTIONSISSUER85000.0000000FOR85000.000000FORS000005329Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To approve, on an advisory basis, the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER85000.0000000FOR85000.000000FORS000005329Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER85000.0000000FOR85000.000000FORS000005329Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D.DIRECTOR ELECTIONSISSUER540000.0000000WITHHOLD540000.000000AGAINSTS000005329Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H.DIRECTOR ELECTIONSISSUER540000.0000000WITHHOLD540000.000000AGAINSTS000005329Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne KarydasDIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER540000.0000000FOR540000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Douglas M. Baker, Jr.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Mary Ellen CoeDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Pamela J. CraigDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Robert M. DavisDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Thomas H. GlocerDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Surendralal L. KarsanbhaiDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Risa J. Lavizzo-Mourey, M.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Stephen L. Mayo, Ph.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Paul B. Rothman, M.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Patricia F. RussoDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Christine E. Seidman, M.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Inge G. ThulinDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Election of Directors: Kathy J. WardenDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Non-binding advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Ratification of the appointment of the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER600000.0000000FOR600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Shareholder proposal regarding a report on DEI risks in federal contracting.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER600000.0000000AGAINST600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Shareholder proposal regarding a report on healthcare coverage gaps.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER600000.0000000AGAINST600000.000000FORS000005329Merck & Co., Inc.58933Y105US58933Y105505/26/2026Shareholder proposal regarding a report on political contributions.OTHER SOCIAL ISSUESSECURITY HOLDER600000.0000000AGAINST600000.000000FORS000005329Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.DIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D.DIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Nancy J. WysenskiDIRECTOR ELECTIONSISSUER285000.0000000FOR285000.000000FORS000005329Cytokinetics, Incorporated23282W605US23282W605705/27/2026To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock.COMPENSATIONISSUER285000.0000000FOR285000.000000FORS000005329Cytokinetics, Incorporated23282W605US23282W605705/27/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER285000.0000000FOR285000.000000FORS000005329Cytokinetics, Incorporated23282W605US23282W605705/27/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER285000.0000000FOR285000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2026.AUDIT-RELATEDISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.AUDIT-RELATEDISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2026.AUDIT-RELATEDISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2025.CORPORATE GOVERNANCEISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on 26 to 56 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on A7 to A18 of Annex A).COMPENSATIONISSUER260000.0000000FOR260000.000000FORS000005329Immunocore Holdings Plc45258D105US45258D105405/27/2026To authorize the Company to make political donations/incur political expenditure.OTHER SOCIAL ISSUESISSUER260000.0000000FOR260000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: C. Noel Bairey Merz, M.D.DIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Quentin BlackfordDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Bruce BodakenDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karen LingDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karen McGinnisDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Kevin O'BoyleDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jason PattenDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Abhijit TalwalkarDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brian YoorDIRECTOR ELECTIONSISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To approve the adoption of our 2026 Equity Incentive Plan.COMPENSATIONISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision.CORPORATE GOVERNANCEISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER74000.0000000FOR74000.000000FORS000005329iRhythm Holdings, Inc.450056106US450056106705/27/2026To approve, on a non-binding advisory basis, the named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER74000.0000000FOR74000.000000FORS000005329Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Mark McKennaDIRECTOR ELECTIONSISSUER390600.00000089400.000000FOR390600.000000FORS000005329Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Cameron Turtle, D.Phil.DIRECTOR ELECTIONSISSUER390600.00000089400.000000FOR390600.000000FORS000005329Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Laurie StelzerDIRECTOR ELECTIONSISSUER390600.00000089400.000000FOR390600.000000FORS000005329Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER390600.00000089400.000000FOR390600.000000FORS000005329Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER390600.00000089400.000000FOR390600.000000FORS000005329Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To approve the Company's amended and restated 2016 Employee Stock Purchase Plan.COMPENSATIONISSUER390600.00000089400.000000FOR390600.000000FORS000005329Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. DableDIRECTOR ELECTIONSISSUER140000.0000000FOR140000.000000FORS000005329Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E.DIRECTOR ELECTIONSISSUER140000.0000000FOR140000.000000FORS000005329Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert MoreDIRECTOR ELECTIONSISSUER140000.0000000FOR140000.000000FORS000005329Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER140000.0000000FOR140000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. BiggarDIRECTOR ELECTIONSISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley ColeDIRECTOR ELECTIONSISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. QuartDIRECTOR ELECTIONSISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025.CORPORATE GOVERNANCEISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025.COMPENSATIONISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve the Company's UK Statutory Directors' Remuneration Policy.COMPENSATIONISSUER380000.0000000FOR380000.000000FORS000005329Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER380000.0000000FOR380000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: Charles BakerDIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: Timothy FlynnDIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: Paul GarciaDIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: Kristen GilDIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: Scott Gottlieb, M.D.DIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: Stephen HemsleyDIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: F. William McNabb IIIDIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: Valerie Montgomery Rice, M.D.DIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Election of Directors: John Noseworthy, M.D.DIRECTOR ELECTIONSISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Advisory approval of the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026.AUDIT-RELATEDISSUER135000.0000000FOR135000.000000FORS000005329UnitedHealth Group Incorporated91324P102US91324P102106/01/2026If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent.CORPORATE GOVERNANCESECURITY HOLDER135000.0000000AGAINST135000.000000FORS000005329Waystar Holding Corp.946784105US946784105506/01/2026Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: Robert A. DeMichieiDIRECTOR ELECTIONSISSUER871667.0000000FOR871667.000000FORS000005329Waystar Holding Corp.946784105US946784105506/01/2026Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: John DriscollDIRECTOR ELECTIONSISSUER871667.0000000FOR871667.000000FORS000005329Waystar Holding Corp.946784105US946784105506/01/2026Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: Paul G. MoskowitzDIRECTOR ELECTIONSISSUER871667.0000000FOR871667.000000FORS000005329Waystar Holding Corp.946784105US946784105506/01/2026Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: Lauren YoungDIRECTOR ELECTIONSISSUER871667.0000000FOR871667.000000FORS000005329Waystar Holding Corp.946784105US946784105506/01/2026Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER871667.0000000FOR871667.000000FORS000005329Waystar Holding Corp.946784105US946784105506/01/2026Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER871667.0000000ONE YEAR871667.000000FORS000005329LifeStance Health Group, Inc.53228F101US53228F101206/02/2026Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: David BourdonDIRECTOR ELECTIONSISSUER2500000.0000000WITHHOLD2500000.000000AGAINSTS000005329LifeStance Health Group, Inc.53228F101US53228F101206/02/2026Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Robert Bessler, M.D.DIRECTOR ELECTIONSISSUER2500000.0000000FOR2500000.000000FORS000005329LifeStance Health Group, Inc.53228F101US53228F101206/02/2026Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2026;AUDIT-RELATEDISSUER2500000.0000000FOR2500000.000000FORS000005329LifeStance Health Group, Inc.53228F101US53228F101206/02/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER2500000.0000000FOR2500000.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors.AUDIT-RELATEDISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: John W. Smither until the 2030 annual general meetingDIRECTOR ELECTIONSISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Janneke van der Kamp until the 2030 annual general meetingDIRECTOR ELECTIONSISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital.CAPITAL STRUCTUREISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Extension of authorization for the Board of Directors to limit or exclude pre-emption rights.CAPITAL STRUCTUREISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER100.000000349900.000000FOR100.000000FORS000005329NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Non-binding, advisory vote to approve the 2025 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER100.000000349900.000000FOR100.000000FORS000005329Oruka Therapeutics, Inc.687604108US687604108706/02/2026Election of Class II Directors for terms expiring in 2029: Lawrence KleinDIRECTOR ELECTIONSISSUER496400.00000063600.000000FOR496400.000000FORS000005329Oruka Therapeutics, Inc.687604108US687604108706/02/2026Election of Class II Directors for terms expiring in 2029: Chris MartinDIRECTOR ELECTIONSISSUER496400.00000063600.000000FOR496400.000000FORS000005329Oruka Therapeutics, Inc.687604108US687604108706/02/2026To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER496400.00000063600.000000FOR496400.000000FORS000005329Oruka Therapeutics, Inc.687604108US687604108706/02/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER496400.00000063600.000000FOR496400.000000FORS000005329Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Tomas KiselakDIRECTOR ELECTIONSISSUER1250400.0000000FOR1250400.000000FORS000005329Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jennifer K. MosesDIRECTOR ELECTIONSISSUER1250400.0000000FOR1250400.000000FORS000005329Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1250400.0000000FOR1250400.000000FORS000005329Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1250400.0000000FOR1250400.000000FORS000005329Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1250400.0000000ONE YEAR1250400.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn SvoronosDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian CannonDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven GannonDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth GarofaloDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin GoverDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick MachadoDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian MortimerDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary PatouDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER600000.0000000ONE YEAR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve the Corporation's 2026 Equity Incentive Plan;COMPENSATIONISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To appoint PricewaterhouseCoopers LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation;AUDIT-RELATEDISSUER600000.0000000FOR600000.000000FORS000005329Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation; andAUDIT-RELATEDISSUER600000.0000000FOR600000.000000FORS000005329Acumen Pharmaceuticals, Inc.00509G209US00509G209306/03/2026To elect three Class II directors to the Board of Directors, each to hold office until the 2029 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: George Golumbeski, Ph.D.DIRECTOR ELECTIONSISSUER357420.0000000FOR357420.000000FORS000005329Acumen Pharmaceuticals, Inc.00509G209US00509G209306/03/2026To elect three Class II directors to the Board of Directors, each to hold office until the 2029 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: Derrell Porter, M.D.DIRECTOR ELECTIONSISSUER357420.0000000FOR357420.000000FORS000005329Acumen Pharmaceuticals, Inc.00509G209US00509G209306/03/2026To elect three Class II directors to the Board of Directors, each to hold office until the 2029 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: Laura Stoppel, Ph.D.DIRECTOR ELECTIONSISSUER357420.0000000FOR357420.000000FORS000005329Acumen Pharmaceuticals, Inc.00509G209US00509G209306/03/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER357420.0000000FOR357420.000000FORS000005329Acumen Pharmaceuticals, Inc.00509G209US00509G209306/03/2026To approve the Company's Amended and Restated 2021 Equity Incentive Plan.COMPENSATIONISSUER357420.0000000FOR357420.000000FORS000005329Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: G. Clare Kahn, Ph.D.DIRECTOR ELECTIONSISSUER350000.0000000FOR350000.000000FORS000005329Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D.DIRECTOR ELECTIONSISSUER350000.0000000WITHHOLD350000.000000AGAINSTS000005329Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne SmithDIRECTOR ELECTIONSISSUER350000.0000000WITHHOLD350000.000000AGAINSTS000005329Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER350000.0000000FOR350000.000000FORS000005329Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER350000.0000000AGAINST350000.000000AGAINSTS000005329Trevi Therapeutics, Inc.89532M101US89532M101806/03/2026Election of one Class I director to our Board of Directors, to serve until the 2029 Annual Meeting of Stockholders: Michael HeffernanDIRECTOR ELECTIONSISSUER500000.0000000FOR500000.000000FORS000005329Trevi Therapeutics, Inc.89532M101US89532M101806/03/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER500000.0000000FOR500000.000000FORS000005329Trevi Therapeutics, Inc.89532M101US89532M101806/03/2026Approval, on an advisory basis, of the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER500000.0000000FOR500000.000000FORS000005329Trevi Therapeutics, Inc.89532M101US89532M101806/03/2026Approval of the Trevi Therapeutics, Inc. Amended and Restated 2019 Stock Incentive Plan.COMPENSATIONISSUER500000.0000000FOR500000.000000FORS000005329Trevi Therapeutics, Inc.89532M101US89532M101806/03/2026Approval of an amendment to our Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares.CAPITAL STRUCTUREISSUER500000.0000000FOR500000.000000FORS00000532910x Genomics, Inc.88025U109US88025U109706/04/2026Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Serge SaxonovDIRECTOR ELECTIONSISSUER950000.0000000FOR950000.000000FORS00000532910x Genomics, Inc.88025U109US88025U109706/04/2026Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Benjamin J. HindsonDIRECTOR ELECTIONSISSUER950000.0000000FOR950000.000000FORS00000532910x Genomics, Inc.88025U109US88025U109706/04/2026Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: John R. StuelpnagelDIRECTOR ELECTIONSISSUER950000.0000000FOR950000.000000FORS00000532910x Genomics, Inc.88025U109US88025U109706/04/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER950000.0000000FOR950000.000000FORS00000532910x Genomics, Inc.88025U109US88025U109706/04/2026A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER950000.0000000FOR950000.000000FORS000005329Alignment Healthcare, Inc.01625V104US01625V104406/04/2026Election of Directors: Jody BilneyDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329Alignment Healthcare, Inc.01625V104US01625V104406/04/2026Election of Directors: David HodgsonDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329Alignment Healthcare, Inc.01625V104US01625V104406/04/2026Election of Directors: Jacqueline KosecoffDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329Alignment Healthcare, Inc.01625V104US01625V104406/04/2026Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026AUDIT-RELATEDISSUER1000000.0000000FOR1000000.000000FORS000005329Alignment Healthcare, Inc.01625V104US01625V104406/04/2026Approval, on an non-binding, advisory basis, of the compensation of our Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER1000000.0000000FOR1000000.000000FORS000005329Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D.DIRECTOR ELECTIONSISSUER715000.0000000FOR715000.000000FORS000005329Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul FonteyneDIRECTOR ELECTIONSISSUER715000.0000000FOR715000.000000FORS000005329Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER715000.0000000FOR715000.000000FORS000005329Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER715000.0000000FOR715000.000000FORS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: David Dean HalbertDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Brian J. BrilleDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Peter M. CastlemanDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: David FredericksonDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Joseph E. GilliamDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Jon S. HalbertDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Laura I. JohansenDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Lloyd B. Minor, M.D.DIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Danny PhillipsDIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026Election of Directors: Jeffrey Vacirca, M.D.DIRECTOR ELECTIONSISSUER1670000.0000000WITHHOLD1670000.000000AGAINSTS000005329Caris Life Sciences, Inc.142152107US142152107106/04/2026To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1670000.0000000FOR1670000.000000FORS000005329CG Oncology, Inc.156944100US156944100906/04/2026To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina RossiDIRECTOR ELECTIONSISSUER300000.0000000FOR300000.000000FORS000005329CG Oncology, Inc.156944100US156944100906/04/2026To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr.DIRECTOR ELECTIONSISSUER300000.0000000FOR300000.000000FORS000005329CG Oncology, Inc.156944100US156944100906/04/2026To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER300000.0000000FOR300000.000000FORS000005329CG Oncology, Inc.156944100US156944100906/04/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER300000.0000000FOR300000.000000FORS000005329CG Oncology, Inc.156944100US156944100906/04/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER300000.0000000ONE YEAR300000.000000FORS000005329MBX Biosciences, Inc.55287L101US55287L101706/04/2026Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. HeronDIRECTOR ELECTIONSISSUER246720.0000000FOR246720.000000FORS000005329MBX Biosciences, Inc.55287L101US55287L101706/04/2026Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. MathersDIRECTOR ELECTIONSISSUER246720.0000000FOR246720.000000FORS000005329MBX Biosciences, Inc.55287L101US55287L101706/04/2026Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2026.AUDIT-RELATEDISSUER246720.0000000FOR246720.000000FORS000005329Outset Medical, Inc.690145206US690145206906/04/2026Election of Class III Directors: Brent D. LangDIRECTOR ELECTIONSISSUER800000.0000000FOR800000.000000FORS000005329Outset Medical, Inc.690145206US690145206906/04/2026Election of Class III Directors: Karen PrangeDIRECTOR ELECTIONSISSUER800000.0000000FOR800000.000000FORS000005329Outset Medical, Inc.690145206US690145206906/04/2026To approve, on a non-binding basis, the 2025 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER800000.0000000FOR800000.000000FORS000005329Outset Medical, Inc.690145206US690145206906/04/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER800000.0000000FOR800000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Pablo LegorretaDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Ted Love, M.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Bonnie Bassler, Ph.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Vlad Coric, M.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Catherine EngelbertDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Carole Ho, M.D.DIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: David HodgsonDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Gregory NordenDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Election of Directors: Elizabeth WeathermanDIRECTOR ELECTIONSISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026A non-binding advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm.AUDIT-RELATEDISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Approve receipt of our U.K. audited annual report and accounts and related directors' and auditor's reports for the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Approve on a non-binding advisory basis our U.K. directors' remuneration report for the fiscal year ended December 31, 2025.COMPENSATIONISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Re-appoint Ernst & Young as our U.K. statutory auditor, to hold office until the conclusion of the next general meeting at which the U.K. annual report and accounts are presented to shareholders.AUDIT-RELATEDISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Authorize the Board to determine the remuneration of Ernst & Young in its capacity as our U.K. statutory auditor.AUDIT-RELATEDISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Approve the terms of the agreements and counterparties pursuant to which we may purchase our Class A ordinary shares.CAPITAL STRUCTUREISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Authorize the Board to allot shares.CAPITAL STRUCTUREISSUER600000.0000000FOR600000.000000FORS000005329Royalty Pharma plcG7709Q104GB00BMVP7Y0906/04/2026Authorize the Board to allot shares without rights of pre-emption (special resolution).CAPITAL STRUCTUREISSUER600000.0000000FOR600000.000000FORS000005329Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David HallalDIRECTOR ELECTIONSISSUER122635.0000000FOR122635.000000FORS000005329Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Kristina BurowDIRECTOR ELECTIONSISSUER122635.0000000FOR122635.000000FORS000005329Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Michael GilmanDIRECTOR ELECTIONSISSUER122635.0000000FOR122635.000000FORS000005329Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie PengDIRECTOR ELECTIONSISSUER122635.0000000FOR122635.000000FORS000005329Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER122635.0000000FOR122635.000000FORS000005329Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER122635.0000000FOR122635.000000FORS000005329Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026Election of Directors: Mark SaadDIRECTOR ELECTIONSISSUER112000.0000000FOR112000.000000FORS000005329Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026Election of Directors: Susan Mahony, Ph.D., MBADIRECTOR ELECTIONSISSUER112000.0000000FOR112000.000000FORS000005329Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER112000.0000000FOR112000.000000FORS000005329Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER112000.0000000FOR112000.000000FORS000005329Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: Mark C. McKennaDIRECTOR ELECTIONSISSUER55316.0000000FOR55316.000000FORS000005329Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: Jennifer FoxDIRECTOR ELECTIONSISSUER55316.0000000FOR55316.000000FORS000005329Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: William (BJ) Jones, Jr.DIRECTOR ELECTIONSISSUER55316.0000000FOR55316.000000FORS000005329Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER55316.0000000FOR55316.000000FORS000005329Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER55316.0000000FOR55316.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. FreireDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. HawkinsDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. LangerDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. MantasDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd MinorDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas PangalosDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish PatolawalaDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. RowinskyDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. SherwinDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. ViehbacherDIRECTOR ELECTIONSISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER28000.0000000FOR28000.000000FORS000005329Biogen Inc.09062X103US09062X103706/09/2026Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER28000.0000000FOR28000.000000FORS000005329Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris CainDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. MorrisDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd ShegogDIRECTOR ELECTIONSISSUER1000000.0000000FOR1000000.000000FORS000005329Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1000000.0000000FOR1000000.000000FORS000005329Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1000000.0000000FOR1000000.000000FORS000005329Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Richard Fair, M.B.A.DIRECTOR ELECTIONSISSUER269000.000000359000.000000FOR269000.000000FORS000005329Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D.DIRECTOR ELECTIONSISSUER269000.000000359000.000000FOR269000.000000FORS000005329Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER269000.000000359000.000000FOR269000.000000FORS000005329Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares.CAPITAL STRUCTUREISSUER269000.000000359000.000000FOR269000.000000FORS000005329Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER269000.000000359000.000000FOR269000.000000FORS000005329Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER269000.000000359000.000000ONE YEAR269000.000000FORS000005329Immunome, Inc.45257U108US45257U108806/09/2026To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: James BoylanDIRECTOR ELECTIONSISSUER32971.0000000FOR32971.000000FORS000005329Immunome, Inc.45257U108US45257U108806/09/2026To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Sandra Swain, M.D.DIRECTOR ELECTIONSISSUER32971.0000000FOR32971.000000FORS000005329Immunome, Inc.45257U108US45257U108806/09/2026To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Philip WagenheimDIRECTOR ELECTIONSISSUER32971.0000000FOR32971.000000FORS000005329Immunome, Inc.45257U108US45257U108806/09/2026To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER32971.0000000FOR32971.000000FORS000005329Immunome, Inc.45257U108US45257U108806/09/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER32971.0000000FOR32971.000000FORS000005329Immunome, Inc.45257U108US45257U108806/09/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER32971.0000000ONE YEAR32971.000000FORS000005329Jade Biosciences, Inc.008064206US008064206106/09/2026To elect two Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Christopher Cain, Ph.D.DIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Jade Biosciences, Inc.008064206US008064206106/09/2026To elect two Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Tom FrohlichDIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Jade Biosciences, Inc.008064206US008064206106/09/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER280000.0000000FOR280000.000000FORS000005329Jade Biosciences, Inc.008064206US008064206106/09/2026To approve an amendment to our Articles of Incorporation to waive jury trials in certain circumstances; andCORPORATE GOVERNANCEISSUER280000.0000000FOR280000.000000FORS000005329Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. IngramDIRECTOR ELECTIONSISSUER300000.0000000FOR300000.000000FORS000005329Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Claire Mazumdar, Ph.D.DIRECTOR ELECTIONSISSUER300000.0000000FOR300000.000000FORS000005329Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER300000.0000000FOR300000.000000FORS000005329Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER300000.0000000FOR300000.000000FORS000005329Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000; andCAPITAL STRUCTUREISSUER300000.0000000FOR300000.000000FORS000005329Upstream Bio, Inc.91678A107US91678A107906/09/2026To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSISSUER400000.0000000FOR400000.000000FORS000005329Upstream Bio, Inc.91678A107US91678A107906/09/2026To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: Liam Ratcliffe, M.B.Ch.B., Ph.D.DIRECTOR ELECTIONSISSUER400000.0000000FOR400000.000000FORS000005329Upstream Bio, Inc.91678A107US91678A107906/09/2026To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER400000.0000000FOR400000.000000FORS000005329Ocular Therapeutix, Inc.67576A100US67576A100706/10/2026To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Pravin U. Dugel, M.D.DIRECTOR ELECTIONSISSUER277371.0000000FOR277371.000000FORS000005329Ocular Therapeutix, Inc.67576A100US67576A100706/10/2026To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Merilee RainesDIRECTOR ELECTIONSISSUER277371.0000000FOR277371.000000FORS000005329Ocular Therapeutix, Inc.67576A100US67576A100706/10/2026To approve an advisory vote on named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER277371.0000000FOR277371.000000FORS000005329Ocular Therapeutix, Inc.67576A100US67576A100706/10/2026To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER277371.0000000ONE YEAR277371.000000FORS000005329Ocular Therapeutix, Inc.67576A100US67576A100706/10/2026To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares.COMPENSATIONISSUER277371.0000000FOR277371.000000FORS000005329Ocular Therapeutix, Inc.67576A100US67576A100706/10/2026To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER277371.0000000FOR277371.000000FORS000005329Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory NordenDIRECTOR ELECTIONSISSUER53000.0000000FOR53000.000000FORS000005329Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio SouzaDIRECTOR ELECTIONSISSUER53000.0000000FOR53000.000000FORS000005329Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungDIRECTOR ELECTIONSISSUER53000.0000000FOR53000.000000FORS000005329Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER53000.0000000FOR53000.000000FORS000005329Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.SECTION 14A SAY-ON-PAY VOTESISSUER53000.0000000FOR53000.000000FORS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Robert W. DugganDIRECTOR ELECTIONSISSUER193800.000000306200.000000WITHHOLD193800.000000AGAINSTS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Mahkam ZanganehDIRECTOR ELECTIONSISSUER193800.000000306200.000000WITHHOLD193800.000000AGAINSTS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Manmeet S. SoniDIRECTOR ELECTIONSISSUER193800.000000306200.000000WITHHOLD193800.000000AGAINSTS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Kenneth A. ClarkDIRECTOR ELECTIONSISSUER193800.000000306200.000000WITHHOLD193800.000000AGAINSTS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Robert BoothDIRECTOR ELECTIONSISSUER193800.000000306200.000000FOR193800.000000FORS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Alessandra CesanoDIRECTOR ELECTIONSISSUER193800.000000306200.000000FOR193800.000000FORS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Yu (Michelle) XiaDIRECTOR ELECTIONSISSUER193800.000000306200.000000WITHHOLD193800.000000AGAINSTS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Mostafa RonaghiDIRECTOR ELECTIONSISSUER193800.000000306200.000000FOR193800.000000FORS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Jeff HuberDIRECTOR ELECTIONSISSUER193800.000000306200.000000FOR193800.000000FORS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER193800.000000306200.000000FOR193800.000000FORS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026Approval, by a non-binding advisory vote, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER193800.000000306200.000000FOR193800.000000FORS000005329Summit Therapeutics Inc.86627T108US86627T108806/10/2026Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock.COMPENSATIONISSUER193800.000000306200.000000AGAINST193800.000000AGAINSTS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav BarrDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna BhanjiDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin EasthamDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. EpsteinDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens HolsteinDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan JonesDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom MillerDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent ShaferDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc StapleyDIRECTOR ELECTIONSISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER670000.0000000FOR670000.000000FORS000005329Veracyte, Inc.92337F107US92337F107506/10/2026The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan.COMPENSATIONISSUER670000.0000000FOR670000.000000FORS000005329Annexon, Inc.03589W102US03589W102706/11/2026To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Bettina M. Cockroft, M.D.DIRECTOR ELECTIONSISSUER750000.0000000FOR750000.000000FORS000005329Annexon, Inc.03589W102US03589W102706/11/2026To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Douglas Love, Esq.DIRECTOR ELECTIONSISSUER750000.0000000FOR750000.000000FORS000005329Annexon, Inc.03589W102US03589W102706/11/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER750000.0000000FOR750000.000000FORS000005329Annexon, Inc.03589W102US03589W102706/11/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER750000.0000000FOR750000.000000FORS000005329Annexon, Inc.03589W102US03589W102706/11/2026To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000.CAPITAL STRUCTUREISSUER750000.0000000FOR750000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the audited Swiss statutory standalone financial statements and the audited Swiss statutory consolidated financial statements of the Company for fiscal year 2025 be and are hereby approved.CORPORATE GOVERNANCEISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the appropriation of the accumulated loss for fiscal year 2025 be and is hereby approved.CAPITAL STRUCTUREISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the members of the Board of Directors and the Executive Management Team be and are hereby discharged from liability for activities during the applicable period under Swiss law.CORPORATE GOVERNANCEISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Olivier Brandicourt be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Mr. Anthony C. Hooper be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Mr. John V. Oyler be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Alessandro Riva be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000AGAINST46000.000000AGAINSTS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Ms. Shalini Sharp be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Xiaodong Wang be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Felix J. Baker be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Charles L. Sawyers be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a member of the Compensation Committee of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a member of the Compensation Committee of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Schweiger Advokatur/Notariat be and is hereby elected to serve as the Independent Voting Representative for a one-year term ending at the closing of the 2027 annual general meeting of shareholders, including any extraordinary general meeting of shareholders prior to the 2027 annual general meeting of shareholders.CORPORATE GOVERNANCEISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 be and is hereby ratified, and Ernst & Young AG be and is hereby re-elected as the Company's statutory auditor for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Board of Directors is hereby authorized to fix the auditors' compensation for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, the maximum aggregate compensation for the Board of Directors for the period between the 2026 annual general meeting and the 2027 annual general meeting, be and is hereby approved.COMPENSATIONISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, the maximum aggregate compensation for the Executive Management Team for fiscal year 2027 be and is hereby approved.COMPENSATIONISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, on an advisory basis, the Swiss Statutory Compensation Report for the fiscal year ended December 31, 2025 be and is hereby approved.COMPENSATIONISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, on an advisory basis, the Swiss Statutory Non-Financial Matters Report for the fiscal year ended December 31, 2025 be and is hereby approved.CORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approved.COMPENSATIONISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the consultant sublimit in the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approvedCOMPENSATIONISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Sixth Amended and Restated 2018 Employee Share Purchase Plan be and is hereby approved.COMPENSATIONISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.CAPITAL STRUCTUREISSUER46000.0000000AGAINST46000.000000AGAINSTS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the granting of a share repurchase mandate to the Board of Directors to repurchase an amount of ordinary shares (excluding the Company's ordinary shares listed on the Science and Technology Innovation Board of Shanghai Stock Exchange and traded in RMB ("RMB shares")) and/or ADSs, not exceeding 10% of the total number of issued ordinary shares (excluding RMB shares and treasury shares) of the Company as of the date of passing of this resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.CAPITAL STRUCTUREISSUER46000.0000000FOR46000.000000FORS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 17 for a period of five years, which period will be subject to an extension on a rolling basis each year.CAPITAL STRUCTUREISSUER46000.0000000AGAINST46000.000000AGAINSTS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the adjournment of the Annual Meeting by the chairman, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals described above, be and is hereby approved.CORPORATE GOVERNANCEISSUER46000.0000000AGAINST46000.000000AGAINSTS000005329BeOne Medicines Ltd.07725L102US07725L102606/11/2026If new or modified agenda items (other than those in the invitation to the Annual Meeting and the 2026 Proxy Statement of the Company) or new or modified proposals or motions with respect to the agenda items listed in the invitation to the Annual Meeting and the 2026 Proxy Statement of the Company are presented at the Annual Meeting, I instruct the Independent Voting Representative to vote in favor of the recommendations of the Board (For), against the proposals (Against) or abstain (Abstain) as follows:CORPORATE GOVERNANCEISSUER46000.0000000AGAINST46000.000000AGAINSTS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Charles N. MillsDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Joseph P. BarattaDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Jacob D. BestDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Todd M. BluedornDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: James M. BoyleDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Richard A. GalantiDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Patrick J. HealyDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Andrew J. MillsDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Robert R. SchmidtDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Anushka M. SunderDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Thomas W. SweetDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Elect Directors: Stephen H. WiseDIRECTOR ELECTIONSISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Advisory Vote to Approve Our Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER620000.0000000FOR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Advisory Vote on the Frequency of Votes on Our Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER620000.0000000ONE YEAR620000.000000FORS000005329Medline Inc.58507V107US58507V107006/11/2026Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026.AUDIT-RELATEDISSUER620000.0000000FOR620000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Rowan ChapmanDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Herm RosenmanDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Jonathan SheenaDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class I Nominee: Eric H. RubinDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER100000.0000000FOR100000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER100000.0000000FOR100000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER100000.0000000ONE YEAR100000.000000FORS000005329Natera, Inc.632307104US632307104206/11/2026To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated.COMPENSATIONISSUER100000.0000000AGAINST100000.000000AGAINSTS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint as a director Carol Stuckley, M.B.A., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint as a director Brett Zbar, M.D., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint as a director Mathias Hukkelhoven, Ph.D., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint KPMG LLP, a United Kingdom entity, as UK statutory auditors of the Company, to hold office until the conclusion of the next meeting at which the Company's annual accounts and reports are laid before the Company.AUDIT-RELATEDISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To ratify the re-appointment of KPMG LLP, a Delaware limited liability partnership, as the Company's independent registered public accounting firm, for the financial year ending December 31, 2026.AUDIT-RELATEDISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To authorize the Audit Committee to determine the Company's auditors' remuneration for the financial year ending December 31, 2026.AUDIT-RELATEDISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To receive and adopt our UK statutory annual accounts and reports for the financial year ended December 31, 2025 and to note that the Company's directors do not recommend the payment of any dividend for the financial year ended December 31, 2025.CORPORATE GOVERNANCEISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To receive and approve, on an advisory basis, the Company's U.K. statutory directors' remuneration report for the financial year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement.COMPENSATIONISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026IMPORTANT: if you wish to vote FOR the Scheme, sign your name in the box marked "FOR the Scheme", or if you wish to vote AGAINST the Scheme, sign your name in the box marked "AGAINST the Scheme". If you sign in both boxes, or if you do not sign in either, then this Form of Proxy will be invalid.EXTRAORDINARY TRANSACTIONSISSUER280000.0000000FOR280000.000000FORS000005329Centessa Pharmaceuticals Plc152309100US152309100706/12/2026For the purposes of giving effect to the Scheme: (a) to authorise the directors of the Company (or a duly authorised committee thereof) to take all such actions as they may consider necessary or appropriate for carrying the Scheme into effect; and (b) with effect from the passing of this resolution, to amend the articles of association of the Company as set out in the Notice of General Meeting.CORPORATE GOVERNANCEISSUER280000.0000000FOR280000.000000FORS000005329Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy WalbertDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER100000.0000000FOR100000.000000FORS000005329Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER100000.0000000FOR100000.000000FORS000005329Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D.DIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Halley Gilbert, J.D.DIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Grant E. Pickering, M.B.A.DIRECTOR ELECTIONSISSUER540000.0000000FOR540000.000000FORS000005329Vaxcyte, Inc.92243G108US92243G108506/15/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER540000.0000000FOR540000.000000FORS000005329Vaxcyte, Inc.92243G108US92243G108506/15/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER540000.0000000FOR540000.000000FORS000005329HeartFlow, Inc.42238D107US42238D107206/16/2026Election of the two nominees as Class I directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Julie A. CullivanDIRECTOR ELECTIONSISSUER500000.0000000FOR500000.000000FORS000005329HeartFlow, Inc.42238D107US42238D107206/16/2026Election of the two nominees as Class I directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: John C.M. FarquharDIRECTOR ELECTIONSISSUER500000.0000000FOR500000.000000FORS000005329HeartFlow, Inc.42238D107US42238D107206/16/2026The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER500000.0000000FOR500000.000000FORS000005329Nuvalent, Inc.670703107US670703107506/16/2026Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D.DIRECTOR ELECTIONSISSUER360000.0000000FOR360000.000000FORS000005329Nuvalent, Inc.670703107US670703107506/16/2026Election of the following nominees as Class II directors: Ron SquarerDIRECTOR ELECTIONSISSUER360000.0000000FOR360000.000000FORS000005329Nuvalent, Inc.670703107US670703107506/16/2026To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER360000.0000000FOR360000.000000FORS000005329Nuvalent, Inc.670703107US670703107506/16/2026To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER360000.0000000FOR360000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Matthew P. YoungDIRECTOR ELECTIONSISSUER2500000.0000000FOR2500000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Elaine V. Jones, Ph.D.DIRECTOR ELECTIONSISSUER2500000.0000000FOR2500000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER2500000.0000000FOR2500000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares;CAPITAL STRUCTUREISSUER2500000.0000000FOR2500000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan;COMPENSATIONISSUER2500000.0000000FOR2500000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated Employee Stock Purchase Plan;COMPENSATIONISSUER2500000.0000000FOR2500000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; andSECTION 14A SAY-ON-PAY VOTESISSUER2500000.0000000FOR2500000.000000FORS000005329CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2500000.0000000ONE YEAR2500000.000000FORS000005329Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026Election of Class III director nominees to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Michael LandsittelDIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026Election of Class III director nominees to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Cameron Turtle, D. Phil.DIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER280000.0000000FOR280000.000000FORS000005329Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026To conduct an advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER280000.0000000ONE YEAR280000.000000FORS000005329Damora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER280000.0000000FOR280000.000000FORS000005329Guardant Health, Inc.40131M109US40131M109906/17/2026Election of Class II Directors: Ian ClarkDIRECTOR ELECTIONSISSUER200000.0000000FOR200000.000000FORS000005329Guardant Health, Inc.40131M109US40131M109906/17/2026Election of Class II Directors: Manuel Hidalgo MedinaDIRECTOR ELECTIONSISSUER200000.0000000FOR200000.000000FORS000005329Guardant Health, Inc.40131M109US40131M109906/17/2026Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER200000.0000000FOR200000.000000FORS000005329Guardant Health, Inc.40131M109US40131M109906/17/2026Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER200000.0000000FOR200000.000000FORS000005329Guardant Health, Inc.40131M109US40131M109906/17/2026Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER200000.0000000ONE YEAR200000.000000FORS000005329Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Sean Bohen, M.D., Ph.D.DIRECTOR ELECTIONSISSUER750000.0000000FOR750000.000000FORS000005329Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Scott GarlandDIRECTOR ELECTIONSISSUER750000.0000000FOR750000.000000FORS000005329Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Yi LarsonDIRECTOR ELECTIONSISSUER750000.0000000FOR750000.000000FORS000005329Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Andrew RappaportDIRECTOR ELECTIONSISSUER750000.0000000FOR750000.000000FORS000005329Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER750000.0000000FOR750000.000000FORS000005329Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER750000.0000000FOR750000.000000FORS000005329Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Ted W. Love, M.D.DIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Raymond Stevens, Ph.D.DIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Daniel G. WelchDIRECTOR ELECTIONSISSUER280000.0000000FOR280000.000000FORS000005329Structure Therapeutics Inc.86366E106US86366E106406/17/2026To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER280000.0000000FOR280000.000000FORS000005329Structure Therapeutics Inc.86366E106US86366E106406/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER280000.0000000FOR280000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Tim CabralDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark CargesDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Peter P. GassnerDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mary Lynne HedleyDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Priscilla HungDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Marshall MohrDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon RitterDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Paul SekhriDIRECTOR ELECTIONSISSUER100000.0000000FOR100000.000000FORS000005329Veeva Systems Inc.922475108US922475108406/17/2026To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Matthew J. WallachDIRECTOR ELECTIONSISSUER100000.0000000AGAINST100000.000000AGAINSTS000005329Veeva Systems Inc.922475108US922475108406/17/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027.AUDIT-RELATEDISSUER100000.0000000FOR100000.000000FORS000005329Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren DeardorfDIRECTOR ELECTIONSISSUER435200.000000234800.000000FOR435200.000000FORS000005329Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D.DIRECTOR ELECTIONSISSUER435200.000000234800.000000FOR435200.000000FORS000005329Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S.DIRECTOR ELECTIONSISSUER435200.000000234800.000000FOR435200.000000FORS000005329Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER435200.000000234800.000000FOR435200.000000FORS000005329Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; andSECTION 14A SAY-ON-PAY VOTESISSUER435200.000000234800.000000FOR435200.000000FORS000005329Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.DIRECTOR ELECTIONSISSUER345000.0000000FOR345000.000000FORS000005329Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D.DIRECTOR ELECTIONSISSUER345000.0000000FOR345000.000000FORS000005329Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D.DIRECTOR ELECTIONSISSUER345000.0000000FOR345000.000000FORS000005329Disc Medicine, Inc.254604101US254604101106/18/2026To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER345000.0000000FOR345000.000000FORS000005329Disc Medicine, Inc.254604101US254604101106/18/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER345000.0000000FOR345000.000000FORS000005329Revolution Medicines, Inc.76155X100US76155X100006/18/2026To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis BorisyDIRECTOR ELECTIONSISSUER90000.0000000FOR90000.000000FORS000005329Revolution Medicines, Inc.76155X100US76155X100006/18/2026To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Mark A. Goldsmith, M.D., Ph.D.DIRECTOR ELECTIONSISSUER90000.0000000FOR90000.000000FORS000005329Revolution Medicines, Inc.76155X100US76155X100006/18/2026To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER90000.0000000FOR90000.000000FORS000005329Revolution Medicines, Inc.76155X100US76155X100006/18/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER90000.0000000FOR90000.000000FORS000005329Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Bruce Booth, D.Phil.DIRECTOR ELECTIONSISSUER179800.00000045200.000000FOR179800.000000FORS000005329Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Nello Mainolfi, Ph.D.DIRECTOR ELECTIONSISSUER179800.00000045200.000000FOR179800.000000FORS000005329Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Maraganore, Ph.D.DIRECTOR ELECTIONSISSUER179800.00000045200.000000FOR179800.000000FORS000005329Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFADIRECTOR ELECTIONSISSUER179800.00000045200.000000FOR179800.000000FORS000005329Kymera Therapeutics, Inc.501575104US501575104406/24/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER179800.00000045200.000000FOR179800.000000FORS000005329Kymera Therapeutics, Inc.501575104US501575104406/24/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER179800.00000045200.000000FOR179800.000000FORS000005329Contineum Therapeutics, Inc.21217B100US21217B100806/26/2026To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Evert SchimmelpenninkDIRECTOR ELECTIONSISSUER53261.000000226739.000000FOR53261.000000FORS000005329Contineum Therapeutics, Inc.21217B100US21217B100806/26/2026To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Lori M. Lyons-WilliamsDIRECTOR ELECTIONSISSUER53261.000000226739.000000FOR53261.000000FORS000005329Contineum Therapeutics, Inc.21217B100US21217B100806/26/2026To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Diego Miralles, M.D.DIRECTOR ELECTIONSISSUER53261.000000226739.000000FOR53261.000000FORS000005329Contineum Therapeutics, Inc.21217B100US21217B100806/26/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER53261.000000226739.000000FOR53261.000000FORS000005329Pharvaris NVN69605108NL00150005Y406/26/2026Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER500000.0000000FOR500000.000000FORS000005329Pharvaris NVN69605108NL00150005Y406/26/2026Ratify PricewaterhouseCoopers Accountants N.V. as AuditorsAUDIT-RELATEDISSUER500000.0000000FOR500000.000000FORS000005329Pharvaris NVN69605108NL00150005Y406/26/2026Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER500000.0000000FOR500000.000000FORS000005329Pharvaris NVN69605108NL00150005Y406/26/2026Authorize Repurchase of Ordinary Shares and Depositary ReceiptsCAPITAL STRUCTUREISSUER500000.0000000FOR500000.000000FORS000005329Pharvaris NVN69605108NL00150005Y406/26/2026Reelect Margareta Elisabeth Bjork as Non-Executive DirectorDIRECTOR ELECTIONSISSUER500000.0000000FOR500000.000000FORS000005329Shoulder Innovations, Inc.82537J108US82537J108806/26/2026The election of the Class I directors: Robert BallDIRECTOR ELECTIONSISSUER310692.0000000WITHHOLD310692.000000AGAINSTS000005329Shoulder Innovations, Inc.82537J108US82537J108806/26/2026The election of the Class I directors: Andrew HykesDIRECTOR ELECTIONSISSUER310692.0000000FOR310692.000000FORS000005329Shoulder Innovations, Inc.82537J108US82537J108806/26/2026The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER310692.0000000FOR310692.000000FORS000005329Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: James B. Tananbaum, M.D.DIRECTOR ELECTIONSISSUER150700.0000000FOR150700.000000FORS000005329Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Lynn Tetrault, J.D.DIRECTOR ELECTIONSISSUER150700.0000000FOR150700.000000FORS000005329Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D.DIRECTOR ELECTIONSISSUER150700.0000000FOR150700.000000FORS000005329Alumis Inc.022307102US022307102006/30/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER150700.0000000FOR150700.000000FORS000005329Odfjell Drilling Ltd.G67180102BMG67180102207/22/2025Approve Remuneration Policy And Other Terms of Employment For Executive ManagementCOMPENSATIONISSUER349356.0000000AGAINST349356.000000AGAINSTS000005330Odfjell Drilling Ltd.G67180102BMG67180102207/22/2025Approve Issuance of Share Options to Simen LieunghCOMPENSATIONISSUER349356.0000000AGAINST349356.000000AGAINSTS000005330Subsea 7 SAL8882U106LU007564635509/25/2025Approve Cross Border MergerEXTRAORDINARY TRANSACTIONSISSUER54900.0000000FOR54900.000000FORS000005330Subsea 7 SAL8882U106LU007564635509/25/2025Approve Distribution of EUR 450,000,000 Out of the Company's Share PremiumCAPITAL STRUCTUREISSUER54900.0000000FOR54900.000000FORS000005330Subsea 7 SAL8882U106LU007564635509/25/2025Approve Distribution of EUR 105,000,000 Out of the Company's Share PremiumCAPITAL STRUCTUREISSUER54900.0000000FOR54900.000000FORS000005330Subsea 7 SAL8882U106LU007564635509/25/2025Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER54900.0000000FOR54900.000000FORS000005330Schlumberger N.V.806857108AN806857108610/07/2025Amendment of the Company's Articles of Incorporation to change the Company's name from Schlumberger N.V. to "SLB N.V.", and to permit that "SLB Limited" and "SLB Ltd." may be used abroad and in transactions with foreign entities, persons or organizations.CORPORATE GOVERNANCEISSUER849518.0000000FOR849518.000000FORS000005330Compass, Inc.20464U100US20464U100701/07/2026Approval of the Compass Share Issuance. To approve the issuance of Compass Class A common stock, par value $0.00001 per share, to Anywhere stockholders in connection with the merger contemplated by the Agreement and Plan of Merger, dated as of September 22, 2025, by and among Compass, Inc., Velocity Merger Sub, Inc. and Anywhere Real Estate Inc. (the agreement, which, as it may be amended from time to time, we refer to as the "merger agreement," and the proposal, which we refer to as the "Compass share issuance proposal"); andEXTRAORDINARY TRANSACTIONSISSUER162487.0000000FOR162487.000000FORS000005331Compass, Inc.20464U100US20464U100701/07/2026Adjournment of the Compass Special Meeting. To adjourn the Compass special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Compass special meeting to approve the Compass share issuance proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to Compass stockholders (which we refer to as the "Compass adjournment proposal").CORPORATE GOVERNANCEISSUER162487.0000000FOR162487.000000FORS000005331